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The main aim of this project was to develop a new synthetic methodology towards 
the total synthesis of the pentacyclic Stemona alkaloid stemocurtisine by first 
preparation of a tricyclic A-B-C ring precursor and then its tetracyclic ether 
derivative by an oxidative photolysis reaction.  
 
In Chapter 2, we report our efforts to construct the A-ring of stemocurtisine using 
three different synthetic strategies. Synthetic strategy 1 failed due to unexpected ring 
opening of the hemiaminal product formed from the reactions between alkynyl 
Grignard reagents and a glutarimide derivative. Synthetic strategy 2 was not efficient 
due to the unsucessful conversion of a terminal alkynyltrimethylsilane to its 
corresponding propiolate methyl ester following the method of Kondo. Using 
synthetic strategy 3 we obtained the racemic desired ene-yne lactam A-ring 
derivative in 11 synthetic steps and in 12.1% overall yield from 4-pentyne-1-ol. In 
Chapter 3, we describe our successful method to construct the bicyclic A-B ring 
system of stemocurtisine following Mori’s ene-yne ring-closing metathesis 
procedure. The successful synthesis of the tricyclic A-B-C ring system of 
stemocurtisine is also discussed in this chapter. The synthesis of this tricyclic 
compound was achieved via a bromolactonization process using NBS/PhSeSePh 
followed by a base-catalysed elimination of the resulting bromolactone. Our attempts 
to reduce the resulting α,β-unsaturated lactone to its saturated derivative were not 
initially successful using the standard reducing reagents NaBH4/NiCl2 or 
NaBH4/CuCl. However, reduction of this α,β-unsaturated lactone using Mg/MeOH 
provided the saturated lactone derivative as a single diastereomer having the desired 
relative configuration at C-1, C-3a, C-11, C-11a and C-11b as stemocurtisine. 
Making the ether bridge of stemocurtisine was examined on two different substrates, 
a tricyclic hydroxyl piperidinone and a tricyclic hydroxy piperidine. Treatment of the 
piperidinone substrate under oxidative photochemical conditions gave an unexpected 
aldehyde byproduct having an O-acetyl hemiaminal structure. Detailed NMR 
analysis of this compound indicated that the piperidinone had undergone oxidative 




tenuous since the NMR spectroscopic and the MS spectromertic data were not 
consistent. 
 
Chapter 4 reports on an alternative pathway to construct the A-B ring system and our 
attempts to make the A-B-C ring system of stemocurtisine. The key step of this 
approach involves the use of the borono-Mannich reaction to prepare a piperidine- 
diene. A RCM reaction of this compound led to the corresponding pyrrido[1,2-
a]azepine. Esterification of the hydroxyl group followed by epoxidation of this 
bicyclic compound resulted in the corresponding epoxide. Base-catalysed cylization 
was then attempted to convert this epoxide ester to a tricyclic compound. Under 
several reaction conditions this attempted cyclization was not successful and only the 
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CHAPTER 1: INTRODUCTION 
 
1.1 Stemona Alkaloids 
1.1.1 Introduction to the Stemona alkaloids 
 
The Stemona alkaloids represent a unique class of natural products exclusively 
isolated from the monocotyledonous family Stemonaceae, mainly distributed in 
South East Asia.1 Structurally the alkaloids are characterised by the presence of 
either a pyrrolo[1,2-a]azepine (Figure 1.1, n = 1), the most common type, or a 
pyrido[1,2-a]azepine core structure ( Figure 1.1, n = 2).2 
 
 
Figure 1.1: Core structure of the Stemona alkaloids 
 
The Stemonaceae family consists of three genera, Stemona, Croomia, and 
Stichoneuron, comprising about 30 species. These plants are found in South East 
Asia, Northern Australia, China, Japan, and Northern America. Stemona is the 
largest genus with about 25 species mainly occurring as twinning herbs with 
perennial tuberous roots. Many species prefer a seasonal climate and occur in rather 
dry areas.2 
 




Herbal extracts made from plants belonging to the Stemonaceae family have been 
used in folk medicine in East Asia for thousands of years, with three species of the 
Stemona genus (S. tuberosa, S. japonica and S. sessilifolia) being listed in the 2000 
edition of the Chinese Pharmacopoedia as antitussive medicinal herbs.4 In fact, the 
dried roots from these species, known as 'Bai Bu' in Chinese traditional medicine, 
'Bach Bo' in Vietnam and 'Non Tai Yak' or 'Pong Mot Ngam' in Thailand, are used to 
suppress coughing, and are claimed to have antituberculosis, antibacterial, antifungal 
and antihelmintic properties.5 
 
1.1.2   Structural classification 
 
Based on biosynthetic considerations Greger1 classified the Stemona alkaloids into 
three skeletal types: (I) stichoneurine-type (tuberostemonine-type); (II) 
protostemonine-type; and (III) croomine-type alkaloids. These three types differ by 








 In 2010 Pilli organized the Stemona alkaloids into eight different structural groups 
(Figure 1.4): stenine (I); stemoamide (II); tuberostemospironine (III); stemoamine 
(IV); parvistemoline (V); stemofoline (VI); stemocurtisine (VII); and a 
miscellaneous group (VIII), formed from those alkaloids which do not display the 
structural motifs mentioned above, or are the sole representative of a new group.2 
Groups I-VII are shown in Figure 1.4. Representative examples of the eight groups 













Figure 1.5: Representative alkaloids of the eight groups of Stemona alkaloids 
1.1.3 Isolation and bioactivities  
 
The first Stemona alkaloid isolated was tuberostemonine 1, from S. tuberosa by 
Suzuki6 in 1934, but only until 1967 was its structure fully elucidated.7 It was also 
the first Stemona alkaloid to be tested for its biological activity. The althelminthic 
activity of this alkaloid was determined against Angiostrongylus cantonensis, 
Dipylidium canium, and Fasciola hepatica. This alkaloid affected the mobility of 
these helminthic worms.8 Tuberostemonine was identified as the bioactive principle 




littoralis, with activity levels comparable to those of the commercial insecticide 
azadirachtin.9  
 
Figure 1.6: Tuberostemonine, the first isolated Stemona alkaloid 
 
More than 190 Stemona alkaloids have now been isolated and structurally elucidated, 
some of them have significant bioactivities.1,2a In this section, we discuss some 
recent publications concerned with both the isolation and biological activities of the 
Stemona alkaloids. 
 
The Pyne group and collaborators in Thailand isolated two new Stemona alkaloids, 
stemocurtisine 210 and stemocurtisinol 3,11 which possessed a new pyrido[1,2-
a]azepine skeleton, along with oxyprotosteminine 4 (Figure 1.7) from the roots of S. 
curtisii in 2003-2004. These compounds were shown to exhibit good larvicidal 
activity on malarial carrying mosquito larvae. The isolated alkaloids were 
significantly more active than the crude extract. Among them, oxyprotostemonine 4 
was the most potent (Table 1.1). 
 
  




Treatment LC50 (ppm) 
Ethanol crude extract 81 
        Stemocurtisine 2 18 
        Stemocurtisinol 3 39 
        Oxyprotostemonine 4 4 
 
Table 1.1: Larvicidal activity of S. curtisii extract and compounds 2-4 on mosquito 
larvae 11 
 
The Greger group isolated eight new Stemona alkaloids, stemokerrin 5, 
methoxystemokerrin-N-oxide 6, oxystemokerrin 7, oxystemokerrin-N-oxide 8, 
pyridostemin 9 (stemocurtisine 2),  dehydroprotostemonine 10, oxyprotostemonine 4 
and stemocochinine 11 (Figure 1.7) from four Stemona species together with four 
known compounds stemofoline 12, 2'-hydroxystemofoline 13, protostemonine 14,  
and parvistemonine 15. Alkaloids 5-9 all had the pyrido[1,2-a]azepine core structure. 
Pyridostemine 9 was the same as stemocurtisine 2. These alkaloids were tested for 
toxicity and growth inhibition against neonate larvae of Spodostera littoralis in 
comparison with the most active derivative 1',2'-didehydrostemofoline. Among these 
alkaloids, stemofoline 12 was the most toxic, followed by oxystemokerrin 7 (IC50 







Figure 1.8: Stemona alkaloids isolated by the Greger group12 
       




In 2007, Yang and collaborators isolated five new Stemona alkaloids; 6β-
hydroxystemofoline 16, 16-hydroxystemofoline 17, neostemofoline 18, 
protostemodiol 19 and 13-demethoxy(11S*,12R*)-dihydroprotostemonine 20 
(Figure 1.9). These alkaloids, together with stemofoline 12 were tested in vitro on 
neurons isolated from the pest insect Heliothis virescens. All of them were active. 
Compounds 16-18 and stemofoline 12 acted as agonists, whereas 19 and 20 were 
antagonists at the insect nicotinic acetylcholine receptors (nAChRs). The authors 
indicated that the significant insectidal activities of the stemofolines may be related 




Figure 1.9: Five new Stemona alkaloids from the leaves of S. japonica13 
 
In 2005, the Lin group isolated and structurally elucidated five new Stemona 
alkaloids, bisdehydrostemoninine 21, isobisdehydrostemoninine  22, 
bisdehydroneostemonine 23, and bisdehidrostemoninine A 24 and B 25 from the 
roots of S. japonica (Figure 1.10).14 Compound 21 displayed significant antitussive 
activity in the citric acid-induced guinea pig cough model (ID50 = 188 ± 13 μM). 




hydroxycroomine 27 (R = OH), dehydrocroomine 28, tuberostemoline 29, 
tridehydrotuberosteminine 30, 9α-bisdehydrotuberostemonine 31 and 9α-
bisdehydrotuberostemonine A 32 (Figure 1.11) from the leaves of same species. 
Two of these alkaloids, compounds 26 and 27 (R = OH), along with croomine 27 (R 
= H) and tuberospironine (two of ten known Stemona alkaloids isolated at the same 
time) were tested for antitussive activity employing the same method. Croomine 27 
(R = H) was the most active compound showing a dose-dependent inhibition of 
coughing with an ID50 value of 0.18 mmol/kg.
15 This group also successfully isolated 
five new alkaloids from the roots of S. tuberosa. These were, stemoenonine 33, 9a-
O-methylstemoenonine 34, oxystemoenonine 35, 1,9a-seco-stemoenonine 36 and 
oxystemonine 37 (Figure 1.12) along with a known compound stemoninoamide 38.  
Alkaloids 33, 34, 38 and stemoninine 39 were screened for their antitussive 
activities. Compounds 38 and 39 exhibited strong antitussive activity after oral and 






















Figure 1.12: Alkaloids isolated by the Lin group from the roots of S. tuberosa16 
 
Another important bioactivity of the Stemona alkaloids is their acetylcholinesterase 
(AChE) inhibitory properties. Four new alkaloids, sessilistemonamine A-C 40-42 
and dihydrostemoninine 43 (Figure 1.13) were isolated from the roots of S. 
sessilifolia and tested for this property by Wang and collaborators.17 Compounds 40 
and 41 were moderately active (IC50 values of 68.8±9.5 and 17.1±2.5 µM, 
respectively) but much less than huperzine A (IC50 = 0.021±0.016 µM), which was 







Figure 1.13: Four new Stemona alkaloids isolated by the Wang group17 
 
In 2013, the Pyne group isolated three new Stemona alkaloids: stichoneurine C 44, 
stichoneurien D 45 and stichoneurine E 46 from Stichoneuron halabalensis along 
with known compounds (+)-α-tocopherol 47 and (R)-(+)-goniothalamin 48 (Figure 
1.14), and four known Stemona alkaloids, bisdehydoxystemoninine A 24, 
stemoninine 39, sessilistemonamine C 42 and sessilistemonamine A 40. Except for 
compounds 44 and 45, they were tested as inhibitors of electric eel and human 
AChE. Compounds 24, 39 and 48 showed significant inhibitory activity against 
human AChE (IC50 values of 5.52±0.13; 3.74±0.09; and 7.24±0.52 μM, respectively) 
but were less active than galantamine (IC50 = 0.54±1.25 μM), the positive control.
18 
Later, the same group obtained two more new Stemona alkaloids, javastemonine A 
49 and javastemonine B 50, together with known alkaloids 13-demethoxy-
(11S*,12R*)-dihydroprotostemonine 20, stemocochinine 11 and isoprotostemonine 
51 (Figure 1.15) from S. javanica. All compounds except for 44 were tested for 
antiplasmodial and hAChE inhibitory activities and their cytotoxicities. Compounds 
20 and 51 demonstrated moderate in vitro antiplasmodial activity against two P. 
falciparum strains (IC50 values of 17.7±3.7 and 16.0±4.2 μg/mL, respectively). 
However none of these compounds showed mammalian cell line cytotoxicities 



















1.1.4   Synthesis of the Stemona alkaloids. 
 
The interesting biological activities and synthetically challenging polycyclic 
structures of the Stemona alkaloids have prompted numerous synthetic studies and 
the total synthesis of many Stemona alkaloids have been reported.2a,b,c Herein, we 
review the total syntheses of selected Stemona alkaloids, one from each of the 
structural groups defined by Pilli.2  
 
1.1.4.1   The total synthesis of Stenine 63 
 
Stenine, a representative group I Stemona alkaloid, was first synthesized by Hart et 
al. in 1993.20 The synthesis started from (E)-3,5-hexendienol, which was treated 
sequentially with n-BuLi and (E)-2,4-pentadienoyl chloride to give the ester 52 
quantitatively (Scheme 1.1). Heating a solution of 52 in toluene at reflux temperature 
in the presence of the Lewis acid Et2AlCl gave the bicyclic lactone 53 via an "endo"-
type transition state. Treatment of this lactone with hydrazine provided an acyl 
hydrazine, which was exhaustively N-methylated (K2CO3, MeI) and then acetylation 
of the resulting primary alcohol provided the acetate 54. Thermolysis of 54 by 
heating at reflux in mesitylene followed by addition of methanol to the intermediate 
isocyanate gave a methyl carbamate. Hydroboration of the terminal alkene of this 
carbamate using 9-BBN followed by oxidation with NaBO3.4H2O gave the primary 
alcohol, which was then converted to the primary mesylate 55. Cyclization of this 
compound to an indoline was achieved by treatment with MeLi, which acted as a 
base to deprotonate the carbamate NH and generated the nucleophilic N-lithiated 
species. Under these conditions, the acetyl group was also cleaved. Jones' oxidation 
of the resulting alcohol provided the acid 56, which was transformed into the lactone 
57 by iodo-lactonization followed by dehydrohalogenation using DBU.  Before 
treatment with N,N-dimethylacetamide dimethyl acetal giving 58, via a Claisen 
rearrangement reaction, the lactone was reduced with NaBH4, followed by protection 
of the resulting primary alcohol as a TBS ether. Treatment of 58 with I2 gave the 
corresponding trans-iodo-lactone with loss of the TBS group, which was converted 
to 59 by a free radical Keck allylation reaction with allyltributyl stannane/AIBN. α-




primary alcohol afforded the corresponding aldehyde, which was transformed to 60 
by Wittig olefination (Ph3P=CHCO2Et) and 1,4-reduction (Red-Al, CuBr) of the 
double bond.  
 
 




The carbamate group of 60 was removed by treatment with TMSI in CHCl3 and then 
cyclization of the resulting amino-ester to the lactam was achieved by heating at 
reflux temperature in mesitylene. Dihydroxylation of the terminal alkene of the 
resulting tetracyclic product, followed by oxidation by NaIO4 provided aldehyde 61. 
This was converted to a thioketal before treatment with Lawesson's reagent 
providing thiolactam 62. The synthesis was completed by the reduction of the 
thioketal and thiolactam over Raney Ni affording stenine 63, in 27 synthetic steps 
from (E)-3,5-hexendienol (Scheme 1.1).20 Stenine has also been synthesized by 
Wifp,21 Aubé,22 Padwa,23 Morimoto,24 Zhang,25 and Fujioka.26 
 
1.1.4.2   The total synthesis of stemoamide 72        
 
Stemoamide 72, the simplest group II Stemona alkaloid, has attracted considerable 
synthetic attention. Mori and Kinoshita27 completed the total synthesis of this 
alkaloid in 14 steps with 9% overall yield from (-)-pyroglutamic acid (Scheme 1.2). 
Their synthesis started from compound 64, which was prepared from pyroglutamic 
acid as described in the literature.28 N-alkylation of the sodium salt of 64 with 5-
bromo-1-pentene proceeded smoothly in DMF and was followed by hydrolysis of the 
ethoxy ethyl (EE) group with TsOH in MeOH to afford alcohol 65. Swern oxidation 
of 65 was followed by treatment with CBr4 and PPh3 to provide the corresponding 
1,1-dibromoalkene, which was treated with n-BuLi at -98 ºC to produce the ene-yne 
66. The terminal alkyne of 66 was deprotonated by LDA and reacted with methyl 
chloroformate (ClCOOMe) to furnish the methyl ester 67. Treatment of this ene-yne 
with Grubbs’ 1st generation ruthenium catalyst led to the bicyclic compound 68 via 
an ene-yne ring-closing metathesis (RCM) reaction. The structures of Grubbs’ 1st and 
2nd generation ruthenium catalysts are shown in Figure 1.16. 1,4-Hydride reduction 
of the enoate group of 68 with NaBH4 in MeOH gave 69 as an inseparable mixture of 
diastereoisomers. These esters were converted to their corresponding acids, which 
underwent bromo-lactonization by treatment with CuBr2 on alumina to form a 
mixture of lactones 70 and 71. Bromide 70 underwent hydrogenbromide elimination 
to form 71 by treatment with Et3N. Stereoselective 1,4-reduction of 71 by NaBH4 in 
MeOH in the presence of NiCl2.7H2O then furnished stemoamide 72 (Scheme 1.2). 




this thesis. This alkaloid was also synthesized by Jacobi,29,30 Gurjar,31 Olivo,32 
Somfai,33 Cossy,34 Bates,35 Honda,36 and Sibi.37 Stemonine, another group II 
Stemona alkaloid, was successfully synthesized by Williams.38 
 
.  
Scheme 1.2:  Synthesis of stemoamide 7228 
 
 




1.1.4.3   The total synthesis of croomine 27 (R = H) 
 
The first total synthesis of a Stemona alkaloid was reported by Williams et al.39 in 
1989, and was concerned with the preparation of (+) croomine 27 (R = H) (group 
III). Methyl (S)-2-methyl-3-hydroxypropionate was converted to the alkyne 73 in 
four steps using standard methods (Scheme 1.3). Homologation of 73 (n-BuLi, 
ClCOOMe) gave the ester 74, which underwent a copper-catalysed conjugate 
addition reaction by the Grignard reagent BnO(CH2)4MgBr, followed by reduction of 
the ester group with DIBAL-H to the desired Z-allylic alcohol 75. Sharpless 
asymmetric epoxidation of 75 gave an epoxy alcohol (dr = 13:1), which upon Swern 
oxidation afforded the corresponding aldehyde, which was converted to the epoxy 
ester 76 (E:Z ratio of 6:1) by Wittig olefination with Ph3P=CHCO2Et. Reduction of 
the ester group of 76 with LiBH4, followed by hydrogenation of the double bond, 
provided the saturated alcohol. This alcohol then was protected as a benzoate ester. 
Regioselective epoxide ring opening with lithium azide in DMPU at 110 ºC gave the 
azide 77. Treatment of 77 with BF3.Et2O yielded the saturated dioxepine, then 
saponification of the benzoate group afforded the corresponding alcohol 78. Swern 
oxidation of this alcohol, followed by Wittig olefination with ylide 79 afforded (Z)-
80. Acid hydrolysis of the acetal of 80, followed by saponification of the benzoate 
group provided a triol, which was oxidized by Jones' reagent to form an acid-γ-
lactone, giving 81 after treatment of the acid with diazomethane. Removal of the 
benzyl ether with BCl3 and subsequent Swern oxidation provided the azido aldehyde 
which underwent an intramolecular Staudinger/aza-Wittig reaction followed by 
reduction with NaBH4 to form 82. The mechanisms of the Staudinger and aza-Wittig 
reactions are discussed in more detail in Chapter 2 of this thesis. Croomine 27 was 
then achieved in a single step by treating 82 with I2 (Scheme 1.3). The yield of this 
final step was only 25% with 50-60% of the starting material reisolated. In this 










The proposed mechanism of this double cyclization step is shown in Scheme 1.4. 
Iodine attacked the alkene group of 82 to form the iodonium ion intermediate 83. 
This first step is thought to be reversible and can give two interconverting 
diasteromeric iodonium ion intermediates (only one is shown in Scheme 1.4). The 
intermediate 83 cycles faster than its diasteromer giving 84 as the kinetically 
favoured product. This undergoes nucleophilic addition by the vicinal tertiary amine 
to form the salt 85. Intramolecular cyclization of this aziridinium salt by participation 
of the nearby ester group results in croomine 27. In 2001, this group reported the 
total synthesis of stemospironine,40 another group III Stemona alkaloid. Later, in 





Scheme 1.4: Proposed mechanism of the iodine-mediated cyclization of 8239 
 
1.1.4.4   The total synthesis of (±) stemonamide 94 and (±) maistemonine 96  
 
The total synthesis of (±) stemonamide 94, a group IV Stemona alkaloid, was 
completed by Tu et al.42 along with that of (±) maistemomine. Their synthesis started 
with the tricarbonyl compound 86 (Scheme 1.5). Selective addition of 
ethynylmagnesium chloride to the aldehyde of 86, followed by mesylation of the 




substitution. The intramolecular Schmidt reaction43 proceeded by treatment of 87 
with TiCl4 in CH2Cl2 to furnish 88 as a single isomer. The proposed mechanism of 
the intramolecular Schmidt reaction, which explains the exclusive formation of 88, is 
illustrated in Scheme 1.6. There are two possible outcomes for the addition of the 
azide group to the two carbonyl groups of 87, these are intermediates 98 and 99. 
Compare to the intermediate 98, intermediate 99 is much less stable due to the 
unfavourable steric interactions between the alkene and the alkyne groups as shown 
in Scheme 1.6, thus only intermediate 98 is formed at this stage. In the next stage, 
the product is formed by Cl3Ti-O assisted migration of the C-C bond to a C-N bond 
as shown in Scheme 1.6. Ozonolysis of 88 to an ethyl ketone, followed by Lindlar 
reduction44 of the alkyne group produced the corresponding terminal olefin, which 
was transformed to the tricyclic ketone 89 by a base catalysed (K2CO3/MeOH) aldol 
condensation process. Deprotonation of 89 with LiHMDS followed by treatment 
with propanal afforded the corresponding β-hydroxy ketone, which was oxidized by 
Dess-Martin periodinane to a β-dicarbonyl compound. This was converted to the 
tertiary alcohol 90 as the major product in 74% yield by treatment with CeCl3.7H2O 
in i-PrOH under an oxygen atmosphere. Reaction with ethyl chloroformate gave the 
carbonate 91, which was converted to 92 via an intramolecular ketone enolate-ester 
condensation (Claisen-type condensation) reaction by treatment with KHMDS 
followed by O-methylation with diazomethane. O-methylation of the lactam by 
MeOTf followed by a chemoselective reductive removal the lactam carbonyl with 
NaCNBH3 furnished the tertiary amine 93. (±) Stemonamide 94 was achieved from 
93 by a Johnson-Lemieux oxidation at elevated temperature (40 ºC), prolonged 
reaction time (10 h) and with an excess of NaIO4 (1.5 equiv).  
 
A further three more steps were performed to obtain maistemonine. Johnson-
Lemieux oxidation of 93 under milder conditions (rt, 3.5 h) afforded the aldehyde 95, 
which was transformed to the unstable α-methylene-γ-lactone by reaction of the 
aldehyde with the organozinc reagent prepared in situ from ethyl 
bromomethylacrylate 97 and zinc in THF. Reduction of the exo-cyclic methylene 
group of the resulting γ-lactone product by H2 over Pd/C catalyst provided (±) 




total synthesis of stemonamine.45 Other total syntheses of group IV Stemona 










Scheme 1.6: Proposed mechanism for the intramolecular Schmidt reaction43 
 
1.1.4.5   The total synthesis of sessilifoliamide C 109 
 
In 2011, Wifp49 reported the total synthesis of sessilifoliamide C 109, a group V 
Stemona alkaloid, from (S)-pyroglutamic acid 100 (Scheme 1.7). The acid group of 
100 was converted to its ethyl thioester before protecting the pyrrolidinone nitrogen 
by the Boc group. Fukuyama reduction (Pd/C, Et3SiH) of the resulting N-Boc 
thioester gave an aldehyde, which was transformed to the alkene 101 by the Wittig 
olefination process. Removal of the Boc of group of 101 with TFA followed by N-
alkylation using iodide 111 under basic conditions (NaOH, H2O) furnished 102. This 
compound was converted to the bicycle 103 by ring-closing metathesis using 
Grubbs’ 2nd generation ruthenium catalyst followed by acid promoted (p-TsOH, 
MeOH) cleavage of the TBS group. Acylation of 103 with butyric acid and EDC.HCl 
afforded the corresponding ester, which upon enolisation by LiHMDS followed by 
trapping with TIPSCl resulted in the (Z)-silyl ketene acetal 104. Heating this 
intermediate at reflux in degassed xylene resulted in an Ireland-Claisen 
rearrangement furnishing 105, which was simply converted to the methyl ester 106 
(dr = 6:1) by removal of the TBS group followed by methylation of the 
corresponding acid with TMSCHN2. This compound was hydrogenated and then the 
ester group was reduced with LiBH4 to the corresponding alcohol before Swern 




column chromatography. This adduct was exposed to vinylmagnesium bromide 
followed by treatment with methacryloyl chloride providing a mixture of 
diasteromeric acrylates 108 (dr = 2:1). Ring-closing metathesis of this mixture led to 
a separable mixture of sessilifoliamide C 109 and its epimer at C11 (84% yield total) 
110, from which 3 mg of pure 109 was isolated for structural elucidation (Scheme 
1.7). Two other group V Stemona alkaloids were synthesized by Lindsley in 2013, 
stemaphylline and stemaphylline-N-oxide.50  
 
 




1.1.4.6   The total synthesis of (±)-isostemofoline 122     
 
The first total synthesis of (±)-isostemofoline 122, having a complex caged structure 
(a group VI Stemona alkaloid), was reported by Kende and co-workers (Scheme 
1.8).51 The synthesis started with the hydrazone 112, which was prepared from 1,2-
hexanediol in three synthetic steps (48% yield). This underwent reductive cyclization 
with sodium persulfate to afford the pyrrole 113, after N-protection by the Boc 
group. A [4+3]-cycloaddition of 113 and diazoester 123 promoted by rhodium 
octanoate dimer gave the bicyclic compound 114, which underwent an enol silane 
deprotection (TBAF), an exo-specific hydrogenation (Pd/C, H2) and a nucleophilic 
decarboxylation (DMSO, H2O, 150 ºC) reaction sequence to produce the bicyclic 
ketone 115. Aldol condensation of 115 with furfuraldehyde (NaOH/MeOH) 
furnished the enone 116, after allylation promoted by LiHMDS. Johnson-Lemieux 
oxidation of the alkene group followed by reduction of the corresponding aldehyde 
provided the desired primary alcohol, which was protected as the TIPS ether 117. 
Conjugated addition of MeLi to 117, followed by a series of functional group 
interconversions including oxidative cleavage of the furan with oxone, resulted in the 
acid 118. Treatment of this product with i-BuOCOCl, followed by reduction of the 
resulting mixed anhydride with NaBH4/MeOH provided the corresponding primary 
alcohol, which was oxidised to the corresponding aldehyde by using the Dess-Martin 
periodinane reagent. Addition of the lithiated anion 124 to this aldehyde, followed by 
Dess-Martin oxidation furnished 119 (dr = 2:1). Treatment 119 with TFA gave the 
intermediate 120, which underwent a triple cyclization by adjustment to pH = 10 to 
furnish 121. This cyclization process included two intramolecular ketal forming 
reactions and an intramolecular N-alkylated reaction. In the final step, dehydration of 
121 by Tf2O afforded (±)-isostemofoline 122, however in only 12% yield (Scheme 
1.8). The synthesis of 122 was completed in 27 steps and less than 0.1% overall yield 
from 1,2-hexanediol. The total synthesis of two other group VI Stemona alkaloids, 
(±)-16,17-didehydro-16(E)-stemofoline and (±)-16,17-didehydro-4(E),16(E)-
stemofoline was completed by Overman.52 Recently, Huang reported the total 











1.4.1.7   The total synthesis of sessilifoliamide J 136 
 
The total synthesis of sessilifoliamide J 136, a group VIII Stemona alkaloid, was 
achieved by Huang and coworkers in 2012.54Their synthesis started from 
commercially available (S)-pyroglutaminol 125 (Scheme 1.9). N-Cbz protection, 
followed by O-TBDPS protection gave 126. Partial reduction of the lactam carbonyl 
of 126 with DIBAL-H afforded a mixture of hemiaminals, which was transformed to 
the mixture of hemiaminal ethers 127 by treatment with CSA in methanol. A 
vinylogous Mannich reaction55 between 127 and the furan 137 proceeded under 
BF3.Et2O catalyst to afford the lactone 128 as a mixture of diastereomers (dr = 
85:15). Reductive removal of the Cbz group and hydrogenation of the alkene group, 
followed by exposure of the resulting amine to NaOMe/MeOH provided the 
indolizidinone 129. Oxidation of this mixture gave the ketone 130, which was 
subjected Corey lactonization56 by treatment with phenyl acetate, Zn-Hg, TMSOTf, 
LiI, and SmI2 in THF to form 131 as a diastereomeric mixture (dr > 20:1). The 
proposed mechanism for the Corey lactonization is shown in Scheme 1.10. The 
reaction of 130 was initiated by the addition of an electron generated from SmI2/Zn-
Hg to 130 to form the ketyl radical A. Michael addition of the radical A to phenyl 
acrylate formed the radical anion B. This anion accepted one electron (from 
SmI2/Zn-Hg) to generate the dianion C. Elimination of PhOˉ from C resulted in the 
ketene D. Cyclization of the ketene D was promoted by TMSOTf to form the 
tricyclic intermediate E. Hydrolysis of E (during the work-up process) yielded the 
tricycle 131. The desired isomer 131 was separated as the major compound by 
column chromatography (Scheme 1.9). Methylation of 131 initiated by 
deprotonation by LiHMDS produced almost exclusively 132, after removing the 
TBDPS group by treatment with TBAF. Swern oxidation of 132 led to the aldehyde 
133, which was treated with the organozinc reagent prepared in situ from 97 and Zn 
at reflux temperature to provide a chromatographically separable mixture of 
diastereomers 134 and 135 (dr = 41:59) in excellent yield. Hydrogenation of the 
desired diastereomer 134 furnished sessilifoliamide J 136. This total synthesis 
















Scheme 1.10: Proposed mechanism for the Corey lactonization reaction56 
 
1.2   Proposed synthetic approach 
 
1.2.1   Aims of this project 
 
Although the total syntheses of many pyrrolo[1,2-a]azepine Stemona alkaloids have 
been reported, none of them involves the synthesis of a member of the  
stemocurtisine group (group VII), which possesses the pyrido[1,2-a]azepine core 
structure. The aim of this project was to investigate the total synthesis of 
stemocurtisine 2 based on the retrosynthesic analysis shown in Scheme 1.11. The 
major challenges in this synthesis are: (1) Controlling the relative stereochemistry of 
the five stereogenic centres in 2; (2) The formation of the ether bridge between C-1 
and C-9 of 2; and (3) Obtaining the (Z) geometry of the alkene moiety between the C 
and D rings. 
 
1.2.2   Retrosynthetic analysis of stemocurtisine 
 
Our restrosynthetic analysis indicated that stemocurtisine 2 could be prepared in 




Olivo using the lithiated anion 124 to introduce the D-ring57 then reduction of the 
lactam carbonyl group. This compound could be obtained from the tricyclic 
compound 138 by a photochemical oxidative cyclization process promoted by I2 in 
the presence of PhI(OAc)2 (BAIB).
58 Tricycle 138 could be obtained from 139 by a 
lactonization then a reduction reaction sequence according to the procedures of Mori 
(compare with Scheme 1.2).27 This material can be achieved from 140 by a 1,4-
hydride reduction of the enoate moiety.27 The bicycle 140 could be obtained from 
141 via an ene-yne ring-closing metathesis reaction by analogy to the work of Mori 
(Scheme 1.2). The piperidinone 141 could be synthesized from the lactam 142 via 
functional group interconversions. The lactam 142 could be in principle synthesized 








Following the retrosynthesis shown in Scheme 1.12 (synthetic strategy 1), compound 
142 could be obtained from the imide 143 via nucleophilic addition of the 
corresponding lithiated terminal alkyne followed by stereoselective reduction of the 
resulting hemiaminal product. Imide 143 could be prepared from D-glutamic acid 





Scheme 1.12: Restrosynthetic analysis of 142 (synthetic strategy 1) 
 
Following synthetic strategy 2 shown in Scheme 1.13, compound 142 could be 
obtained from the lactone 144 via a base-catalysed amino-lactone to hydroxy-lactam 
rearrangement. Compound 144 could be prepared from the azide 145 via a 
Staudinger/aza-Wittig reaction with aldehyde 146. Azide 145 could be prepared from 
alcohol 147 via a functional group interconversion. Compound 147 could be 
obtained from the ene-yne 148 via a syn-dihydroxylation process. The ene-yne 148 
could be synthesized from the iodide 149 via a Sonogashira coupling reaction with 







Scheme 1.13: Restrosynthetic analysis of 142 (synthetic strategy 2) 
 
Following synthetic strategy 3 shown in Scheme 1.14, compound 142 could be 
synthesized from the lactone 150 (R = CH2OPg) via a base-catalysed rearrangement. 
Lactone 150 could be obtained from compound 151 via an oxidation reaction (X = 
CH2OH) or lactonization process (X = COOMe). Amino alcohol 151 could be 
prepared from the epoxide 153 via an aminolysis reaction with amine 152. Epoxide 
153 could be obtained from the iodide 154 via a Sonogashira coupling reaction 






Scheme 1.14: Restrosynthetic analysis of 142 (synthetic strategy 3) 
 
 
Our overall synthetic plan towards the synthesis of stemocurtisine was to 
consecutively construct the A, A-B, and A-B-C ring systems of this alkaloid, 
respectively and then the ether-bridge to produce 137. In Chapter 2 we report on 
several different approaches (using synthetic strategies 1-3) to make the A- ring. 
Construction of the A-B, and A-B-C ring systems and attempts to make the ether 
linkage are discussed in Chapter 3. Chapter 4 reports on an alternative synthetic 
strategy to prepare the A-B-C ring system from L-glutamic acid using a ring-closing 





CHAPTER 2: SYNTHESIS OF THE RING A OF STEMOCURTISINE 
 
This chapter reports on our successful and unsuccessful attempts to prepare a highly 
functionalised A-ring precursor, of the general structure 142, of stemocurtisine 2 





Figure 2.1: General structure of the A-ring target lactam 142 
2.1   First attempts from L-glutamic acid (synthetic strategy 1) 
 
Earlier a PhD student (Swamy) working in our laboratory reported the synthesis of 
the 5-membered ring ene-yne lactam analogue 161 to our target compound 142 (R = 
COOMe) (Scheme 2.1).60 The synthesis started from L-malic acid and resulted in the 
synthesis of 161 in seven synthetic steps. Heating a solution of L-malic acid and 
PMBNH2 in xylene at reflux temperature gave the imide 155, which was protected as 
the benzyl ether 156 by O-benzylation under basic conditions. Oxidative removal of 
the PMB group of 156 by CAN, followed by N-alkylation of the resulting imide 
afforded 158. Nucleophilic addition of the lithium acetylide TBSOCH2CCLi, 
prepared in situ from the corresponding terminal alkyne and n-BuLi, to the more 
electrophilic carbonyl group of 158 provided a diasteromeric mixture of the 
hemiaminals 159 (dr = 2:1). This mixture underwent reduction and TBS deprotection 
by NaCNBH3/HOAc to provide the cis-isomer 160 in 58% yield. The primary 
alcohol 160 was then oxidized with Jones' reagent followed by esterification to 






Scheme 2.1: The synthesis of lactam 16160 
 
Based on the success of this work, our retrosynthetic analysis of the O-protected 
piperidinone 162 (142, R= CH2OTBS) is shown in Scheme 2.2 starting from L-
glutamic acid. It should be noted that if this route was successful it would produce 
the enantiomer of stemocurtisine. We chose to use L-glutamic acid rather than the D-
form in our preliminary studies because of its cheaper cost. 
 
Following this retrosynthetic analysis, compound 162 could be obtained from the 
imide 163 by the addition of the organolithium reagent TBSOCH2CCLi followed by 
reduction of the resulting hemiaminal. This imide could be prepared from the amide 




reaction. Amide 164 could be obtained from the reaction between 1-amino-4-pentene 
152 and the acid chloride 165, which could be synthesized from L-glutamic acid in 




Scheme 2.2: Retrosynthesis of lactam 162 
 
In our initial model studies, L-glutamic acid was treated with NaNO2 and HCl to give 
initially the corresponding α-hydroxy acid, which underwent lactonization to form 
the lactone 166 (Scheme 2.3).61 A mechanistic scheme for the formation of the 
lactone 166 is shown in Scheme 2.4. The amino group of L-glutamic acid was 
converted to the unstable diazonium salt A by HNO2 prepared in situ from HCl and 
NaNO2. Nucleophilic displacement of N2 from A via the α-carboxylic acid group 
formed the unstable 3-membered ring lactone B. Nucleophilic addition of H2O to the 
α-carbon of B generated the hydroxyl-acid C, which upon lactonization would form 
the lactone acid 166. Alternatively, the acid hydroxyl group of B can attack the α-
carbon of the unstable 3-membered ring to form 166 directly. Either mechanism can 
account for the overall retention of configuration for this process. Acid 166 was 
converted to the corresponding acid chloride 165 by treatment with thionyl chloride 
at reflux temperature.61 The acid chloride was then converted to the amide 167 in 




0 ºC. The relatively strong base t-BuOK (0.4 equiv) was employed to transform the 
amide 167 into the imide 168 at -78 ºC to -55 ºC using the method reported by 









Scheme 2.4: Formation of lactone 166 
 
Protection of the hydroxy group of 168 by either Bn62 or TBS63 groups using 
standard reaction conditions produced compounds 169 and 170, respectively 
(Scheme 2.5). The next step involved the nucleophilic addition of a lithium acetylide 
(RCCLi, R = Ph or TMS) to the carbonyl group of imides 169 or 170 to produce the 
desired adducts 171 (Scheme 2.5). The reactions using phenylacetylene were for 
model studies to develop the methodology. None of these desired products were 
formed at the reaction temperature of -78 ºC or when the reaction mixture was 
warmed to -30 ºC, only the starting imides were recovered. These results are in 




of 170 with TMSCCLi was warmed to 0 ºC the ring-opening product 172 was 










Scheme 2.5: (a) Attempted addition of RCCLi to imides 169 and 170 and (b) the 





Presumably the addition of the organolithium to the more nucleophilic carbonyl 
group of 170 initially formed the intermediate A. This intermediate was then 
converted to the intermediate B. Protonation of B during work up process forms the 
ring opening product 172. We did not attempt to purify this product, however the 1H 
NMR spectrum of the crude reaction mixture showed a broad resonance for the 
amide NH group at δ 6.2. A similar problem was reported by Huang et al. 64 In their 
report, the addition of Grignard reagents to the imide 173 formed mixtures of the 
desired products 174 and the ring opened products 175 (Scheme 2.6). Clearly, the 5 
and 6-membered ring imides behave differently upon nucleophilic addition, with the 
5-membered ring imides favouring the ring closed products (Scheme 2.1). 
 
 
                                                                              (product ratios not given) 
 
Scheme 2.6: Huang’s study of the addition of Grignard reagents to 17364 
 
Another possible method for the synthesis of 176 (142; Pg = H, R = CH2OTBS) was 
also considered but not pursued (Scheme 2.7). Pyne reported a method for the 
synthesis of cis-lactams 178 via the borono-Mannich reaction of the hemiaminal 177 
with potassium alkynyltrifluoroborate salts (Scheme 2.8).65 Although these reactions 
gave the desired products with good diasteroselectivities, the yields were not 
satisfactory (maximum yield of 36% with R = Ph) and therefore this procedure was 







Scheme 2.7: Pyne’s synthesis of cis-lactams 17865 
 
During the writing of this thesis, an alternative synthesis of cis-lactams 181, which 
could be applied to synthesize the lactam 179 (142; Pg = OTBS, R = CH2OTBS) 
(Scheme 2.8), was reported. Wei prepared lactams 181 by treatment of the chiral α-
OTBS aldimine 180 with Grignard reagents followed by N-protection by the Boc 
group.66 However, lactams 181 were prepared in low yields (maximum yield = 32%) 











2.2   Second synthetic pathway, via an azido lactone (synthetic strategy 2) 
 
Because of the aforementioned problems, we then investigated another synthetic 
route to prepare the ene-yne lactam 182 (142, Pg = H, R = COOMe) following the 
retrosynthetic analysis shown in Scheme 2.9. In principle, compound 182 could be 
prepared from the azido-lactone 183 via a Staudinger/aza-Wittig reaction of the azide 
group with 4-pentenal, followed by a base catalysed (t-BuOK) rearrangement of the 
corresponding amino-δ-lactone to the hydroxyl lactam 182. Azido lactone 183 could 
be synthesized from the hydroxy lactone 184 via a functional group interconversion 
sequence. The lactone 184 could be prepared from the ene-yne 185 via syn-
dihydroxylation of the alkene group and then lactonization. The ene-yne 185 could 




Scheme 2.9: Retrosynthetic analysis of the lactam 182 
 
For the synthesis of 185, iodination of 4-pentyn-1-ol with I2/KOH in MeOH led to 
the iodide 186, which underwent syn-reduction of the alkyne by diimide (NH=NH), 
prepared in situ from potassium azodicarboxylate and AcOH, to give the known (Z)-
vinyl iodide 18767 in 56% yield (Scheme 2.10). In fact, this reduction reaction gave 
two products, the desired vinyl iodide 187 and its saturated derivative 188. The latter 
undesired product was removed by treatment of the reaction product mixture with 
BuNH2 at rt for 10 h. This process converted 188 to its amine derivative, which could 











Scheme 2.11: Removal of the byproduct 188 by n-BuNH2 
 
Jones' oxidation of the primary alcohol 187 gave the known corresponding acid,68 
which was converted to the known methyl ester 149 by treatment with Me3SiCl in 
MeOH (Scheme 2.12).68 Sonogashira coupling of 149 with trimethylsilylacetylene 
catalysed by PdCl2(PPh3)2/CuI
69 in a solvent  mixture of THF-Et3N under a N2 
atmosphere provided the novel ene-yne 185 in 71% yield (Scheme 2.12). The Z-
configuration of 185 was confirmed by the magnitude of the coupling constant J4,5 









The accepted mechanism for the Sonogashira coupling reaction is shown in Scheme 
2.13.71 Initially, the catalyst reacts with a vinyl or aryl halide (RX) via an oxidative 
addition process to produce the Pd(II) complex A. This complex undergoes 
transmetalation with the copper acetylide D, which is formed from the reaction 
between the copper halide, the terminal alkyne and the tertiary amine (Et3N), to give 
the Pd(II) complex B. Complex B undergoes a trans/cis isomerization of the two 
ligands L to form the complex C. In the final step, complex C undergoes reductive 












It should be noted that in the proceeding schemes all compounds are racemic, 
although only one enantiomer is shown for convenience with the desired 
configuration for the synthesis of stemocurtisine. 
 
Syn-dihydroxylation of the alkene 185 with catalytic OsO4, prepared in situ from 
K2OsO4 (0.05 equiv) and NMO (2.5 equiv), gave a chromatographically separable 
mixture of the racemic desired lactone 184, the desilylated lactone 189 and the diol 
ester 190 (Scheme 214).72 The undesired lactone 189, which formed via loss of the 
terminal TMS group, accounted for 29% of the reaction product. Perhaps, this loss 
was due to the formation of the base N-methylmorpholine (from the reduction of 
NMO) which could generate a low concentration of hydroxide from water, which 
could cleave the TMS group. 
 
 
Scheme 2.14: Syn-dihydroxylation reaction of 185 
 
The IR spectrum of 184 showed bands for a δ-lactone carbonyl at 1757 cm-1, a 
hydroxyl group at 3402 cm-1 and an alkyne triple bond at 2170 cm-1. In the 1H NMR 
spectrum of 184, the signals for the two oxymethine protons, H-5 and H-1', 
overlapped and resonated at δ 4.37-4.27 (m, 2H). The 13C NMR spectrum of 184 
showed diagnostic resonances for the carbonyl group at δ 174.9, the two oxymethine 
carbons C-5 and C-1' at δ 73.7 and 66.9, respectively and the CH3-Si group at δ 0.12.  
 
The IR spectrum of 189 showed bands for a δ-lactone carbonyl at 1763 cm-1, a 




The 1H NMR spectrum of 189 was similar to that of 184 except that the resonances 
for H-5 and H-1' overlapped and resonated at δ 4.66-4.56 (m, 2H). In addition, the 
alkynyl CH proton resonated at δ 2.49 (s, 1H, H3'). The 13C NMR spectrum showed 
a resonance for the carbonyl group at δ 178.3. The lactone 189 was a known 
compound and its NMR spectroscopic data were consistent with those reported in the 
literature.73 
 
In the 1H NMR spectrum of compound 190, the H-5 proton resonance appeared as a 
doublet at δ 4.32 with a coupling constant J4.5 = 3.5 Hz, which is typical for this type 
of anti-1,2-diol. For example, in the 1H NMR spectrum of compound 191 A, H-3 
resonated at δ 4.35 with the coupling constant J2,3 = 3.5 Hz, while J2,3 = 6.5 Hz in its 
syn-isomer 191 B (Figure 2.2).74 In addition, HRESIMS analysis (calcd. for 
C11H20O4SiNa, (M+Na)
+  267.1029, found 267.1026) confirmed the molecular 




Figure 2.2: Structures and J2,3 for the diols 191 A and 191 B
74 
 
The diol 190 could be converted to the hydroxy-lactone 184 in 88% yield by 
treatment with TsOH (1.5 equiv) in MeOH at rt for 2 h (Scheme 2.15).75 This 








The next step in the synthesis was to replace the terminal TMS substituent of 184 
with an ester group. Kondo reported a method of carboxylation of 
alkynyltrimethylsilanes to make the corresponding esters.76 In this procedure, the 
silanes were treated with CsF and a primary halide (RX) in DMSO under a CO2 
atmosphere to provide the appropriate alkyne esters (yields = 63-81%). This reaction 
most likely proceeds via the ionic intermediates shown in Scheme 2.16, with the 
formation of PhCCCO2Cs in situ followed by its irreversible O-alkylation with RX to 




Scheme 2.16: Kondo’s synthesis of alkyne esters from terminal alkyne silanes76 
 
We first examined this method using the model compound 192, which was obtained 
in 98% yield from 4-fluoro-iodobenzene and trimethylsilylacetylene via a 
Sonogashira coupling reaction.69 Under the literature conditions, the methyl ester 193 
was obtained in 62% yield from 192 (Scheme 2.17 (a)). Using similar conditions we 
obtained the diester 194 in 63% yield from 185 (Scheme 2.17 (b)). Unfortunately, 
the desired ester 195 was not formed when we applied the same conditions to 184. 
Only the undesired terminal alkyne 189, which we observed earlier in Scheme 2.14, 
was formed via a proto-desilylation reaction (Scheme 2.18). We suspect that the 
hydroxyl group (pKa ≈ 16)
77 in 184, being more acidic than the terminal alkyne group 
(pKa ≈ 25),
77 protonates the initially formed cesium acetylide intermediate to give the 









Scheme 2.17: Model work using Kondo’s method 
 
 
Scheme 2.18: Attempted synthesis of 195 using Kondo’s protocol 
 
We also attempted to prepare the lactone ester 195 directly from the diester 194 by a 
syn-dihydroxylation reaction. However this reaction failed to form the desired 
product 195 and only unreacted starting material was recovered (Scheme 2.19). The 
poor reactivity of 194 was due to the electron withdrawing effect of the alkyne ester 
substituent which made the alkene more electron deficient and therefore less relative 





Scheme 2.19: Attempted dihydroxylation reaction of 194 
 
Due to the low overall yield in the preparation of 184 (8.5% over 5 steps) and its 
failure to be converted to its corresponding ester 195, we next examined an 
alternative synthetic pathway to prepare the target ene-yne lactam 142. 
 
2.3    The third synthetic pathway, via an epoxide (synthetic strategy 3) 
 
An alternative route to the synthesis of the lactam 196 (142, Pg = H, R = CH2OTBS) 
was examined following the retrosynthetic analysis outlined in Scheme 2.20. 
Following this synthetic strategy, lactam 196 could be obtained from the azide 197 
via a Staudinger/aza-Wittig reaction by treatment with 4-pentenal, followed by a 
base-catalysed rearrangement of the resulting 5-membered ring amino-lactone to a 6-
membered ring hydroxy-lactam. The azide 197 could be prepared by an azidolysis 
reaction of the epoxide 198, which could be obtained from 149 via a Sonogashira 
coupling reaction followed by an epoxidation process.  
 
 




Sonogashira coupling of the Z-vinyliodide 149 with the prepared alkyne 199 
proceeded smoothly to provide the ene-yne 200 in good yield (75%) (Scheme 2.21). 
The Z-configuration of alkene 200 was confirmed by the coupling constant J4,5 = 
10.7 Hz (δ 5.53 (d, J = 10.7 Hz, 1H, H5)).70 Epoxidation of 200 with m-CPBA in 
CH2Cl2 gave a chromatographically separable mixture of the racemic epoxide 198 
(56% yield) and the starting material (24% recovered) (Scheme 2.21). The 1H NMR 
coupling constant J4,5 = 4.0 Hz (δ 3.48 (d, J = 4.0 Hz, 1H, H5) and δ 3.14 (ddd, J = 
6.5, 5.5, 4.0 Hz, 1H, H4)) confirmed the cis-configuration of the epoxide 198 at C-4 
and C-5. These chemical shifts and coupling constants for H-4 and H-5 were 
consistent with those for the related protons, H-3 and H-4, of compound 201 (Figure 





    










Barua reported a method for the azidolysis of epoxides using NaN3 with 4Å 
molecular sieves in CH3CN.
79 With monoalkyl substituted epoxides, the azide group 
attacked the less hindered carbon of the epoxide and gave β-hydroxy azide products 
in excellent yields (92-97%). Whereas with aryl epoxides the azide group mainly 
attacked the aryl (Ar) substituted carbon to give ring opened products in very good 




Scheme 2.22: Barua’s synthesis of azides79 
 
Margarita reported the synthesis of chiral azides from chiral 2-aryl epoxides using 
NaN3 in hot water.
80 Azides were obtained in high yields and with excellent 




Scheme 2.23: Margarita’s synthesis of chiral azides80 
 
We tried both of these methods to make an azide from the ring opening of the 
epoxide 198 with NaN3. However, both methods failed, and only the unreacted 







Scheme 2.24: Attempted epoxide ring opening of 198 under Buara’s and 
Margarita’s conditions 
 
Kesselmayer reported a method of ring opening of 2-hydroxymethyl epoxides with  
Ti(O-iPr)2(N3)2,
81 which was prepared in situ from the reaction of Ti(O-iPr)4 and 
TMSN3. Noticeably, with the phenyl epoxide (R = Ph) the reaction gave almost 
exclusively the products arising from attack at C3 (A:B > 100:1) (Scheme 2.25). 
McDonald employed the same reagent to prepare the azide 203 from the alkynyl 
epoxide 202 in 77% yield (Scheme 2.26).82 
 
 




Scheme 2.26: McDonald’s synthesis of azide 20382 
 
Righi reported that treatment of vinyl epoxides with TMSN3 and BF3.Et2O gave 
mixtures of C-2 and C-3 ring-opened products in moderate to excellent yields (48-





Scheme 2.27: Righi’s azidolysis of chiral vinyl epoxide using TMSN3
83 
 
The results from our attempts at the ring opening of epoxide 198 under 
Kesselmayer’s conditions were not so impressive. The desired azide lactone 197 was 
obtained in a relatively low yield (40%). Surprisingly, the diol i-propyl ester 204 was 
also formed in 19% yield (Scheme 2.28).  
 
 
Scheme 2.28: Synthesis of azide 197 
 
In the IR spectrum of 197, the δ-lactone carbonyl gave rise to a band at 1774 cm-1, 
and the azide group gave rise to a band at 2140 cm-1, while the alkyne triple bond 
appeared as a band at 2220 cm-1. In the 1H NMR spectrum of 197, H-5 resonated 
downfield at δ 4.54 (dt, J = 7.0, 6.0 Hz, 1H, H5). These spectroscopic data were 
consistent with ring opening by azide at the activated propargyl carbon of the 
epoxide 198 and formation of a δ-lactone. The 13C NMR spectrum of 197 showed a 
resonance for the carbonyl group at δ 176.2. The molecular formula of 197 was 
confirmed by HRESIMS (calcd. for C14H24O3N3Si, (M+H)
+ 310.1587, found: 
310.1589). 
 
In contrast to compound 190 (Scheme 2.14), H-5 in the 1H NMR spectrum of 204 




shift and the relatively large coupling constant J4,5 = 6.5 Hz were consistent with 
those of the syn-isomer 191 B (H3 δ 4.15, J2.3 = 6.5 Hz) (Figure 2.2)
74 and allowed 
for the relative 4,5-syn configuration of 204 to be assigned at C-4 and C-5. 
Resonances for the isopropyl group occurred at δ 5.04 (heptet, J = 6.0 Hz, 1H, 
OCH(CH3)2) and δ 1.23 (d, J = 6.0 Hz, 6H, OCH(CH3)2). The molecular formula of 
204 was confirmed by HRESIMS (calcd. for C17H32O5SiNa, (M+Na)
+ 367.1918, 
found: 367.1917).  
 
Since the diol ester 204 was formed under anhydrous conditions, the formation of 
204 possibly involves an intramolecular epoxide ring opening of 198 by the ester 
carbonyl group to form the intermediate 5-membered ring lactone A via a 5-exo-tet 
process (Scheme 2.29). An alternative intermediate is the 6-membered ring lactone B 
formed via a 6-endo-tet process. According to Baldwin’s rules84 for the tetrahedral 
(tet) system, 5-exo-tet attack is favoured in this step and the intermediate 5-
membered ring lactone A is predicted to be formed (3 to 7-exo-tet cyclizations are 
favoured, while 5 to 6-endo-tet cyclizations are disfavoured).84 Addition of iPrO- to 
the carbonyl group of lactone A produces diol 204 after protonolysis. The same 
racemic diol (drawn as ent-204 in Scheme 2.29) could also possibly arise from the 
disfavoured 6-endo-tet process. These possibilities are summarized in Scheme 2.29. 
 
 




Lee reported a method for the preparation of polyamines from polyazides in 
excellent yields (84-98%) based on the Staudinger/aza-Wittig reaction (Scheme 
2.30).85 For example the bisamine 206 was obtained from the bisazide 205 in 97% 
yield. The Staudinger/aza-Wittig reaction starts with the addition of PPh3 to the azide 
group to form a phosphorane intermediate (Staudinger reaction, Scheme 2.31). The 
phosphorane then reacts slowly with the aldehyde to give the unstable 4-membered 
ring azaphosphetane intermediate A, then the corresponding imine and Ph3PO (aza-
Wittig reaction). Reduction of this imine with NaBH4/MeOH then gives the 










Scheme 2.31: Proposed mechanism for Staudinger/aza-Wittig reaction 
 
Follow this method, azide 197 was treated with PPh3 (1.1 equiv) and 4-pentenal (1.4 




stirred for 12 h. Unfortunately, only the primary amine 207 was formed instead of 
the desired product 208 (Scheme 2.32). Presumably, the quality of the aldehyde 
caused this deviation. 4-Pentenal is not commercially available, and was prepared 
from 4-penten-1-ol by oxidation with PCC. The aldehyde was very volatile and 
therefore we used it directly as a solution in CH2Cl2 and diethylether without 
purification. It appears that water in the aldehyde (perhaps as the hydrate) may have 









Scheme 2.33: Formation of the primary amine 207 
 
Amine 207 was obtained as a mixture with Ph3PO. We did not isolate the amine 207 




the protons H-5 and H-1' at δ 4.46 (dd, J = 6.8, 6.8 Hz, 1H, H5) and δ 3.78 (d, J = 6.8 
Hz, 1H, H1'), respectively. These resonances were consistent with the proposed 
structure 207. This mixture then was heated with Et3N in methanol at reflux 
temperature for 14 h to form the lactam 209 in 81% yield (over two steps from 197) 




Scheme 2.34: Synthesis of lactam 209 
 
The IR spectrum of 209 showed a lactam carbonyl band at 1638 cm-1. The 1H NMR 
and 13C NMR spectra of 209 are shown in Figures 2.5 and 2.6, respectively. The 
NMR assignments of 209 were based on 2D NMR experiments (COSY, HSQC and 
HMBC). In the 1H NMR spectrum of 209, the lactam NH resonated at δ 5.75 (bs, 1H, 
NH). When compared to the chemical shift of H-1' (δ 3.78) in 207, the corresponding 
proton H-6 in the 1H NMR spectrum of lactam 209 appeared at lower field (δ 4.40, s) 
due to the deshielding and electron-withdrawing effects of the carbonyl group, while 
H-5 of 209 resonated at higher field (δ 4.10 (s, 1H, H5)) than H-5 (δ 4.46) in the 1H 
NMR spectrum of 207. These chemical shift differences between compounds 207 
and 209 were therefore consistent with their assigned structures. The very small J5,6 
value of < 1 Hz in the 1H NMR spectrum of 209 was consistent with the 5,6-cis-
stereochemistry. For example, in the 1H NMR spectrum of the cis compound 210 A, 
the H-6 resonance appeared as a doublet at δ 4.66 with a coupling constant J5,6 = 2.9 
Hz, while in the 1H NMR spectrum of 210 B, the H-6 resonance appeared as a 
doublet at δ 4.48 with a coupling constant J5,6 = 4.6 Hz (Figure 2.4).
86  Furthermore, 
the HRESIMS (calcd. for C14H26O3NSi, (M+H)
+ 284.1678, found: 284.1682) 

























Figure 2.6: 13C NMR spectrum (CDCl3, 125 MHz) of 209 
 
Due to the low yield of the azide 197 and the unsuccessful formation of 208, we 
decided to modify the original route from the epoxide. The azidolysis step was 
replaced by an aminolysis reaction with the aim of developing a more efficient 
synthesis of 196. 
 
Pyne reported a method for aminolysis of a vinyl epoxide by heating the components 
in a microwave reactor using LiOTf (1.0 equiv) as a promoter.87 The reactions 
proceeded well in high yield and with very good regioselectivity due to exclusive 





















Vasella reported an intramolecular aminolysis of the alkynyl epoxide 213 by the 
nitrogen of a trichloroimidate. Treatment of the trichloroimidate 213 with AlEt3 in 
Et2O provided cyclised compound 214 in 78% yield (Scheme 2.36) formed via a 6-
endo-tet process.88 The regiochemistry of this ring opening reaction is clearly 





Scheme 2.36: Vasella’s aminolysis of alkynyl epoxide 21388 
 
We decided to try Pyne’s aminolysis method using commercially available 
allylamine first to optimize the reaction conditions. When a solution of the epoxide 
198, allylamine (2 equiv) and LiOTf (1 equiv) in CH3CN was heated in a microwave 
reactor at 120 ºC for 20 min, four compounds 215-218 (Scheme 2.37) were formed 
and separated by column chromatography.  
 
 




Compounds 215-217 are isomers and their respective HRESIMS (calcd. for  
C17H29O3NSiNa, (M+Na)
+ 346.1814, found: 346.1818; calcd. for  C17H29O3NSiNa, 
(M+Na)+ 346.1814, found 346.1811; calcd. for  C17H30O3NSi, (M+H)
+ 324.1985, 
found: 324.1995, respectively) confirmed their identical formulae.  
 
The δ-lactone carbonyl of 215 gave rise to a characteristic stretching band at 1776 
cm-1 in its IR spectrum. In the 1H NMR spectrum, H-5 and H-1' resonated at δ 4.59-
4.53 (m) and δ 3.58 (s), respectively. The two diastereotopic protons H-1" resonated 
at δ 3.48 (dd, J = 13.5, 4.5 Hz, 1H, H1'') and δ 3.25 (dd, J = 13.5, 6.5 Hz, 1H, H1''). 
These chemical shifts were consistent with the proposed structure of 215. The 
conversion of 215 to lactam 216 (Scheme 2.39) further supported the structural 
assignments made to these compounds. 
 
The IR spectrum of 216 showed bands for the lactam carbonyl at 1621 cm-1 and for 
the hydroxyl group at 3352 cm-1. The 1H NMR spectrum of 216 was similar to that of 
the lactam 209. For example H-6 and H-5 resonated at δ 4.41-4.32 (m) and δ 4.02-
3.96 (m), respectively. However unlike the 1H NMR spectrum of 209, no NH 
resonance was observed. The two diasterotopic H-1" protons resonated at lower field 
(δ 4.71 (dd, J = 15.0, 2.5 Hz) and δ 3.50 (dd, J = 15.0, 8.0 Hz)) in comparison to 
those of 215, consistent with the structures of 215 and 216 and the stronger electron 
withdrawing effect of the lactam nitrogen and the deshielding effect of the carbonyl 
group in 216. 
 
The IR spectrum of 217 showed a band for the lactam carbonyl at 1689 cm-1. In the 
1H NMR spectrum of 217, the H-1' proton appeared as a doublet at δ 4.57 (d, J = 3.0 
Hz, 1H, H6)), while the two diasterotopic H-1" protons resonated at δ 4.36 – 4.28 (m, 
1H) and δ 3.79 – 3.69 (m, 1H), respectively. These methylene chemical shifts are 
similar to those of lactam 216 and downfield in comparison to H1" found in the 1H 
NMR spectrum of lactone 215. These methylene chemical shifts also supported the 
structure assigned to 217. 
 
The molecular formula of amide 218 was confirmed by it HRESIMS (calcd. for  
C20H37O3N2Si, (M+H)




amide proton CONH appeared at δ 6.03 (br, s, 1H), while H-5 resonated at δ 3.19 (d, 
J = 8.5 Hz, 1H, H5). The coupling constant J4,5 = 8.5 Hz was similar to J2,3 = 8.3 Hz 
found in the 1H NMR spectrum of the syn-1,2-amino alcohol 219 (Figure 2.7)89 and 
confirmed the relative syn-configuration of 218 at C-4 and C-5. 
                                                                         
 
J2,3 = 8.3 Hz 
 
Figure 2.7: Structure and J2,3 coupling constant for the syn- amino alcohol 219
89 
 
The desired products in this reaction were the lactone 215 and the lactam 216. We 
tried to optimize the reaction conditions by changing the reaction time and the molar 
equivalents of the amine to obtained high yields of these compounds. In the first 
reaction, we used a large excess of allylamine (5.5 equiv) and heated the reaction 
mixture in a microwave reactor for 1 h. This led, as would be expected, to a high 
yield of the undesired amide 218 (79%) (Table 3.1.1; entry 1). In the second attempt, 
we reduced the reaction time and equivalents of allylamine (20 min, 2.0 equiv) and 
this resulted in formation of four products but resulted in a low combined yield of 
215 and 216 (27%), although the yield of amide 218 had reduced by a factor of 
nearly 50% (Table 3.1.1; entry 2). In the third attempt, we used 1.2 equivalents of 
allylamine and heated the reaction mixture for 20 min, then added an extra 0.8 
equivalent of the amine and heated the reaction mixture for an additional 40 min 
after checking the progress of the reaction by TLC analysis. Under these conditions, 
the desired lactam 216 was formed in 40% yield while the yield of the amide 218 
was reduced remarkably to 20% (Table 3.1.1; entry 3). We then increased the 
reaction time and reduced the equivalents of allylamine, however this variation did 
not improve the combined yield of 215 and 216 (Table 2.3.1; entries 4 and 5). The 









Isolated Yield (%) 
215 216 217 218 
1 1 h 5.5 0 2 0 11 79 
2 20 min 2.0 21 8 19 8 38 














4 1.5 h 2.0 11 5 32 8 27 
5 3 h 1.5 3 9 23 8 31 
 
 
Table 2.1: Reaction conditions and yields of products (215-218) formed from the 
aminolysis reactions of epoxide 198 with allylamine at 120 ºC in a microwave 
reactor 
 
A scheme to explain the formation of this mixture of four products from the 
aminolysis reaction of 198 is provided in Scheme 2.38. The allylamine can attack at 
C-1 or C-2 of the epoxide moiety of 198 (Scheme 2.38 (1), routes a and b, 
respectively) to form the regioisomeric amino alcohols A and B, respectively. Attack 
at the propargylic C-1 is favoured since the alkynyl group can stabilise any incipient 
positive charge formed at C-1 upon epoxide ring opening. Cyclization of A through 
the hydroxyl group and B through the amino group then gives the 5-membered ring 
lactone 215 and the lactam 217, respectively. The lactam 217 could also be formed 
from the reaction of the ester carbonyl of 198 with allylamine, which initially forms 
the amide epoxide intermediate C. Then a favoured 5-exo-tet attack (in contrast to a 
less favourable 6-endo-tet attack)84 of the amide nitrogen onto the epoxide ring of C 
could also give lactam 217 (Scheme 2.38 (1), route c). Based on the highly 
regioselective outcomes of the later epoxide aminolysis described in this Chapter on 
substrate 234 (Scheme 2.43), which lacks the methyl ester group, we suggest that 
pathway c in Scheme 2.38 (1) is followed to form the 5-membered ring lactam 217. 
 
The 5-membered ring lactone of 215 is quite vulnerable to ring opening by amine. 
Intramolecular attack of the amine group in 215 to the lactone moiety would produce 




lactone of 215 would form the amide 218 (Scheme 2.38 (2), route e). The major 
product from these competing reactions is dependent upon the molar equivalents of 
allylamine used, with an excess amount of allylamine favouring formation of 218 via 






Scheme 2.38: Scheme for the formation of products 215-218 from the aminolysis 
reaction of 198 
 
Lactone 215 was converted to the lactam 216 in 92% yield by heating a solution of 
215 and Et3N (10 equiv) at reflux temperature in MeOH for 3 d. We assume that this 
reaction involves Et3N assisted attack of MeOH to the lactone carbonyl to give the 
corresponding methyl ester A, which then cyclises to the lactam by attack of the 









Scheme 2.39: Synthesis of 216 and the proposed mechanism for the conversion of 
amino lactone 215 to the lactam 216 
 
The aminolysis reaction of the epoxide 198 was next examined using the more 
relevant amine, 1-amino-4-pentene (152). This amine was prepared from 
commercially available 4-penten-1-ol in two synthetic steps. Treatment of this 
alcohol with MsCl, Et3N in CH2Cl2 gave the expected mesylate 220, which was 
converted to the amine 152 by stirring with a mixture of MeOH and saturated NH3 




Scheme 2.40: Synthesis of amine 152 
 
The aminolysis reaction of the epoxide 198 with the amine 152 using the best 
conditions from the model work (the only difference was the addition 2.0 equiv of 
amine 152 in one portion at the beginning of the reaction) gave a mixture of four 
products, compounds 196 and 221-223 (Scheme 2.41). The structure elucidation of 




analysis and from comparisons made with the spectroscopic data of the related 





Scheme 2.41: Ring opening of the epoxide 198 with the amine 152 
 
Under similar reaction conditions developed for the conversion of the lactone 215 to 
the lactam 216, lactone 221 was converted to the lactam 196 in 96% yield by heating 
at reflux with Et3N in MeOH (Scheme 2.42). The 
1H and 13C NMR spectra of the 
lactam 196 are displayed in Figures 2.9 and 2.10, respectively. The NMR resonance 
assignments made to 196 were based on 2D NMR experiments (COSY, HSQC and 
HMBC). In the 1H NMR spectrum, H-5 and H-6 resonated at δ 4.32 (d, J = 4.5 Hz, 
1H, H6) and δ 3.99 (dt, J = 10.0, 4.5 Hz, 1H, H5), respectively. These chemical shifts 
and J5,6 coupling constant were consistent with those of H-5 and H-6 in the cis 
compound 224 (Figure 2.8) reported in the literature (δ 4.14 (d, J = 4.6 Hz, 1H, H6) 






                                                                          J5,6 = 4.5 Hz 
 
Scheme 2.42: Conversion of lactone 221 to lactam 196 
 
 
J5,6 = 4.6 Hz 
 



























Figure 2.10: 13C NMR spectrum (CDCl3, 125 MHz) of 196 
 
2.4   The successful synthesis of the ene-yne lactam 225 (synthetic strategy 3) 
 
In this section, we report the main and most effective pathway to synthesize the ene-
yne lactam 225 (142, Pg = H, R = CH2OPMB) using the retrosynthetic analysis 
outlined in Scheme 2.43. Follow this scheme, 225 could be obtained from 226 via a 
base-catalysed-lactone to lactam rearrangement. This lactone could be prepared from 
the diol 227 by selective oxidation. The diol 227 could be obtained from epoxide 228 
by an epoxide aminolysis reaction with the amine 152, after deprotection of the 
primary hydroxy group. Epoxide 228 could be obtained from the Z-alkene 229 via 
epoxidation. The ene-yne 229 could be prepared from the iodide 187 via a 
Sonogashira coupling reaction with the alkyne 230, followed by hydroxyl group 
protection. The potential advantage of this synthetic route was the absence of the 
methyl ester group in the epoxide 228, which had caused problems in our earlier 
























Scheme 2.43: Retrosynthetic analysis of lactam 225 
 
We first examined this method using allylamine. The Sonogashira coupling reaction 
between iodide 187 and the alkyne 230 worked smoothly with a favourable yield 
(79%) to provide the ene-yne 231. The coupling constant J4,5 = 10.5 Hz in the 
1H 
NMR spectrum of 231 (δ 5.57 (d, J = 10.5 Hz, 1H, H5)) confirmed its Z-
configuration.70 The alcohol 231 then was protected as the TBDPS ether 232 in 81% 
yield (Scheme 2.44). The alkyne 230 was obtained from the reaction of 
commercially available propargyl alcohol with PMBCl (233), which was prepared 











Scheme 2.45: Synthesis of alkyne 230 
 
Epoxidation of 232 using m-CPBA in CH2Cl2 gave the racemic epoxide 234 in 64% 
yield (Scheme 2.46). The cis-configuration of the epoxide 234 was confirmed by the 
coupling constant J4,5 = 3.5 Hz (δ 3.50 (d, J = 3.5 Hz, 1H, H5)) in its 
1H NMR 
spectrum (similar to epoxides 198 (Scheme 2.21) and 201 (Figure 2.3)).77 The 
aminolysis reaction of 234 with allylamine (3.0 equiv) and LiOTf (1.0 equiv) with 
microwave heating at 120 ºC for 1.5 h afforded the racemic amine 235 in 72% yield 
(Scheme 2.46). The molecular formula of 235 was confirmed from its HRESIMS 
(calcd. for  C35H46O4NSiNa, (M+Na)
+  572.3196, found: 572.3224). In the 1H NMR 
spectrum of 235, the H-5 resonance appeared as a doublet at δ 3.19 with a coupling 
constant J4,5 = 8.5 Hz (δ 3.19 (d, J = 8.5 Hz, 1H, H5)). This coupling constant was 
the same as that found in the amino alcohol 218 (Scheme 2.38) and was similar to 
that found in the syn-2,3 amino alcohol 219 (Figure 2.7) (J2,3 = 8.3 Hz).




diasterotopic H-1' protons resonated at δ 3.53-3.45 (m, H1') and δ 3.29 (dd, J = 13.5, 




                                    J4,5 = 8.5 Hz 
 
Scheme 2.46: Synthesis of amine 235  
 
Removal of the TBDPS group of 235 by treatment with TBAF in THF produced the 











Forsyth reported the oxidation of 1,5-diols to δ-lactones in very good yields (77-
94%) using TEMPO/BAIB (Scheme 2.48).92 Martin applied this method to construct 








Scheme 2.49: Martin’s synthesis of lactone 23893 
 
Oxidation of the diol 236 under Forsyth’s conditions gave a complex mixture of 
inseparable products. An alternative method for oxidation of 1,4-diols and 1,5-diols 




Scheme 2.50: Brillet’s synthesis of lactones from the corresponding diols94 
 
However, our attempts to oxidize the diol 236 to the desired lactone under Brillet’s 
conditions also gave a complex mixture of products. Presumably, these reagents 
oxidized the amine group together with the primary hydroxyl group. To avoid this 




Initially, we chose a Boc group as the amine protecting group for the amino alcohol 
236. Pyne reported N-protection of the amino alcohol 239 by the Boc group to 




Scheme 2.51: Pyne’s synthesis of 24095 
 
This procedure worked well with diol 236. The Boc-diol 241 was obtained in better 
yield (88%) and shorter reaction time (18 h) in comparison with Pynes' report 




Scheme 2.52: Synthesis of Boc-diol 241 
 
To our delight, the oxidation of 241 with TEMPO/BAIB proceeded smoothly and the 
corresponding lactone 242 was obtained in good yield (84%) (Scheme 2.53). The 
presence of the Boc group made some resonances in the 1H NMR and 13C NMR 
spectra of 242 broad and difficult to interpret. However, the IR spectrum showed a 
band at 1754 cm-1 for the δ-lactone group and the HRESIMS (calcd. for 
C24H31O6NNa, (M+Na)
+ 452.2037, found: 452.2049) further helped confirm the 







Scheme 2.53: Synthesis of Boc-lactone 242 
 
When searching the literature for a method to remove the Boc group of 242, we 
found that many reagents used for N-Boc deprotection, for example TFA, also cleave 
the PMB protecting group. Therefore we tried Choy’s method for removal of the Boc 
group (Scheme 2.54).96 Compound 242 was dissolved in trifluoroethanol (TFE) and 
heated in microwave reactor at 150 ºC for 1 h. This reaction gave a separable mixture 
of the lactone 243 and the lactam 244 in low yields (19% and 31%, respectively). 
The starting material was also recovered in 30% yield (Scheme 2.55). A proposed 
mechanism for this Boc deprotection method is shown in Scheme 2.56 and involves 
fragmentation of the t-butyl group assisted by the carbonyl group of the carbamate. A 
possible mechanism for the formation of the lactam 244 is shown in Scheme 2.57 
and is similar to the mechanism for the conversion of 215 to 216 (Scheme 2.39) 
involving first formation of the ester intermediate A. 





















Scheme 2.57: Proposed mechanism for the formation of lactam 244 
 
While a longer reaction time may have improved the yields of 243 and 244, the 
Fmoc group was also examined as an amine protecting group for 236. Fmoc 
protection of amines has been widely used in the synthesis of peptides because of its 
ease of formation as well as its cleavage. For example, to protect the amine group of 
the amino alcohol 245, Pyne prepared 246 via Fmoc protection in excellent yield 







Scheme 2.58: Pyne’s synthesis of 24695 
 
This procedure worked perfectly well with the amino alcohol 236. The Fmoc-diol 
247 was achieved in excellent yield (97%). The Fmoc-diol 247 then was oxidised to 
the expected Fmoc-lactone 248 in 86% yield (Scheme 2.59). Similar to the Boc 
protecting group, the Fmoc group caused almost all of the resonances in the 1H NMR 
spectra and some those in the 13C NMR spectra of 247 and 248 to be broad and 
obstructed NMR data analysis. However the HRESIMS of 247 and 248 (calcd. for 
C34H37O6NNa, (M+Na)
+ 578.2519, found: 5782526 and C34H37O6NNa, (M+Na)
+ 
552.2386, found: 552.2397, respectively) confirmed their molecular formulae, while 
the IR spectrum of 248 showed bands for the carbonyl group of the δ-lactone at 1779 











The Fmoc group can be easily removed by treatment with base in CH3CN. DBU, 
piperidine, and morpholine are usually employed for Fmoc deprotection.97,98 
However, treatment of the Fmoc-lactone 248 with piperidine in CH3CN led to the 
lactone 243 in only 40% yield due to a reaction between 243 and piperidine occuring 
when evaporating the solvent at the end of the reaction giving rise to a morpholino-
amide by-product. Alternatively, treatment of 248 with Et3N (20% volume in 
CH3CN) gave the expected lactone 243 in 88% yield (Scheme 2.60). The accepted 
mechanism for the general Fmoc deprotection reaction is shown in Scheme 2.61.99 
Initially, deprotonation of the fluorene group, which is greatly facilitated by the 
aromatic nature of the resultant dibenzocyclopentadienide anion A, is accomplished 
with Et3N. Subsequently, an elimination reaction of A generates dibenzofulvene and 
a carbamate residue, which then decomposes with loss of CO2 to release the free 
amine.  
 
Scheme 2.60: Formation of the lactone 243 
 
Scheme 2.61: Accepted mechanism for the Fmoc deprotection reaction99 
Previously, we successfully converted the amino lactones 215 and 221 to the 
corresponding lactams 216 and 196, respectively, by heating in MeOH at reflux 




reduce the reaction time to convert lactone 243 to lactam 244. The results are 
summarised in Table 2.4.1. Heating 243 with Et3N in MeOH in a microwave reactor 
for 3 h or 8 h gave conversions of 49% and 70%, respectively, by 1H NMR analysis 
(Table 2.4.1, entries 1 and 2). The stronger base DBU did not help improve the yield 
of lactam 244 (Table 2.4.1, entry 4). Heating 243 with DBU in CH3CN in a 
microwave reactor gave no reaction (Table 2.4.1, entry 5). This result provided 
important evidence of the mechanism for the conversion of lactone 215 to lactam 
216, which involves ring opening of the lactone with MeOH and then cyclization of 
the resulting δ-amino ester (Scheme 2.39). The best conditions found were heating 
243 and Et3N in MeOH at reflux temperature for 3 d (Table 2.4.1, entry 3) (Scheme 
2.62). These conditions were used before for the synthesis of the lactams 216 and 
196. 
 
Scheme 2.62: Synthesis of lactam 244 
 
Entry Base (equiv) Solvent Temperature Time  Yield of 244 
1 Et3N (10) MeOH 110 ºC (MW) 3 h 49% (by NMR) 
2 Et3N (10) MeOH 110 ºC (MW) 8 h 70% (by NMR) 
3 Et3N (10) MeOH reflux 3 d 91% (isolated) 
4 DBU (1) MeOH 110 ºC (MW) 3 h 52% (by NMR) 
5 DBU (1) CH3CN 110 ºC (MW) 3 h 0% 





With the model work with allylamine proceeding efficiently, we then proceeded to 
prepare the ene-yne lactam 225. TBSCl, a less expensive protecting reagent, was 
employed rather than TBDPCl, and the TBS ether 249 was obtained from alcohol 
231 in 93% yield. Epoxidation of 249 using m-CPBA in CH2Cl2 led to the racemic 
epoxide 250 in 63% yield, which underwent ring opening upon aminolysis with the 
amine 152 to provide the amino alcohol 251 in 74% yield (Scheme 2.63). 
 
Scheme 2.63: Synthesis of amine 251 
 
Removal the TBS group of 251 by treatment with TBAF in THF provided the diol 
227 in 91% yield, which was converted to the Fmoc derivative 252 in excellent yield 
(96%) by treatment with FmocCl in THF-sat. Na2CO3 at 0 ºC for 4 h. Oxidation of 
the Fmoc-diol 252 with TEMPO/BAIB in CH2Cl2 led to the corresponding δ-lactone 
253 in good yield (84%) (Scheme 2.64). The IR spectrum of 253 showed a band for 
the δ-lactone carbonyl group at 1773 cm-1. In the 1H NMR spectrum of diol 227, the 
protons H-4 and H-5 resonated at δ 3.48 – 3.43 (m, 1H, H4) and δ 3.15 (d, J = 9.0 
Hz, 1H, H5), respectively. The relative syn-configuration of 227 at C-4 and C-5 was 
consistent with the coupling constant J4,5 = 9.0 Hz. This coupling constant is similar 








Scheme 2.64: Formation of Fmoc-lactone 253 
 
Finally the Fmoc group of 253 was removed by treatment with Et3N in CH3CN in 
86% yield and the resulting lactone 226 was converted to the expected lactam 225 by 
heating with Et3N in MeOH at reflux temperature in 84% yield (Scheme 2.65). The 
1H NMR and 13C NMR spectra of the lactone 226 are displayed in Figures 2.11 and 
2.12, respectively. The NMR resonance assignments of 226 are based on 2D NMR 
experiments (COSY, HSQC and HMBC). The 1H NMR spectrum showed 
resonances for H-5 and H-1' at δ 4.60 (dd, J = 7.0, 5.5 Hz, 1H, H5) and δ 3.59 (d, J = 
5.5 Hz, 1H, H1'), respectively. The two diasterotopic protons H1'' resonated at δ 2.92 
(dt, J = 11.5, 7.0 Hz, 1H, H1'') and δ 2.67 – 2.59 (m, H1''). The 1H NMR chemical 
shifts are consistent with the structure of the expected compound (226). In the 13C 
NMR spectrum, the resonances for C-2, C-4" and C-5" appeared in the expected 
chemical shift regions at δ 177.1, 138.5 and 115.1, respectively. 
 
The 1H NMR and 13C NMR spectra of the lactam 225 are displayed in Figures 2.13 
and 2.14, respectively. The 1H NMR spectrum shows resonances for the H" protons 
at δ 3.81 – 3.71 (m, 1H, H1'') and δ 3.12 (dt, J = 14.0, 7.0 Hz 1H, H1''), downfield in 




of 225, C-5 resonated at δ 66.8 (C5), an expected upfield chemical shift compared to 




































































Figure 2.14: 13C NMR spectrum (CDCl3, 125 MHz) of 225 
 
2.5   Conclusions 
 
In conclusion, we have examined three different synthetic strategies to synthesize an 
ene-yne lactam similar to 142. The first strategy failed due to the ring opening of the 




























The second synthetic strategy failed because of the low yield of the lactone 184 and 
its unsuccessful conversion to the ester derivative 195 due to a competing proto-
desilylation process.  
 
Scheme 2.67: Summary of outcomes from synthetic strategy 2 
 
Using synthetic strategy three, we achieved the synthesis of the ene-yne lactam 196 
via the aminolysis ring opening reaction of the epoxide 198, however we could not 
improve the yield of the desired products (196 and 221) over 40% due to competing 
reactions of the reactive ester group. Finally, we have successfully synthesized the 
ene-yne lactam 225 via the epoxide 250 (228; Pg = TBS), in which the problematic 
ester group was replaced with a CH2OTBS group. Lactam 225 was obtained in 11 
synthetic steps and 12.1% overall yield from 4-pentyne-1-ol. Construction of the A-B 
and A-B-C ring systems and attempts to make the ether linkage of stemocurtisine 
from the lactam 225 will be discussed in Chapter 3.  
 
 





CHAPTER 3: CONSTRUCTION OF THE A-B AND A-B-C RING SYSTEMS 
OF STEMOCURTISINE 
 
3.1   Construction of the A-B ring system of stemocurtisine 
 
3.1.1   With an O-acetyl protecting group 
 
With the ene-yne lactam 225 in hand, we then examined the construction of the A-B 
ring system of stemocurtisine, following the retrosynthestic analysis shown at 
Scheme 3.1. The bicyclic compound 254 could be obtained from the ene-yne 255 
(142, R = COOMe) following the ene-yne ring closing metathesis procedure 
described by Mori.27 Compound 255 could be obtained from 225 via hydroxyl group 




Scheme 3.1: Retrosynthestic analysis of 254 
 
Initially, the acetyl group was chosen to protect the hydroxyl of 225 due to its ease 
formation and subsequent cleavage. Follow Argade’s procedure (preparation of 257 
from 256),100 treatment of the alcohol 225 with Ac2O and Et3N in CH2Cl2 afforded 









Scheme 3.2: Acetylation of 256 and 225 under Argade’s conditions100 
 
The next step involved the removal of the PMB protecting group of 258. There are 
many methods to achieve this (Scheme 3.3). Enders reported the oxidative removal 
of the PMB ether group in 259 using CAN to prepare the primary alcohol 260 in 
90% yield.101 Jung used TFA and 1,3-dimethoxybenzene to cleave the PMB group of 
261 to produce the corresponding primary alcohol 262 in 85% yield.102 The PMB 
deprotection of 263 was carried out in CH2Cl2 using DDQ and Mn(OAc)3 to provide 
the secondary alcohol 264 in 86%.103 Tang used DDQ in CH2Cl2 and H2O (15:1) to 












Scheme 3.3 (continued): Literature methods for PMB deprotection101-104 
 
In order to maximize the yield of the PMB deprotection reaction of compound 258, 
the four methods described above for PMB removal were examined. The results are 
summarized in the Table 3.1. Treatment of the PMB ether 258 with DDQ in CH2Cl2 
and H2O (10:1) gave the best yield (78%) of the corresponding alcohol 267 (Table 
3.1, entry 4) (Scheme 3.4). 
 
Entry Reagent Solvent Time Yield of 267 
1 CAN CH3CN-H2O (4:1) 16 h 66% 
2 TFA and 1,3- 
dimethoxybenzene 
CH2Cl2 14 h 54% 
3 DDQ and Mn(OAc)3 CH2Cl2 16 h 77% 
4 DDQ CH2Cl2-H2O (10:1) 18 h 78% 
 






Scheme 3.4: Optimal conditions for PMB deprotection of 258 
 
Jones’ oxidation (acetone, 0 ºC) of 267 gave the corresponding acid. Treatment of 
this acid with TMSCl/MeOH provided the methyl ester 182, with loss of the acetate 
group. Unfortunately the overall yield of these two steps was very low. The ester 182 




Scheme 3.5: Synthesis of ester 182 
 
To our surprise, treatment of the ene-yne 182 with Grubbs’ 1st generation Ru catalyst 
in CH2Cl2 gave no product. Heating the reaction mixture at reflux did not help the 
reaction occur. We thought that perhaps the OH group could co-ordinate to the 
catalyst and then deactivate it. To prevent this co-ordination, Ti(OiPr)4 was added to 
the reaction mixture before heating at reflux temperature.105 It was anticipated that 
the Ti(OiPr)4 would prevent deactivation of the catalyst by coordination to the OH 
group of 182. However, this modifiation failed to form the desired product 268 and 







Scheme 3.6: Attempted RCM reactions of 182 
 
We then decided to protect the hydroxyl group of 182 before trying the RCM 
reaction. Treatment of 182 with Ac2O and Et3N in CH2Cl2 produced compound 269 
in 81% yield. Finally, RCM of 269 catalysed by Grubbs’ 1st generation Ru catalyst in 




Scheme 3.7: Preparation of the bicycle 270 
 
The proposed mechanism for the ene-yne ring closing metathesis reaction is shown 
at Scheme 3.8.106 In the initiation step (a), the initial Ru complex undergoes loss of 
Cy3P to generate an active catalyst abbreviated as  [Ru]=CHPh.  This undergoes a 
cycloaddition reaction with the alkene group of the substrate forming the 
ruthenacyclobutane A. A subsequent cycloelimination reaction then releases styrene 




triple bond to yield the bicyclic ruthenacyclobutene C. After cycloelimination the 
vinyl carbene catalyst D is generated. In the catalytic cycle (b), the vinyl carbene D 
first adds to the double bond of the substrate forming the ruthenacyclobutane E. 
Cycloelimination then gives the product and the ruthenium carbene intermediate B 
which undergoes a subsequent intramolecular cycloaddition with the alkyne give the 
bicyclic ruthenacyclobutene C. After cycloelimination, the vinyl carbene D is 










The structure of 270 was clearly evident from an analysis of its 1H NMR spectrum 
(Figure 3.1). The H-9 and H-10a protons resonated at δ 5.83 (t, J = 6.0 Hz, 1H, H9) 
and 4.46 (s, 1H, H10a), respectively. In addition, the two H-4' protons appeared at δ 
6.20 (s, 1H, H4', Z) and 5.60 (s, 1H, H4', E). The 13C NMR spectrum showed 
resonances for the correct number and types of carbons. Furthermore, the HRESIMS 
(calcd. for  C16H21O5NNa, (M+Na)
+ 330.1317, found: 330.1302) analysis confirmed 
the molecular formula of compound 270. The 1H and 13C NMR spectroscopic 
assignments are shown in Figures 3.1 and 3.2. These were based on 2D NMR 























Figure 3.2: 13C NMR spectrum (CDCl3, 125 MHz) of 270 (x: impurities) 
 
3.1.2   Using an O-benzyl protecting group  
 
Due to the unsatisfactory overall yield of 182 (30%), the benzyl group was next 
examined as a hydroxyl protecting group for 225. In contrast to the benzylation 
reaction of the imide 168 (Scheme 2.6), benzylation of the lactam 225 with BnBr, 
Ag2O in Et2O gave the corresponding benzyl ether 271 in very poor yield (29%) 
(Scheme 3.9). A slight improvement was achieved (45% yield and 19% starting 
material recovered) under William’s type conditions used for the synthesis of 273 
from 272 (Scheme 3.10).107 
 
 























Scheme 3.10: O-benzylation of 272 and 225 under William’s conditions107 
 
PMB deprotection of compound 271 was carried out using DDQ in CH2Cl2-H2O at rt 




Scheme 3.11: Removal the PMB group of 271 by DDQ 
 
The primary alcohol group of 274 was oxidized to the corresponding acid by Jones’ 
reagent in acetone at 0 ºC. We did not employ TMSCl/MeOH for the esterification of 
this acid because of our concerns for the benzyl protecting group, which may have 
been cleaved under the strong acid conditions (HCl is generated in situ from the 
reaction of TMSCl and MeOH). Kambe reported the synthesis of the ester 276 by 





Under these conditions, we obtained the ester 277 in 65% yield over the two steps 








Scheme 3.13: Synthesis of ester 277 
 
The bicyclic compound 278 was achieved in 80% yield via an ene-yne RCM reaction 
by treatment of 277 with Grubbs’ 1st generation Ru catalyst in CH2Cl2 for 8 h under a 












3.1.3   Using an O-TBS protecting group 
 
Because of the low yields in the conversion of the alcohol 267 to the ester 182 and 
O-benzylation reaction of 225, we next examined the use of the TBS protecting 
group. 
  
TBS protection of the hydroxyl group of the lactam 225 was quite a challenging 
process. Treatment of compound 225 with TBSCl and imidazole in DMF (under 
similar conditions that were used to prepare the TBS ether 170 shown in Scheme 
2.6) gave only 20% yield of the expected product 279 (Scheme 3.15). Casiraghi 
reported the TBS-protection of 280 in 92% yield using TBSOTf and 2,6-lutidine in 
CH2Cl2.
109 Our first attempt using these conditions gave the desired TBS ether 279 in 
30% yield (61% starting material recovered). Finally, with a slight modification we 
increased the yield of 279 to 81% (Scheme 3.16). TBSOTf (0.67 equiv) and 2,6-
lutidine (1.0 equiv) were added dropwise to a solution of 22 at 0 ºC then the mixture 
was warmed to rt and stirred for 1 h. This process was repeated three times and then 
the reaction mixture was stirred at rt for 14 h. TLC analysis then showed complete 
disappearance of the starting alcohol. The TBS ether 279 was obtained in 81% yield 















Scheme 3.16: TBS protection of 225 and 280 under Casiraghi’s conditions109 with 
modification 
 
The PMB group of 279 was removed by treatment with DDQ to provide the 




Scheme 3.17: Synthesis of the primary alcohol 282 
 
Jones’ oxidation of 282, followed by methylation (K2CO3/MeI in DMF) provided the 
ester 141 in 67% yield (over two steps from 282) (Scheme 3.18). 
 
 




Treatment of the ene-yne 141 with Grubbs’ 1st generation Ru catalyst in CH2Cl2 





Scheme 3.19: Preparation of the bicycle 140 
 
3.2   Synthesis of the A-B-C ring system of stemocurtisine 
 
With the three bicyclic compounds, 140, 270 and 278 in hand, we continued to 
follow Mori’s procedures27 to construct the corresponding tricyclic compounds 
possessing the core A-B-C ring structure of stemocurtisine 2. 
 
Mori27 reported the synthesis of the saturated ester 69 from the reduction of α,β-
unsaturated ester 68 with NaBH4/MeOH  via a 1,4-“hydride” reduction reaction. This 
reaction gave 69 as an inseparable mixture of diasteromers in 85% yield (Scheme 
1.1.1). Swamy60 successfully applied this procedure to prepare a diasteromeric 
mixture of 284 in good yield (75%, dr = 4:1) from the reduction of the α,β-






Scheme 3.20: Mori’s27 and Swamy’s60 reduction of α,β-unsaturated esters 68 and 
283 
 
This procedure proceeded smoothly with our compounds 140, 270 and 278. We 
obtained the corresponding saturated esters 139, 285 and 286, in 75-78% yields as 
mixtures of two diastereomers (Scheme 3.21 and Table 3.2). Noticeably, in all three 
reactions, the products and the starting materials had the same Rf values (by TLC 
analysis). So the success of these reactions was indicated by 1H NMR analysis of the 
crude reaction mixture before purification by column chromatography. 
 
 
Scheme 3.21: Synthesis of saturated esters 139, 285 and 286 
 
Starting material R Product Yield dr 
140 TBS 139 78% 3:1 
270 Ac 285 75% 2.5:1 
278 Bn 286 77% 4:1 
 




Mori in his total synthesis of stemoamide 72 (Scheme 3.21),27 hydrolysed the ester 
69 using NaOH/MeOH-H2O at 0 ºC for 7 h to furnish the corresponding acid. Then 
bromolactonization of this acid by treatment with CuBr2 on alumina proceeded 
smoothly via a 5-endo-trig cyclization, and two products 70 and 71 were obtained in 
25% and 31% yields, respectively. Treatment of the bromide 70 with Et3N in EtOAc 




Scheme 3.22: Mori’s synthesis of the tricyclic compound 71 
 
Swamy applied Mori’s procedure to the compound 287.60 This reaction resulted in 
the synthesis of desired tricyclic compound 288 and its diasteromer 289 (dr = 1:1) in 
a combined yield of only 27% (Scheme 3.23). 
 
 
Scheme 3.23: Swamy’s bromolactonization of 287 
 
We tried this method of bromolactonization on our compounds 139, 285 and 286. 
Unfortunately, these reactions failed to form the desired tricyclic lactone products 








Scheme 3.24: Attempted bromolactonization of compounds 139, 175 and 176 
 
Figueredo reported that the dihydroxylation reaction of the alkene 292 with 
OsO4/NMO in acetone-H2O at 65 ºC for 1.5 h provided the desired dihydroxylated 
product 293110 in an excellent yield of 92% (Scheme 3.25). Swamy60 successfully 
synthesized the tricyclic lactone 294 from 287 following this dihydroxylation method 
with some modifications. Lactone 294 was obtained in moderate yield (56%) and 










Our attempts at the dihydroxylation reactions of compounds 139, 185 and 186 under 
Swamy’s conditions were not successful. We also tried to dihydroxylate these 
compounds using AD-mix-α and MeSO2NH2 using a co-solvent system of t-BuOH-
H2O, but these reactions also failed to form the desired products. Only the starting 
materials were recovered (Scheme 3.26). We are not sure why compounds 139, 185 
and 186 were so unreactive towards these bromolactonization and dihydroxylation 




Scheme 3.26: Attempted dihydroxylation reactions of 139, 185 and 186 
 
Tunge reported a method of halolactonization of β,γ-unsaturated carboxylic acids 
using NBS or NCS.111 These reactions gave mixtures of β-lactones and γ-lactones 
(Scheme 3.27). With the substrate 295, the yield of the latter (compound 296) was 
maximised by using diphenyldiselenide as a catalyst. For example, γ-lactone 299 was 
obtained in excellent yield (90%) from 4-phenyl-3-butenoic acid (Scheme 3.27). 
 
 






Scheme 3.27 (continued): Tunge’s halolactonization111 
 
The proposed mechanism111 of this halolactonization reaction is shown in Scheme 
3.28. Initially, the electrophilic NBS is activated via nucleophilic attack by 
PhSeSePh to form the ionic intermediate A. This intermediate then converts the 
alkene 298 to the bromonium ion intermediate B, where the selenium derivative 
remains coordinated to the bromine. Intramolecular attack by the carboxylate anion 









Our model work with this bromolactonization method proceeded well. Treatment of 
4-pentenoic acid with PhSeSePh and NBS in CH3CN at -30 ºC gave the 
corresponding lactone 300 in 68% yield, which had NMR spectroscopic data 




Scheme 3.30: Synthesis of lactone 300 
 
We then applied this procedure to compound 139 with some modifications. First, the 
ester 139 was hydrolysed to the corresponding acid by treatment with NaOH/MeOH-
H2O at 0 ºC for 8 h followed by acidification with HCl. The crude acid was then 
treated with NBS and PhSeSePh in CH3CN at -30 ºC for 3 h. Instead of attempting to 
isolate the intermediate bromolactone, the crude reaction mixture was treated with 
Et3N in EtOAc to promote elimination of hydrogenbromide. Purification of the 
reaction mixture by column chromatography gave the two bicyclic lactones 301 and 
302 in yields of 31% and 20%, respectively (Scheme 3.30). Treatment of the minor 
product 302 with DBU in CHCl3 converted it to the desired compound 301 in 60% 
yield. This interconversion most likely proceeds via the resonance stabilized 









Scheme 3.30: Synthesis of the tricyclic compound 301 via Tunge’s halolactonization 
method 
 
The identical molecular formulae of compounds 301 and 302 was confirmed by 
HRESIMS analysis (calcd. for C19H32NO4Si, (M+H)
+ 366.2101, found: 366.2099 
and calcd. for C19H32NO4Si, (M+H)
+ 366.2101, found: 366.2110). In their 1H NMR 
spectra, the H-11a protons of 301 and 302 resonated as singlets at δ 4.71 and δ 4.27, 
respectively, while the H-3a protons resonated at δ 4.97 (d, J = 9.5 Hz, 1H, H3a) and 
δ 4.80 (d, J = 11.0 Hz, 1H, H3a), respectively. The H-1' proton resonances of 301 
and 302 appeared, as expected, as singlets at δ 1.90 (s, 3H, H1') and 2.10 (s, 3H, 
H1'), respectively. The 1H and 13C NMR spectroscopic assignments of the desired 
diasteromeric product 301 are shown in Figures 3.3 and 3.4, respectively. 
 
Evidence for the relative configuration of 302 was obtained from NOESY NMR 
experiments, which showed a significant correlation between resonances for H3a and 
H11a ((Figure 3.6). In compound 301 however, no NOESY correlation between 
these corresponding resonances was observed (Figure 3.5). NOESY correlations 
between the resonances for H-11 and H-11a and H-6β and H-11a were also observed 





















































Figure 3.5: Spartan model (AM1) of 301 with atomic labelling and NOESY 
correlations shown by double-headed arrows 
 
 
Figure 3.6: Spartan model (AM1) of 302 with atomic labelling and NOESY 




The major product of the bromolactonization of 139 (compound 301) and the 
conversion of compound 302 to compound 301 under basic conditions suggest that 
compound 301 is thermodynamically more stable than compound 320. Initially these 
structures were drawn in Spartan and a conformationed library was generated using 
molecular mechanics (MM force field). The lowest energy conformation was then 
geometry optimized using Semi-Empirical calculations (AM1). The AM1 heats of 
formation calculated for compound 301 and 302 were -863.2 kJ/mol and -851.5 
kJ/mol, respectively, indicating 301 was thermodynamically more stable than 302 in 
the gas phase by about 12 kJ/mol. The calculated distances between H-3a and H-11a, 
H-3a and H-6β, and H-1 and H-11a in compound 302 were 2.73 Å, 2.45 Å and 2.39 
Å, respectively, while for compound 301 the distances between H-3a and H-6α and 
H-11and H-11a were 2.79 Å and 2.45 Å, respectively. These interproton distances (< 
3.0 Å) are consistent with the proposed structures of 301 and 302 and the observed 
NOESY correlations. The difference in energy between 301 and 302 was attributed 
to the sterically unfavourable pseudo-1,3-diaxial interactions between H-3a and H-6β 
and H-3a and H-11a in 302 and the closer distance between Me-1'a and the OTBS 
group in 302 (2.30 Å ) compared to that in 301 (2.73 Å) (Figures 3.5 and 3.6). 
 
Mori27 reported that treatment of the α,β-unsaturated lactone 71 with NaBH4 in the 
presence of NiCl2.6H2O in MeOH furnished (-)-stemoamide 72 in 76% yield. 
Following this procedure, Swamy60 obtained an inseparable mixture of lactones 304 
and 305 in 78% yield from the reduction of the α,β-unsaturated lactone 303 (dr = 87: 
13) (Scheme 3.32). The 1H NMR spectrum of the major product 304 showed 
resonances for the H-1' proton as a doublet at δ 1.32 (d, J = 7.2 Hz, 3H, H1') and the 
H-1 proton as a dq at δ 3.30 (dq, J = 12.3, 7.2 Hz, 1H, H1). The coupling constant 
J1,1a = 12.3 Hz was consistent with that of stemoamide 72 reported in the isolation 












Scheme 3.32: Reduction of α,β-unsaturated lactones 7127 and 30360 
 
A proposed mechanism for this reduction reaction is shown in Scheme 3.33. This is 
based on the proposed mechanism for a related reduction using Cu2Cl2/NaBH4,
114 it 
is postulated that a nickel “hydride” species is formed in situ, which is responsible 










However, compound 301 was not reduced under these conditions. Treatment of 301 
with NaBH4 and NiCl2 in MeOH at -30 ºC gave no product. This reaction did not 
occur when it was warmed to 0 ºC or rt. We also replaced the NiCl2 by Cu2Cl2 as the 
catalyst (following Takeda’s procedure)114 but again the reduction reaction did not 
occur (Scheme 3.34).  
 
 
Scheme 3.34: Attempted reduction reactions of the α,β-unsaturated lactones 301 
 
We thought that the bulky TBS protecting group may have hindered these reactions. 
Therefore the TBS group of 301 was removed by treatment with TBAF in THF 
buffered by AcOH to provide the alcohol 307 in 78% yield (Scheme 3.35). However 
compound 307 was also unreactive under the aforementioned reduction conditions. 
We have no good explanation as to why these α,β-unsaturated lactones (301 and 307) 
were so unreactive in comparison to compounds 71 and 303 (Scheme 3.36). Perhaps 
the double bond in these compounds is less conjugated with the lactone carbonyl 
group because of the larger A-ring making it less electron deficient and more 
difficult to reduce. 
 
 






Scheme 3.36: Attempted synthesis of 138 
 
Pak reported that α,β-unsaturated esters could be reduced to the corresponding 
saturated esters in high yields (76-98%) using Mg/MeOH (Scheme 3.37).115 Viterbo 
followed this method to prepare compounds 309 and 310 from the enone 308 in good 











More impressively, Zarecki applied this method to reduce the conjugated unsaturated 





Scheme 3.38: Zarecki’s synthesis of 312117 
 
We decided to examine this procedure on the α,β-unsaturated lactone 301. 
Compound 301 was treated with Mg turnings (10 equiv) in MeOH for 1 d at rt. To 
our delight, the desired product 306 was obtained in good yield (71%) and excellent 
diasteroselectivity (dr > 95:5) (Scheme 3.39). This was the most impressive result of 
our synthesis. Presumably, the reduction of 301 led to a mixture of diastereomers 306 
and 313. However 313 is the thermodynamically less stable isomer due to an 
unfavourable steric repulsion between the CH3 group and the bulky TBS group. 
Under the basic conditions of Mg(OMe)2, we assume that if 313 was formed it would 










Scheme 3.39 (continued): Reduction of 301 by Mg/MeOH 
 
The structure of 306 was confirmed by NMR, IR, MS and single crystal X-ray 
crystallographic analyses. The molecular formula of 306 was also confirmed by 
HRESIMS analysis (calcd. for C19H34O4NSi, (M+H)
+ 368.2257, found: 368.2256). In 
the 1H NMR spectrum of 306, H-3a and H-6β resonated at δ 4.79 (td, J = 11.5, 2.5 
Hz, IH, H3a) and δ 4.48 (d, J = 13.5 Hz, IH, H6β), respectively. The resonances for 
the H-11 and H-11a protons appeared at δ 4.25 (s, 1H, H11) and δ 3.73 (d, J = 7 Hz, 
1H, H11a), respectively. H-1 and H-1' resonated typically at δ 2.86 (dq, J = 14.0, 7.0 
Hz, 1H, H1) and 1.30 (d, J = 7.0 Hz, 3H, H1'). The coupling constant J1,11b = 14.0 Hz 
was quite close to the corresponding coupling constant of stemoamide113 and is 
consistent with the 1,2-diaxial like relationship between H-1 and H-11b in the X-ray 
structure (ϕ1,11b = -156.1º). The 1H and 13C NMR spectroscopic assignments of the 
tricyclic compound 306 are shown in Figures 3.7 and 3.8, respectively and are based 
on 2D NMR experiments (COSY, HSQC, HMBC). 
 
Evidence for the configuration of 306 was obtained from NOESY NMR experiments 
(Figure 3.9). Strong NOESY correlations were observed between H-11 and H-11a, 
H-11 and H-11b, H-11a and H-11b, H-11b and H-6β, H-11a and H-6β, H-1 and H-3a 
and H-3a and H-1' (Figure 3.9). No correlations were observed between H3a and 
H11b or between H1 and H11b, which further confirmed the relative configurations 



















































Figure 3.9: Spartan model (AM1) of 306 with atomic labeling and NOESY 
correlations shown by double-headed arrows. 
 
Finally, the relative configuration of 306 was confirmed by its single crystal X-ray 
crystallography structure (Figure 3.10). 
 
 




We also used the Mercury software to visualise the X-ray structure of compound 306 
and to measure some important distances between atoms (Figure 3.11). The results 
are given in Table 4.2 with a comparison made with the corresponding distances 










Figure 3.11 (continued): Mercury displayed X-ray crystal structure 306 with atomic 






Entry Selected atom pairs Distances (Å) 
Spartan model X-ray 
1 H-11-H-11a 2.39 2.33 
2 H-11a-H-1’b 3.02 2.36 
3 H-11-H-1’b 4.27 3.09 
4 H-11b-H-6β 2.43 2.14 
5 H-11a-H-6β 2.34 2.65 
6 H-3a-OTBS 3.43 2.43 
7 H-11b-H-1'a 2.34 2.37 
 
Table 3.3: Comparison of the calculated distances between selected atoms in 306 
from X-ray analysis with calculations using Spartan (AM1) 
 
While the Spartan calculations were made with a low level of theory and in the gas 
phase, there is a reasonable agreement between the modeled distances and those in 
the solid state for four of the seven distances shown in the Table 3.3 (entries 1, 4, 5 
and 7). These four distances are for protons in the ridged tricyclic structure. Major 
differences are seen between the gas-phase and solid state distances between the C-1 
methyl proton (H-1b') and H-11a and H-11; and H-3a and the oxygen at C-11 (Table 
3.3, entries 2, 3, and 6). The modeling predicts these distances to be significant 
longer. This could be due to crystal-packing effects in the solid state in which these 
large ring substituents are forced into a position to minimize interactions with 
neighboring molecules in the crystal lattice.  
 
Similar to the α,β-unsaturated lactone 301, the α,β-unsaturated lactone 307 was 









Scheme 3.40: Reduction of 307 by Mg/MeOH 
 
Treatment of 306 with TBAF buffered with AcOH in THF also provided compound 
138 in 80% yield, which was ready for attempts to prepare the ether linkage between 
C-11 and C-3a (Scheme 3.41). The 1H and 13C NMR spectroscopic assignments of 










































3.3   Attempts to make the C-3a-C-11 ether linkage 
 
Making the ether linkage between C-3a and C-11 of 138 was a very challenging and 
crucial step in our synthesis. The literature indicated that this might be achieved 
under photochemical oxidative conditions. 
Brimble reported a successful photochemically induced cyclization reaction of the 
spirocyclic compound 314. Compound 314 was irradiated in the presence of I2 and 




Scheme 3.42: The photochemical oxidative cyclization of 314118 
 
A possible mechanism of this reaction is shown in Scheme 3.43. Compound 314 
reacts with I2 to form the corresponding hypoiodite A, which undergoes homolytic 
cleavage (in the presence of light) to form the free radical B. The radical B is then 
transformed to the radical C by intramolecular H-atom abstraction. This radical is 
oxidized to the cation D by PhI(OAc)2. Finally, intramolecular attack of the hydroxyl 






Scheme 3.43: Proposed mechanism for the formation of 315118 
In a related process, Burton reported the photosynthesis of the O-bridge steroid 317. 
Irradiation of compound 316 in the presence PhI(OAc)2 and I2 in CH2Cl2 resulted in 
compound 317 in excellent yield (89%) (Scheme 3.44).58 These reactions favour H-
atom abstraction by the RO• radical from a CH or CH2 five atoms away (through a 




Scheme 3.44: Burton’s synthesis of 31758 
These procedures could in principle be applied to make the ether linkage in 137 from 




in Scheme 3.45. Compound 138 can react with I2 to form the hypoiodite A, which 
can undergo homolytic cleavage (in the presence of light) to form the free radical B. 
The radical B can then be transformed to the radical C by intramolecular H-atom 
abstraction. As stated above, the distance between the oxygen at C-11 and H-3a is 
2.43 Å in the X-ray structure (Table 3.3, entry 6), which would seem to be 
sufficiently close enough for this method to be successful. Further, the radical C can 
be resonance stabilize by the neighbouring lactone oxygen substituent. This radical 
then can be oxidized to the resonance stabilized cation D by PhI(OAc)2. Finally, 
intramolecular attack of the hydroxyl group to the electrophilic carbon in D can 
furnish the desired product 137. 
 
Scheme 3.45: Anticipated synthesis of the cyclic ether 137 
Thus, compound 138 was dissolved in CH2Cl2 then irradiated in the presence of I2 
and PhI(OAc)2. Compound 138 was very reactive under these reaction conditions. 
TLC analysis showed the disappearance of the starting material after 30 min of 
irradiation. However, after workup we obtained a very complex mixture of products, 
from which the major product tentatively assigned as structure 318 was isolated in 
18% yield (Scheme 3.46). The 1H NMR spectrum of this compound indicated the 
presence of two isomeric compounds (A: major isomer, B: minor isomer) in a ratio 
of 2.5:1. Both products had an aldehyde resonance (δ 9.81 (s, H4'B); δ 9.79 (s, 
H4'A)), an acetoxy resonance (δ 2.11 (s, CH3COA); δ 2.03 (s, CH3COB)), a 
resonance for a hemiaminal proton (δ 7.06 (d, J = 9.0 Hz, H4B); δ 6.66 (d, J = 8.0 
Hz, H4A)), and a resonance for a methyl group attached to a CH δ 1.25 (d, J = 6.5 




H-3a in the COSY spectrum (observed in both isomers). COSY correlations were 
also observed between H-3 and H-1" and H-3 and H3a (weak) (Figure 3.14 A). 
Other proton assignments were deduced from 2D NMR spectra (COSY, HSQC, 
HMBC) (Figure 3.15). Similarly, the 13C NMR spectrum showed resonances for an 
aldehyde group (δ 200.9 C4'A; 200.6 C4'B), a lactone carbonyl group (δ 177.4 C2B; 
177.0 C2A), an amide carbonyl group (δ 171.8 C1'A; 171.5 C1'B), an acetoxy 
carbonyl group (δ 170.0 COMeA; 169.0 COMeB), a hemiaminal carbon (δ 82.6 
C4A; 78.2 C4B), a methyl (δ 21.0, C1'A; 20.8, C1' B) and an acetyl methyl group (δ 
15.0 COMeB; 14.7 COMeA). HMBC correlations were observed between H-3 and 
C-2; H-1' and C-2 ; H-4' and C-2' and C-3'; and H-4 and the acetoxy carbonyl group 
(Figure 3.14 B). The 13C NMR carbon assignment resonances were deduced from 
2D NMR spectra (COSY, HSQC, HMBC) (Figure 3.16).  
From the analysis of this spectroscopic data, the structure of the major compound 
was deduced as structure 318 (Scheme 3.46) despite being unable to assign all the 
proton and carbon resonances for the minor isomer. However, both the low and high 
resolution mass spectra showed that the molecular formula of this compound was 
C15H21O8N (HRESIMS calcd. for C15H21O8NNa, (M+Na)
+ 366.1165, found 
366.1158) indicating that this molecule had two more oxygen atoms compared to the 
proposed structure 318. Clearly, the NMR data and MS data are at odds with each 
other and the structure assigned to 318 remains uncertain as it is difficult to 
accommodate two more oxygen atoms into structure 318 without significant changes 
in the NMR spectra. 
 










Figure 3.15: 1H NMR spectrum (CDCl3, 500 MHz) of 318 (A refers to the major 





















































A proposed a mechanism for the formation of the tentative structure 318 as shown in 
Scheme 3.47. The hypoiodite A, which forms from the reaction of 138 with I2 
(Scheme 3.45), can undergo an ionic-fragmentation to form the N-acyliminium ion B 
(Scheme 3.47, path a). Alternatively, the intermediate A can undergo homolytic 
cleavage of the hypoiodite to form the free radical C (Scheme 3.47, path b), which 
can undergo radical fragmentation to form the radical intermediate D. This 
intermediate then can be oxidized to the N-acyliminium ion B by PhI(OAc)2. 
Addition of acetate to this acyliminium ion (from both faces of the iminium ion) can 
provide hemiaminal 318 as a mixture of diastereomers.  
 
 
Scheme 3.47: Proposed mechanism for the formation of the tentative structure 318 
A related oxidative fragmentation was reported by Sarpong. Treatment of compound 
319 with PhIO gave compound 320 in 75% yield (Scheme 3.48).119 The reaction was 
thought to proceed via the intermediates A or B, the latter intermediate being similar 






Scheme 3.48: Sarpong’s synthesis of 320119 
Based on the Sarpong mechanism, other possible mechanisms for the formation of 
the N-acyliminium ion B are shown Scheme 3.49. These mechanisms however do 
not involve I2.  
 
 




Earlier, Swamy attempted to make the ether 321 from the tricyclic compound 304 
using a similar photochemical synthetic procedure.60 A mixture of compound 304, 
PhI(OAc)2 and I2 in CH3CN were irradiated at 40W for 6 h. However, no desired 
product was formed, only the unreactive starting material was recovered (Scheme 
3.50). In this case, the alcohol 342 was not soluble in CH2Cl2 and the photolysis was 
attempted in CH3CN. This change in solvent may have been detrimental to the 
reaction. 
 
Scheme 3.50: Swamy’s attempted photosynthesis of 321 
Because of the aforementioned fragmentation process, which was possibly related to 
the formation of a N-acyliminium ion, we decided to reduce the lactam carbonyl 
group of 138 to avoid the formation of such an N-acyliminium ion intermediate in 
these reactions. 
 In the total synthesis of (-)-stenine, Zhang reported the conversion of lactam 322 to 
(-)-stenine 67.25 Treatment of the lactam 322 with Lawesson’s reagent in CH2Cl2 
gave the corresponding thiolactam 323. Reduction of thiocarbonyl group by 
treatment with Raney Ni in EtOH afforded stenine 67 in 90% yield over the two 
steps (Scheme 3.51).25 
 
 




This procedure proceeded smoothly with lactam 306 after some modifications. Thio-
lactam 324 was obtained in 80% yield from 306 by treatment with Lawesson’s 
reagent in THF at reflux temperature (Scheme 3.52). The molecular formula of thio-
lactam 324 was confirmed by HRESIMS analysis (calcd. for C19H34O3NSiS, (M+H)
+ 
384.2029, found: 384.2036). The IR spectrum of 324 showed a band for the thio-
lactam C=S group at 1154 cm-1. In the 13C NMR spectrum of 324 the C=S resonance 
appeared at δ 201.1. Reduction of this thio-lactam by treatment with Raney Ni in 
ethanol at reflux temperature resulted in the corresponding amine 325 in 75% yield 
(Scheme 3.52). The molecular formula of amine 325 was also confirmed by 
HRESIMS analysis (calcd. for C19H36O3NSi, (M+H)
+ 354.2452, found: 354.2464). 
Removal of the TBS group of 325 by treatment with TBAF in THF buffered with 
AcOH gave the alcohol 326 in 78% yield (Scheme 3.52). 
 
Scheme 3.52: Synthesis of amine 326 
In the 1H NMR spectrum of 326, H-3a and H-11 resonated at δ 4.77 (td, J = 11.0, 3.5 
Hz, 1H, H3a) and 3.86 (s, 1H, H11), respectively, while resonances for H-11a and H-
11b protons appeared at δ 2.46 – 2.42 (m, 1H, H11a) and δ 2.20 (ddd, J = 12.5, 10.0, 
8.0 Hz, 1H, H11b), significantly upfield in comparison to the corresponding 
resonances of H-3a and H-11 of the lactam 138 (δ 3.85 (m, H11a) and 2.61-2.54 ( m, 
1H, H11b)). The H-6 protons resonances appeared at 2.62 (dd, J = 19.0, 8.0 Hz, 1H, 
H6) and 2.48-2.40 (m, 2H, H6 and H8) and there were new regions for H-8 protons 




and 13C NMR spectroscopic assignments of 326 were shown in Figure 3.17 and 
3.18, respectively and based on 2D NMR experiments (COSY, HSQC, HMBC). 
 
Figure 3.17: 1H NMR spectrum (CDCl3, 500 MHz) of 326 
 































Similar to the lactam 138, amine 326 was very reactive under the aforementioned 
photochemical reaction conditions. The reaction was complete in 20 min (by TLC 
analysis) when irradiating a solution of 326, PhI(OAc)2 and I2 in CH2Cl2. However, 
again we obtained a very complex mixture of products. Due to the small amount of 
amine 326 available, as well as the multiple products by TLC analysis, we could not 
isolate any pure product in sufficient quantity to enable its characterization (Scheme 





Scheme 3.53: Attempted photochemical synthesis with amine 326 
 
3.4   Conclusions 
 
Towards the synthesis of stemocurtisine, we have successfully employed the ene-yne 
RCM reaction to the synthesis of an A-B ring precursor 140. Compound 140 was 




Scheme 3.50: Synthesis of tricyclic compound 306 
 
The bicyclic compound 140 was then converted to the tricyclic compound 306 in 




bromolactonization (PhSeSePh, NBS) of the corresponding acid of 139 to construct 
the ring C of stemocurtisine with the desired configuration at C-3a in the tricyclic 
lactone 301. More impressively, reduction of the α,β-unsaturated lactone moiety of 
301 by Mg/MeOH furnished the tricyclic compound 306 in 71% yield as a single 
diastereomer with the same relative configuration at C-1, C-3a, C-11, C-11a and C-
11b as stemocurtisine. The structure of 306 was confirmed by NMR, IR, MS and 
single crystal X-ray crystallographic analyses. 
 
We attempted to make the ether linkage between C-11 and C-3a in the alcohol 138 
and it C-8 reduced piperidine derivative 326 via a photochemical oxidative process 
using I2/PhI(OAc)2. The reactions of both substrates led to the formation of 
fragmentation products. From the reaction of 138, we isolated a main product, which 
had NMR spectroscopic data consistent with the aldehyde 318, formed from the 
fragmentation of the piperidinone ring. However MS analysis of this compound 
indicated that the isolated compound had two more oxygen atoms than the proposed 
structure. The photochemical oxidation reaction of 326 gave a complex mixture of 
products, which could not be separated or characterized due to the small amount of 
starting material used as well as the close Rf values of the products formed. Time 
constraints prevented us from examining other reaction conditions or methods to 





CHAPTER 4: AN ALTERNATIVE METHOD TO CONSTRUCT THE A-
B-C RING SYSTEM OF STEMOCURTISISNE 
 
4.1   Retrosynthetic analysis 
 
This chapter reports the results of a study on an alternative pathway to prepare a 
tricyclic compound possessing the A-B-C ring system of stemocurtisine following 
the retrosynthetic analysis shown in Scheme 4.1 starting from L-glutamic acid rather 
than the more expensive D-glutamic acid. If this method were successful, we would 
obtain the enantiomer of stemocurtisine. In principle, compound 138 could be 
prepared from compound 327 by a methylation process (MeI, LiHMDS) following 
the method reported by Morimoto.24 The tricyclic lactone-ester 327 could be 
obtained from compound 328 via a decarboxylation process. Compound 328 could 
be prepared from the ester-epoxide 329 via a base catalysed intramolecular epoxide 
ring opening reaction followed by cyclization of the resulting hydroxyl ester 
intermediate. This ester epoxide could be obtained from the alkene 330 via an 
esterification and epoxidation process. The alkene 330 could be formed from 
compound 331 via a diene RCM reaction. Diene 331 could be synthesized from the 
hemiaminal 332 via a borono-Mannich reaction with β-styrenylboronic acid. The 
hemiaminal 332 could be prepared from the lactone amide 333 by a base-catalyzed 
rearrangement process followed by reduction. Alkylation of the primary amide 334 
by the corresponding alkyl halide should provide amide 333. The amide 334 could be 
obtained from L-glutamic acid in three synthetic steps. The synthesis of compound 
330 was developed earlier in our group121 but was not published and 330 and ít 







Scheme 4.1: Retrosynthsis of the pyrido-azepine 138 
 
4.2   Construction of the A-B ring system 
 
The amide 334 was prepared by bubbling NH3 gas through a solution of acid 
chloride 165 (prepared from L-glutamic acid in Scheme 2.3) in anhydrous Et2O in 




ene, t-BuOK, TBAI and 18-crown-6 gave a mixture of the secondary amide 333 
(62% yield) and the imide 335 (23% yield). The IR spectrum of 333 showed bands 
for the lactone and amide carbonyl groups at 1743 cm-1 and 1665 cm-1, respectively. 
In the 1H NMR spectrum of 333, the resonances for H-5 and H1' appeared at δ 4.84 
(t, J = 7.5 Hz, 1H, H5) and 3.39 – 3.23 (m, 2H, H1'). The lactone amide 333 was then 
converted to the imide 335 by treatment with t-BuOK in THF at – 78 ºC in 91% yield 
(Scheme 4.2). In the 1H NMR spectrum of 335, resonances for the H-3 and H-1' 
protons appeared at δ 4.20 (dd, J = 12.5, 5.5 Hz, 1H, H3), 3.83 – 3.75 (m, 1H, H1'), 




Scheme 4.2: Synthesis of lactam 335 
 
Reduction of the more nucleophilic carbonyl group of 335 by NaBH4 in MeOH at -








Scheme 4.3: Synthesis of the diol 332 
 
Pyne reported the synthesis of the compound 337 from the hemiaminal 336 using 
trans-β-styrylboronic acid and the Lewis acid BF3.Et2O in CH3CN. The cis product 
was obtained in good yield and high diasteroselectivity.120 When potassium β-
styryltrifluoroborate was employed the yield and the diasteroselectivity were slightly 
reduced (Scheme 4.4). In unpublished work,121 Morgan in our laboratory found that 
using a mixture (1:1) of trans-β-styrylboronic acid and potassium-β-





Scheme 4.4: Pyne’s synthesis of 337120 
 
The proposed mechanism of this borono-Mannich reaction is shown at Scheme 4.5. 




“ate” intermediate A. The Lewis acid (BF3.Et2O) promoted the removal of the 
hemiaminal OH group to form the N-acyliminium ion B. The R group then migrates 
from the boron centre to the sp2 carbon of the iminium ion from the same face to 






Scheme 4.5: The proposed mechanism of the borono-Mannich reaction 
 
In our study, treatment of the diol 332 with trans-β-styryl boronic acid (0.55 equiv), 
trans-β-styrylpotassiumtrifluoroborate (0.55 equiv) and BF3.Et2O (3.0 equiv) in 








Scheme 4.6: Synthesis of the diene 331 
 
The structure of the diene 331 was clearly evident from an analysis of its 1H NMR 
spectrum. The H-1" and H-2" protons resonated at δ 6.25 (dd, J = 16.0, 7.0 Hz, 1H, 
H1'') and δ 6.51 (d, J = 16.0 Hz, 1H, H2''). While H-6 and H-5 resonated at δ 4.14 
(dd, J = 7.0, 5.0 Hz, 1H, H6) and 4.08 (dt, J = 10.0, 5.0 Hz, 1H, H5). The coupling 
constant J1",2" = 16.0 Hz confirmed the trans configuration of the alkene.
65 The 
coupling constant J5,6 = 5.0 Hz was similar those of cis compounds 196 and 224 
(Scheme 2.42 and Figure 2.7, Chapter 2). The relative cis-configuration at C-5 and 
C-6 was further confirmed by the NOESY correlation between H-5 and H-6. The 1H 
and 13C NMR spectra of 321 are shown in Figures 4.1 and 4.2. The assignments are 













































Treatment of the diene 331 with Grubb’s 2nd generation Ru catalyst (0.2 equiv) in 
CH2Cl2 at reflux temperature led to an inseparable mixture of desired product 330 
and its isomer 338 (330 : 338 = 87:13, as determined by 1H NMR) due to the 
migration of the carbon-carbon double bond (Scheme 4.7). In the 1H NMR spectrum 
of 330, H-9 and H-10 resonated at δ 6.00 (dt, J = 10.8, 5.0 Hz, 1H, H9) and 5.73 (d, J 
= 10.8 Hz, 1H, H10), respectively, while in the 1H NMR spectrum of mixture of 330 





Scheme 4.7: Ring closing metathesis of diene 331 without an additive 
 
A proposed mechanism for the formation of 338 is shown in Scheme 4.8. The Ru 
catalyst can coordinate with the desired product 330 to form the Ru-alkene complex 
A. This complex can be converted to the allyl cation+-[RuH]-, from which the 
hydride on the Ru can add back to the allyl system to give the Ru-alkene complex C. 




Scheme 4.8: Proposed mechanism for the formation of 338 
 
This phenomenon is not uncommon in diene RCM reactions and ene-ene cross 
metathesis reactions. Grubbs reported a study of the RCM reaction of diallylether 




shown in Table 4.1. With this substrate, acetic acid and 1,4-benzoquinone were 
found to be  ideal to suppress the double bond migration process and stop the 





Scheme 4.9: Ring closing metathesis of diene 339 with additive122 
 
Additive Equiv (relative 
to 339) 
Product distribution (by 1H NMR) 
340 341 
none none < 5% > 95% 
acetic acid 0.1 >95% none 
1,4-benzoquinone 0.1 > 95% none 
galvinoxyl 0.2 80% 20% 
TEMPO 0.5 7% 93% 
4-methoxyphenol 0.5 17% 83% 
BHT 0.5 4% 93% 
 
Table 4.1: Ratio of 340 and 341 under RCM of 339 with different additives122 
 
In another study of the diene cross metathesis of compound 342 (Scheme 4.10), 
Grubbs showed that 1,4-benzophenone was a better reagent than acetic acid for 
suppressing double bond isomerisation (Table 4.2).122 
 
 




Additive Product distribution (by 1H NMR) 
343 344 
none none > 95% 
1,4-benzoquinone 92% none 
acetic acid none > 95% 
 
Table 4.2: Ratio of 343 and 344 under alkene cross metathesis of 342 with different 
additives122 
 
From these results, we chose 1,4-benzoquinone as the additive to avoid the by 
product 338. Treatment of diene 331 with Grubbs’ 2nd generation Ru catalyst in the 
presence of 1,4-benzoquinone (0.2 equiv) followed by separation of the minor 
diastereomer by column chromatography provided the pure bicyclic compound 330 




Scheme 4.11: Synthesis of the diene 330 
 
The proposed mechanism of the diene ring closing metathesis reaction is shown at 
Scheme 4.12.123 In the initiation step ((a) in Scheme 4.12), the stable catalyst 
undergoes cycloaddition to the substrate forming the ruthenacyclobutane A. 
Subsequent cycloelimination releases styrene. The catalyst is then bound to the 
substrate in the form of the metal carbene B, which reacts intramolecularly with the 
double bond to yield the cyclobutane derivative C. This adduct undergoes a 
cycloreversion to form the cycloalkane product and the real catalyst (CH2=[Ru]). In 
the catalytic cycle (b), this catalyst adds to the double bond of the substrate forming 




E with the release of ethylene. Subsequent intramolecular cycloaddition with the 
alkene gives the ruthenacyclobutane F. A cycloreversion gives the product 
cycloalkene and the catalyst is then regenerated; this reacts with another substrate 











4.3   Attempts to make the C-ring 
 
Treatment of alcohol 330 with malonyl chloride (MeO2CCH2COCl) and Et3N in 
CH2Cl2 gave the corresponding ester 345 in 50% yield (with 36% starting material 
recovered) (Scheme 4.13). In the 1H NMR spectrum of 345, the OMe and H-2' 
protons resonated at δ 3.72 (s, 3H, OMe) and δ 3.37 (s, 2H, H2''), while the H-9 and 
H-10 protons resonated at δ 5.90 (dt, J = 10.0, 5.0 Hz, 1H, H9), 5.54 (d, J = 10.0 Hz, 





Scheme 4.13: Synthesis of ester 345 
  
Treatment of alkene 345 with m-CPBA in CH2Cl2 for 24 h provided the epoxide 329 





Scheme 4.14: Synthesis of epoxide 329 
 
The molecular formula of the epoxide 329 was confirmed by HRESIMS (calcd. for 
C14H19O6NNa, (M+Na)




spectrum of 329, H-9a and H-9 resonated at δ 3.21 (dd, J = 5.5, 4.5 Hz, 1H, H9a) and 
3.12 (apparent q, J = 5.5 Hz, 1H, H9), respectively, while H-9b resonated at δ 3.64 
(apparent t, J = 6.5 Hz, 1H). The 1H and 13C NMR assignments are shown in Figure 
4.3 and 4.4, respectively and are based on 2D NMR experiments (COSY, HSQC, 
HMBC).  The relative configuration of 329 was tentatively based on the NOESY 
correlations between H-1 and H-9b, and H-9 and H-9a. However no NOESY 
correlations were observed between H-9a and H-9b or H-1, or between H-9b and H-9 
(Figure 4.5). If the alternative α-epoxide had been formed we would have expected 


























Figure 4.5: NOESY correlations of 329 
 
Kohnz reported the synthesis of the compound 347 by the intramolecular epoxide 
ring opening with the potassium malonate ester derivative of 346 (generated from the 





















Scheme 4.15: Kohnz’s synthesis of 347124 
 
Florio reported the one-pot synthesis of compound 350 from oxirane 348 and diester 
349.125 Treatment of the bromide-oxirane 348 with n-BuLi in THF at -78 ºC led to 
the aryllithium A. Michael addition of this aryllithium to the α,β-unsaturated 
malonate ester 349 formed the intermediate B. This adduct then cyclized onto the 
oxirane via a sterospecific intramolecular SN2 reaction (5-exo-tet mode reaction) 









The reaction of the oxirane 351 with the diester 349 (R = Ph) gave the corresponding 
diester 352 (dr = 98:2). Treatment of this compound with t-BuOK/t-BuOH resulted 





Scheme 4.17: Florio’s synthesis of 353125 
 
From Kohnz’s and Florio’s results, we proposed that the bicyclic epoxide ester 329 
could be converted to the tricyclic compound 328 under similar reaction conditions 
(Scheme 4.18). Treatment of 329 with a strong base could form the intermediate 
anion A by deprotonation. Intramolecular epoxide ring opening of the intermediate A 
by the malonate anion (6 – exo-tet mode) could result in the intermediate B. An 
intramolecular rearrangement could transform the 6-membered ring lactone of B to 
more stable form, the 5-membered ring lactone compound 328, as is illustrated in 







Scheme 4.18: The proposed formation of 328 
 
However, treatment of the epoxide 329 with base (t-BuOK in t-BuOH; or LDA in 
THF; or n-BuLi in THF) at rt gave none of the desired product 328. Only the starting 
material 329 was recovered (Scheme 4.18). The failure of this cyclization reaction 
may indicate that 329 was the α-epoxide rather than the desired one. If this step had 
proceeded we could have synthesized the targeted tricyclic compound 139 (two steps 
more from 328) in 13 overall synthetic steps from L-glutamic acid and possibly in 










4.4   Conclusions 
 
 
Scheme 4.19: Summarized synthesis of 329 
 
In conclusion, we have synthesized the diene 331 from L-glutamic acid in seven 
synthetic steps. The key step involved a borono-Mannich reaction between the 
hemiaminal 322 and trans-β-styryl boronic acid and trans-β-
styrylpotassiumtrifluoroborate to prepare the cis diene 331. From this diene, we 
obtained the epoxide 329 in three synthetic steps via a diene RCM reaction, 
esterification and epoxidation sequence. Epoxide 329 was synthesized in 6% overall 
yield from L-glutamic acid. We have attempted to prepare compound 328 from the 
ester-epoxide 329 via an intramolecular epoxide ring opening reaction followed by 
cyclization of the resulting hydroxyl ester intermediate. Different bases (t-BuOK in t-
BuOH, LDA in THF, BuLi in THF) were examined. However all reactions failed to 
form the desired product 328 and only unreacted epoxide 329 was recovered. Further 
studies, including using higher reaction temperatures and the use of Lewis acid 
catalysts (for example, LiOTf) are warrented however time restraints did not allow 




CHAPTER 5: CONCLUSIONS AND FUTURE DIRECTION 
 
5.1   Conclusions 
 
The main aim of this project was to develop a new synthetic methodology towards 
the total synthesis of stemocurtisine 2 as shown in Figure 5.1. In order to synthesize 





Figure 5.1: Stemocurtisine 2 and targeted compounds 137, 138 and 142 
 
In Chapter 2 we examined three different synthetic strategies to construct an ene-yne 
lactam of the general structure 142, which possessed the A-ring structure of the 
target compound 138 and an ene-yne moiety, which was necessary for synthesis of 
the azepine ring (B-ring). Following our synthetic strategy 1, we conducted model 
work to make imides 169 and 170. However our attempts at nucleophilic additions of 
alkynyl Grignard reagents to 169 or 170 led to the ring opening of the desired 







Scheme 5.1: Summary of synthetic strategy 1 
 
Following synthetic strategy 2, we prepared the lactone 184. However, the next step, 
which involved conversion of the TMS group of 184 to an ester group, failed to form 
the desired product 195 (Scheme 5.2), which in principle could be converted to 142 




Scheme 5.2: Summary of synthetic strategy 2 
 
We then examined the synthetic strategy 3. Initially, from the Z-iodide 149 we 
prepared the epoxide 198 in two synthetic steps. Azidolysis of this epoxide led to the 
azide 197. However the Staudinger/aza-Wittig reaction between this azide and 4-
pentenal did not give the desired product 208, only the Staudinger product 207 was 





Scheme 5.3: Outcomes from our first attempts at synthetic strategy 3 
 
Finally continuing this synthetic strategy with modifications, we successfully 
synthesized the ene-yne lactam 225 in 11 synthetic steps and 12.1% overall yield 
from 4-pentyne-1-ol. The key steps here involved an aminolysis reaction of the 
epoxide 250 with 4-pentene-1-amine and the oxidation of the N-Fmoc derivative of 
the 1,4-diol  227 to the lactone 253. After Fmoc deprotection of 253, the resulting 
lactone was then converted to the lactam 225 via a base catalysed rearrangement 
process. An alternative method to prepare the propiolate ester analogue of 227 was 
unsuccessful due to competing aminolysis of the terminal ester group (Scheme 5.4). 
 
 




In Chapter 3, we described synthesis of the A-B, A-B-C ring systems and attempts to 
make the ether linkage of stemocurtisine 2. The bicyclic compound 140 was obtained 
from the lactam 225 in five synthetic steps and in 35% overall yield. The key step 
involved an ene-yne RCM reaction of 141 to form the 7-membered ring (the B-ring) 




Scheme 5.5: Construction of the A-B ring of stemocurtisine 
 
Compound 140 was then converted to a diastereomeric mixture of esters 139 via an 
1,4-"hydride" reduction reaction using NaBH4/MeOH. Attempts to prepare 301 from 
the corresponding acid 329 via bromolactonization with CuBr2 on alumina or syn 
dihydroxylation with OsO4 failed. Finally compound 301 was obtained from the 
mixture of 139 via bromolactonization of its corresponding acid derivative 329 using 
NBS/PhSeSePh followed by a base-catalysed elimination of the resulting 
bromolactone (Scheme 5.6). This process also produced the C-3a epimer of 301 
(compound 302), which could be converted to 301 by treatment with DBU in CHCl3. 
 
 




Reduction of the C-C double bond of the α,β-unsaturated lactone 301 using 
NaBH4/NiCl2.6H2O or NaBH4/CuCl did not proceed at 0 ºC or rt. Surprisingly, 
treatment of 301 with Mg/MeOH led to the corresponding the tricylic lactone 306 as 
a single diastereomer in 71% yield. The relative configurations at C-1, C-3a, C-11, 
C-11a and C-11b in 306 were the same as those of stemocurtisine and were 
confirmed by NMR and single crystal X-ray crystallographic analyses. Finally, we 
attempted the photochemical oxidative cyclization reactions on compound 138 with 
the aim of preparing the ether linkage of 137. This reaction resulted in a mixture of 
products and we could only isolate the major product, whose structure was proposed 
as 318, as a 2.3:1 mixture of diastereomers (Scheme 5.7). NMR analysis of this 
compound indicated thet the piperidinone ring had undergone a cleavage reaction to 
give an aldehyde-O-aetyl hemiaminal. The proposed structure of this compound 
could not be confirmed from MS analysis, which indicated that the product had two 
extra oxygens. A similar photochemical oxidative cyclization process was attempted 
on the piperidine 328. This reaction led to a complex mixture of products (Scheme 
5.8). We could not isolate any pure compound due to the small amount of starting 
material used and the close Rf values of the products found (by TLC analysis). Time 
constrains prevented us to examine other variations or methods to make the ether 













Scheme 5.8: Synthesis of 326 and attempts with photochemical oxidative reaction on 
this compound 
 
In Chapter 4 we discussed an alternative method to construct an A-B ring system of 
stemocurtisine as well as attempt to build the C-ring from L-glutamic acid. We 
synthesized the epoxide ester 329 in 10 synthetic steps. However attempts to prepare 
compound 328 from the ester-epoxide 329 via a base-catalysed intramolecular 
epoxide ring opening reaction followed by cyclization of the resulting hydroxyl ester 







Scheme 5.9: Synthesis of 329 from L-glutamic acid 
 
5.2   Future directions 
 
In the future we will continue to examine other methods to make the ether linkage to 
prepare the tetracyclic compound 137. One possible method involves the 
hydroboration of the alkene of 139 followed by oxidation to the ketone 328. 
Deprotection of the TBS ether of 328 may the provide access to the desired 
tetracyclic compound 137 via a series of two intramolecular cyclization reactions 
(Scheme 5.10). Introduction of the D-ring onto 137 would then be examined 
following method described Olivo57 to prepare the A-B-C-D ring system of 
stemocurtisine 2. We will also try to make an enantiomerically enriched version of 
the epoxide 250 using the Shi epoxidation reaction (instead of the racemic epoxide 
250 in this thesis).78 This method should lead to 138 in high enantiomeric purity with 








CHAPTER 6: EXPERIMENTAL SECTION 
 
6.1   General experimental 
 
6.1.1   Reaction conditions 
 
All reactions were performed in oven dried glassware under an atmosphere of dry 
nitrogen, unless otherwise stated. Reactions were monitored by thin-layer 
chromatography analysis. 
Anhydrous MeOH, EtOH, DMSO and dioxane were purchased form Sigma-Aldrich 
Chemical Co. 
Anhydrous THF was obtained by distillation from sodium wire/benzophenone. 
Anhydrous CH2Cl2, Et2O, DMF and toluene were obtained from a Johnson Morris 
anhydrous solvent dispenser. 
 
6.1.2   Nuclear Magnetic Resonance (NMR) Spectroscopy 
 
1H and 13C NMR spectra were recorded on a Varian Inova NMR Spectrometer (1H 
NMR running at 500 MHz and 13C NMR running at 125 MHz) instrument. CDCl3 
was used as the NMR solvent unless otherwise stated. NMR assignments were based 
on COSY, HSQC, HMBC, NOESY and DEPT experiments. 
1H NMR chemical shifts are quoted in δ values in ppm and are referenced relative to 
the chemical shift of CDCl3 (7.26 ppm) unless otherwise noted. Some spectra were 
acquired on a Varian Inova NMR Spectrometer (300 MHz). Coupling constants (J) 
are reported in Hz, with signal multiplicities designated at singlet (s), doublet (d), 
doublet of doublet (dd), doublet of doublet of doublet (ddd), triplet (t), quartet (q), 
doublet of triplets (dt), triplet of doublets (td), doublet of doublet of triplets (ddt), 
multiplet (m), broad singlet (bs), broad multiplet (bm), quintet (quin), doublet of 
quartets (dq). The order in which the signal was described in the text is mulplicity, 
number of protons (integration), coupling constant (J), and assignment. 
13C NMR chemical shifts are quoted in δ values in ppm and are referenced relative to 




acquired on a Varian Inova NMR Spectrometer (75 MHz). Resonances were 
assigned as follows: Chemical shift (assignment). In some cases carbon resonances 
appeared broad (b). 
 
6.1.3   Mass Spectrometry 
 
Low-resolution mass spectra were obtained on a Shimadu GC spectrometer (EI) or 
Water LCZ single quadropole (ESI). High resolution spectra were obtained on a VG 
Autospec mass spectrometer (EI) or Waters QTOF (ESI). HRMS were obtained in 
lieu of elemental analysis and 1H and 13C NMR spectroscopy and TLC analysis were 
used as the criteria for purity. 
 
6.1.4   Melting point 
The melting points were recorded on a Gallenhamp MF-370 carpillary tube, melting 
point apparatus and are uncorrected. The values are expressed in degree Celcius (ºC). 
Uncertanties in the quoted values are ±2 ºC. 
 
6.1.5   Infrared spectroscopy 
Infrared spectra were obtained as neat samples on a Smart Omni-Sampler Avator 
ESP Nicolet-Brand. 
 
6.1.6   Polarimetry 
Optical rotations were measured using a 1 cm cell, in a Jasco DIP-370 digital 
polarimeter. Specific rotations were calculated by using the average value of 10 
optical rotation measurements. 
 
6.1.7   Chromatography 
 
TLC analyses were performed using aluminium backed Merck silica gel TLC plates. 
Compounds were detected under a 254 nm ultraviolet lamp, if applicable, or by a 
staining with acidified aqueous solution of ammonium molybdate and cerium(IV) 




performed using Meck silica gel (40-63 μm) packed by the slurry method, under a 
positive pressure of air. 
 
6.1.8   Microwave reactor 
 
Microwave reactions were performed in a CEM microwave reactor at 120 ºC, 60 W 
using CH3CN as a solvent in a 3 mL capped vial. 
 
6.2   Experimental 
 
 




To the suspension of glutamic acid (10.0 g, 68 mmol) and NaNO2 (7.5 g, 108.7 
mmol, 1.6 equiv) in water (100 mL) was added HCl (10 mL concentrated diluted to 
50 mL) dropwise via an addition funnel at 0 ºC with vigorous stirring for 1 h. The 
mixture was warmed to rt and stirred for 18 h.61 The water was evaporated and then 
EtOAc (200 mL) was added. The mixture was stirred for 30 min and filtered. The 
solid cake was washed with EtOAc (2 x 75 mL). The organic extracts were combined 
and dried over MgSO4. The solvent was evaporated in vacuo and the residue was left 
under high vacuum for 12 h to give the lactone acid 166 (8.67 g, 98% yield) as a 
solid syrup.  
 
1H NMR (500 MHz, CDCl3) δ 5.01 – 4.97 (m, 1H, H2), 2.68 – 2.53 (m, 3H, 2H4 and 
H3), 2.44 – 2.35 (m, 1H, H3). 











A mixture of (S)-γ-butyrolactone-γ-carboxylic acid 166 (5.5 g, 42.3 mmol) and 
thionyl chloride (26 mL, 127 mmol, 3 equiv) was heated and stirred at 60 ºC for 6 h 
under a N2 atmosphere. The excess thionyl chloride was removed under vacuum, and 
the residue was dissolved in dry CH2Cl2 (80 mL). To the resulting solution was 
added, under a N2 atmosphere, a mixture of benzylamine (8.3 mL, 76 mmol) and 
triethylamine (11.7 mL, 80 mmol) at 0 ºC. After 3 h stirring at 0 ºC, water (35 mL) 
was added and the aqueous phase was extracted with CH2Cl2 (2 x 30 mL). The 
combined organic phases were washed with brine (3 x 10 mL), dried over anhydrous 
Na2SO4, filtered, and concentrated. The residue was subjected to column 
chromatography (2:3, EtOAc/petroleum spirit) to give the lactone amide 167 (7.25 g, 
71% yield) as a white solid. 
 
Rf = 0.69 (1:1, EtOAc/petroleum spirit). 
1H NMR (500 MHz, CDCl3) δ 7.37 – 7.20 (m, 5H, ArH), 6.92 (bs, 1H, NH), 4.82 
(dd, J = 9.5, 5.5 Hz, 1H, H2), 4.51 – 4.33 (m, 2H, CH2-Ar), 2.58 (ddd, J = 12.5, 9.5, 
6.5 Hz, 1H, H4), 2.50 (dd, J = 9.5, 6.5 Hz, 2H, H3), 2.33 (ddt, J = 15.5, 12.5, 6.5 Hz, 
1H, H4). 









To a cooled solution (-78 ºC) of the lactone amide 167 (1.25 g, 5.7 mmol) in dry 
THF (120 mL) was added portionwise potassium t-butoxide (351 mg, 3.14 mmol, 
0.55 equiv) under a N2 atmosphere. The mixture was stirred for 10 min at the same 
temperature and then allowed to warm to -55 ºC and stirred for about 30 min. The 
reaction was quenched with water (30 mL) at -55 ºC. The organic phase was 
separated and the aqueous phase was extracted with EtOAc (3 x 40 mL). The 
combined organic extracts were washed with water (30 mL), dried over anhydrous 
Na2SO4, filtered, and concentrated under reduced pressure. The crude product was 
purified by column chromatography (2:3, EtOAc/petroleum spirit) to give the imide 
168 (4.94 g, 78% yield) as a white solid. 
 
Rf = 0.61 (1:1, EtOAc/petroleum spirit). 
1H NMR (500 MHz, CDCl3) δ 7.37-7.27 (m, 5H, ArH), 4.95 (s, 2H, CH2-Ar), 4.22 
(dd, J = 12.5, 5.5 Hz, 1H, H3), 2.91 (d, J = 18.0 Hz, 1H, H5), 2.70 – 2.61 (m, 1H, 
H5), 2.36 – 2.30 (m, 1H, H4), 1.90 (qd, J = 13.0, 4.5 Hz, 1H, H4). 
13C NMR (125 MHz, CDCl3) δ 175.5 (C2), 171.4 (C6), 136.8 (ArC), 129.2 (ArCH), 
128.9 (ArCH), 128.1 (ArCH), 68.8 (C3), 44.0 (CH2Ar), 31.2 (C5), 25.6 (C4). 






Silver oxide (1.39 g, 6 mmol, 3 equiv) and BnBr (1.43 mL, 12 mmol, 6 equiv) were 
added to a solution of the alcohol 168 (440 mg, 2 mmol) in anhydrous Et2O (20 mL) 
and the mixture was stirred at rt for 2 d in the dark.61 The mixture the filtered through 
a pad of celite and the solid cake was washed with Et2O (2 x 50 mL). The solvent 
was removed in vacuo and the residue was purified by column chromatography (1:4, 





Rf = 0.67 (1:1, EtOAc/petroleum spirit). 
1H NMR (500 MHz, CDCl3) δ 7.38 – 7.21 (m, 10H, ArH), 4.93 (s, 2H, PhCH2N), 
4.80 (d, J = 12.0 Hz, 1H, PhCHHO), 4.62 (d, J = 12.0 Hz, 1H, ArCHHO), 4.08 – 
4.04 (m, 1H, H3), 2.91 (ddd, J = 18.0, 8.0, 6.0 Hz, 1H, H5), 2.57 (dt, J = 18.0, 6.0 
Hz, 1H, H5), 2.06 (dt, J = 9.5, 6.0 Hz, 2H, H4). 






Imidazole (374 mg, 5.5 mmol, 2.5 equiv) and TBSCl (364 mg, 2.42 mmol, 1.1 equiv) 
were added to a solution of the alcohol 168 (482 mg, 2.2 mmol) in DMF (20 mL) and 
the mixture was stirred for 14 h at rt under a N2 atmosphere.
63 Water (30 mL) was 
added and the aqueous phase was extracted with EtOAc (3 x 50 mL). The organic 
extracts were combined, dried over MgSO4, and filtered. The solvent was removed in 
vacuo and the residue was purified by column chromatography (3:7, 
EtOAc/petroleum spirit) to afford the TBS ether 170 (506 mg, 69% yield) as a pale 
yellow oil. This is a known compound however its spectroscopic data was not 
published.127 
 
Rf = 0.58 (2:3, EtOAc/petroleum spirit). 
1H NMR (500 MHz, CDCl3) δ 7.36 – 7.22 (m, 5H, ArH), 4.94 (s, 2H, CH2-Ar), 4.35 
(dd, J = 7.5, 4.0 Hz, 1H, H3), 2.95 (ddd, J = 17.5, 8.5, 5.5 Hz, 1H, H5), 2.63 (ddd, J 
= 17.5, 7.5, 5.5 Hz, 1H, H5), 2.10 – 1.97 (m, 2H, H4), 0.90 (s, 9H, (CH3)3C), 0.13 (s, 
6H, (CH3)2Si). 
13C NMR (125 MHz, CDCl3) δ 172.5 (C2), 172.1 (C6), 137.3 (ArC), 128.9 (ArC), 
128.7 (ArC), 127.7 (ArC), 69.6 (C3), 43.23 (CH2-Ar), 29.3 (C5), 26.7 (C4), 26.0 
((CH3)3C), 18.5 ((CH3)3C), -4.43 (CH3-Si), -5.09 (CH3-Si). 




HRESIMS calcd. for C18H27O3N NaSi, (M+Na)
+ 356.1658, found: 356.1654. 
 
Attempted addition of lithium trimethylsilylacetylide to 170 
 
To a solution of trimethylsilylacetylene (60 mg, 0.6 mmol, 2 equiv) in THF (4 mL) at 
-78 ºC under a N2 atmosphere was added a solution of 1.6 M n-BuLi in THF (360 
μL, 0.57 mmol, 1.9 equiv) and the mixture was stirred at -78 ºC for 15 min. To this 
mixture, was added dropwise a solution of 170 (92 mg, 0.3 mmol) in THF (0.5 mL). 
The reaction mixture was stirred at -78 ºC for 30 min, at -40 ºC for 1 h, and -0 ºC for 
1 h (by TLC analysis).60,61 The reaction mixture was quenched with saturated NH4Cl 
solution (5 mL) and extracted with EtOAc (3 x 15 mL). The organic extracts were 
combined, dried over MgSO4 and filtered. The solvent was then evaporated. 
1H 
NMR analysis of the resulting residue showed signals of the ring opening product 
172 
1H NMR (500 MHz, CDCl3) in part δ 6.20 (bs, 1H, NH), 4.03 (dd, J = 2.5, 4.5 Hz, 







A solution of KOH (8.40 g, 150 mmol, 2.5 equiv) in H2O (12 mL) was added to a 
solution of 4-pentyn-1-ol (5.04 g, 60 mmol). Then I2 (16.76 g, 66 mmol, 1.1 equiv) 
was added portionwise to the resulting solution over a period of 30 min.67 After 
being stirred 3 h at rt, a saturated solution of Na2S2O3 (60 mL) was added and the 
mixture was extracted with Et2O (3 x 100 mL). The combined organic layers were 
concentrated by rotary evaporation to give a brown residue. The residue was 
dissolved in CH2Cl2 (100 mL) which was washed with brine (50 mL) and then was 
dried over Na2SO4 and filtered. The solvent was removed by rotary evaporation to 




EtOAc/petroleum spirit) to afford the iodide 186 (9.32g, 75% yield) as a colourless 
oil. 
 
Rf = 0.57 (2:3, EtOAc/petroleum spirit). 
1H NMR (500 MHz, CDCl3) δ 3.74 (t, J = 6.0 Hz, 2H, H1), 2.50 (t, J = 7.0 Hz, 2H, 
H3), 1.80 – 1.74 (m, 2H, H2). 
13C NMR (125 MHz, CDCl3) δ 94.2 (C4), 61.8 (C1), 31.4 (C3), 17.7 (C2), -5.9 (C5). 






To a solution of alkene 186 (10.5 g, 50 mmol) in MeOH (80 mL) were added 
pyridine (22.9 mL, 300 mmol, 6.0 equiv) and potassium azodicarboxylate (5.82 g, 30 
mmol, 0.6 equiv) sequentially at rt. Acetic acid (18.1 mL, 316 mmol, 6.3 equiv) was 
then added slowly via a syringe pump over 10 h at rt. During the addition of acetic 
acid, additional potassium azodicarboxylate (0.6 equiv) was added at 2 h, 4 h, 6 h, 
and 8 h, respectively. After complete addition of the acetic acid, the mixture was 
poured into a 1-L beaker together with Et2O (150 mL) and aqueous HCl solution 1M 
(300 mL). The aqueous layer was extracted with Et2O (3 x 150 mL) and the 
combined organic layers were concentrated by rotary evaporation to give a pale 
yellow residue. The residue was dissolved in Et2O (150 mL) which was washed with 
aqueous 1M HCl solution (2 x 75 mL), saturated aqueous NaHCO3 solution (100 
mL) and brine (100 mL), then was dried over Na2SO4 and filtered. After removal of 
the solvent, the residue was treated with n-BuNH2 (8 mL) and the solution was 
stirred at rt for 10 h to remove the over reduced product. The mixture was dissolved 
in Et2O (150 mL) which was washed with aqueous 1M HCl solution (2 x 100 mL), 
saturated aqueous NaHCO3 (100 mL) solution, and brine (100 mL), then was dried 




column chromatography (1:3, EtOAc/petroleum spirit) to give the (Z)-vinyl iodide 
187 (5.94 g, 56% yield) as a colourless oil.67 
 
Rf = 0.61 (2:3, EtOAc/petroleum spirit). 
1H NMR (500 MHz, CDCl3) δ 6.25-6.17 (m, 2H, H4 and H5), 3.68 (t, J = 8.5 Hz, 
2H, H1), 2.25 (q, J = 7.0 Hz, 2H, H3), 1.74 – 1.66 (m, 2H, H2). 
13C NMR (125 MHz, CDCl3) δ 140.9 (C4), 83.4 (C5), 62.4 (C1), 31.5 (C3), 31.1 
(C2). 
NMR spectroscopic data matched with the published data.67 
 




To a stirred solution of the primary alcohol 187 (3.18 g, 15 mmol) in acetone (90 
mL) at 0 ºC was added dropwise Jones’ reagent (21.4 mL) until an orange colour 
became permanent.68 The reaction mixture was stirred for 30 min at 0 ºC. Methanol 
(10 mL) was added dropwise and the resulting mixture was stirred for additional 15 
min at 0 ºC. Chromium salts were filtered off and the solvent was evaporated to give 
a pale yellow residue. Water (50 mL) was added to the residue and the aqueous 
phase was extracted with EtOAc (5 x 100 mL). The combined organic extract was 
dried over MgSO4, filtered and evaporated to give the crude corresponding acid (3.02 




1H NMR (500 MHz, CDCl3) δ 6.31 (d, J = 7.5 Hz, 1H, H5), 6.28 – 6.22 (m, 1H, H4), 
2.52 – 2.44 (m, 4H, H2 and H3). 
To a stirred solution of the above acid (3.00 g, 13.3 mmol) in methanol (100 mL) 




stirred for 14 h at rt and the volatiles were evaporated. The crude product was 
dissolved in CH2Cl2 (100 mL), washed with saturated NaHCO3 solution (50 mL) and 
water (50 mL), dried over MgSO4 and filtered. The solvent was evaporated in vacuo 
and the crude product was purified by column chromatography (1:9, 
EtOAc/petroleum spirit) to give the ester 149 (2.13 g, 67% yield) as a pale yellow 
oil. 
 
Rf = 0.68 (1:4, EtOAc/petroleum spirit).  
1H NMR (500 MHz, CDCl3) δ 6.28 (d, J = 7.3 Hz, 1H, H5), 6.25 – 6.19 (m, 1H, H4), 
3.69 (s, 3H, MeO), 2.44 (s, 4H, H2 and H3). 
13C NMR (125 MHz, CDCl3) δ 173.3 (C1), 139.5 (C4), 84.1 (C5), 52.0 (MeO), 32.6 
(C3), 30.5 (C2). 
NMR spectroscopic data matched with the published data.128 
 




To a solution of the vinyl iodide 149 (800 mg, 3.33 mmol) in Et3N (12 mL), were 
added PdCl2(PPh3)2 (47 mg, 0.067 mmol, 0.02 equiv) and CuI (128 mg, 0.67 mmol,  
0.2 equiv) under an argon atmosphere.69 The mixture was stirred for 15 min then a 
solution of trimethylsilylacetylene (1457 mg, 4.66 mmol. 1.4 equiv) in THF (6 mL) 
was added dropwise over period of 30 min. After being stirred for 16 h, the mixture 
was diluted with Et2O (150 mL) then washed with saturated NH4Cl solution (2x 30 
mL). The organic layer was dried over Na2SO4 and filtered. The solvent was 
evaporated in vacuo and the residue was purified by column chromatography (1:9, 
Et2O/petroleum spirit) to give the ene-yne 185 (496 mg, 71% yield) as a colourless 
oil. 
 





-1): 2958, 1734, 1507, 1249, 1168, 841. 
1H NMR (500 MHz, CDCl3) δ 5.94 (dt, J = 10.5, 7.5 Hz, 1H, H4), 5.52 (d, J = 10.5 
Hz, 1H, H5), 3.67 (s, 3H, OMe), 2.62 (q, J = 7.5 Hz, 2H, H3), 2.43 (t, J = 7.5 Hz, 
2H, H2), 0.18 (s, 9H, (CH3)3Si). 
13C NMR (125 MHz, CDCl3) δ 173.5 (C1), 142.8 (C4), 111.0 (C5), 101.6 (C7), 
100.0 (C6), 51.9 (OMe), 33.4 (C3) 25.9 (C2), 0.3 (CH3Si). 
Satisfactory EI or ESI MS data could not be obtained on this compound. 
 




Potassium osmate dihydrate (18.4 mg, 0.05 mmol, 0.05 equiv) and NMO (382 mg, 
2.5 mmol, 2.5 equiv) were added to a solution of the alkene 185 (210 mg, 1 mmol) in 
acetone and water (10 mL, 3:2) and the mixtute was allowed to stir at 35 ºC for 1 d.72 
The organic phase was removed in vacuo and water (10 mL) was added. The 
aqueous phase was extracted with EtOAc (3 x 30 mL). The organic extracts were 
combined, dried over MgSO4, and filtered. The solvent was removed in vacuo and 
the residue was purified by column chromatography (1:9 to 3:2, EtOAc/petroleum 
spirit) to give three compounds 184 (91 mg, 43% yield), 185 (41 mg, 29% yield) and 










-1): 3402, 2957, 2170, 1757, 1181, 1060, 992, 838. 
1H NMR (500 MHz, CDCl3) δ 4.32 (m, 2H, H5 and H1'), 2.52 (m, 2H, H3), 1.94 (m, 
1H, H4), 1.84 (m, 1H, H4), 0.18 (s, 9H, (CH3)3Si). 
13C NMR (125 MHz, CDCl3) δ 174.9 (C2), 103.1 (C2'), 92.5 (C3'), 73.7 (C5), 66.9 
(C1’), 30.7 (C3), 27.6 (C4), 0.12 (CH3Si). 
ESIMS m/z 235 [(M+Na)+ 100%]. 
HRESIMS calcd. For C10H16O3NaSi, (M+Na)




Mp = 73-74 ºC 
Rf = 0.63 (3:2, EtOAc/petroleum spirit) 
IR (neat, νmax/cm
-1): 3280, 2921, 2312, 2180, 1763, 1184, 1054, 1015, 990, 938 
1H NMR (500 MHz, CDCl3) δ 4.61 (m, 2H, H5 and H1'), 2.70 – 2.59 (m, 1H, H3), 
2.51 – 2.42 (m, 1H, H3), 2.49 (s, 1H, H3'), 2.39 – 2.24 (m, 2H, H4). 
13C NMR (125 MHz, CDCl3) δ 178.3 (C2), 81.7 (C2'), 80.3 (C3'), 75.5 (C5), 63.8 
(C1'), 28.5 (C3), 22.0 (C4). 
NMR spectroscopic data matched with the published data.73 
 
(4S*,5R*)-Methyl 4,5-dihydroxy-7-(trimethylsilyl)hept-6-ynoate (190) 
Colourless oil. 
Rf = 0.63 (3:2, EtOAc/petroleum spirit). 
IR (neat, νmax/cm
-1): 3431, 2960, 2179, 1763, 1249, 1180, 1016, 840, 759. 
1H NMR (500 MHz, CDCl3) δ 4.32 (d, J = 3.5 Hz, 1H, H5), 3.67 (s, 4H, OMe and 
H4), 2.52 (dd, J = 6.6, 4.6 Hz, 2H, H2), 1.97-1.90 (m, 1H, H3), 1.88-1.80 (m, 1H, 
H3) 0.16 (s, 9H, (CH3)3Si). 
13C NMR (125 MHz, CDCl3) δ 174.9 (C1), 103.1 (C7), 92.5 (C6), 73.7 (C4), 66.9 
(5), 52.1 (OMe), 30.7 (C2), 27.6 (C3), 0.12 ((CH3)3Si). 
ESIMS m/z 245 [(M+H)+ 100%]. 
HRESIMS calcd. for C14H26O3NaSi, (M+Na)







Conversion of 190 to 184 
 
Compound 190 (41 mg, 0.17 mmol) was dissolved in methanol (2 mL) and catalytic 
amount of p-TSA (3 mg, 0.17 mmol, 0.1 equiv) was added to this solution.75 The 
reaction mixture was stirred at rt till completion of the reaction. Saturated sodium 
bicarbonate solution (3 mL) was added to the reaction mixture and stirred for 5 min. 
Methanol was removed in vacuo and the aqueous layer was extracted with 
dichloromethane (3 x 10 mL), washed with brine solution, dried over Na2SO4 and 
concentrated in vacuo. The crude product was purified on silica gel column 
chromatography using petroleum ether/EtOAc (1:1) as eluant to give the lactone 184 






To a solution of 4-fluoro-iodobenzene (222 mg, 1 mmol) in Et3N (3 mL), were added 
PdCl2(PPh3)2 (7 mg, 0.01 mmol, 0.01 equiv) and CuI (10 mg, 0.05 mmol,  0.05 
equiv) under an argon atmosphere.69 The mixture was stirred for 15 min then a 
solution of trimethylsillylacetylene (185 µL, 11.3 mmol. 1.3 equiv) in THF (1.5 mL) 
was added dropwise over a period of 15 min. After being stirred for 16 h, the mixture 
was diluted with Et2O (50 mL) and washed with saturated NH4Cl solution (2 x 20 
mL). The organic layer was dried over Na2SO4 and filtered. The solvent was 
evaporated in vacuo and the residue was purified by column chromatography (1:9, 
Et2O/petroleum spirit) to afford compound 192 (188 mg, 98% yield) as a yellow 
solid. 
 
Mp = 57-59 ºC 
Rf = 0.63 (2:3, Et2O/petroleum spirit) 
1H NMR (500 MHz, CDCl3) δ 7.48 (dd, J = 8.5, 5.5 Hz, 2H, ArH), 7.02 (t, J = 8.5 




The 1H NMR spectroscopic data matched with the published data.129 
 




A dried and CO2 (balloon) infused Schlenk-flask, equipped with a magnetic stirrer 
and a septum, was charged with CsF (182 mg, 1.2 mmol, 1.2 equiv) in DMSO (2.5 
mL). Alkynylsilane 192 (192 mg, 1 mmol) was added via a syringe to the reaction 
mixture and the reaction was stirred at rt for 3 h. Methyl iodide (140 µL, 2.4 mmol, 
2.4 equiv) was added to the reaction mixture and the reaction was stirred at rt for 1 
h.76 Saturated aqueous NH4Cl (10 mL) was added and the whole mixture was 
extracted with EtOAc (3 x 20 mL). The combined organic layers were washed with 
brine (10 mL) and dried over MgSO4. The organic phase was concentrated under 
reduced pressure and the crude material was purified by silica gel column 
chromatography (1:9, Et2O/petroleum spirit) to afford the methyl ester 193 (110 mg, 
62% yield) as a colourless oil. 
 
Rf = 0.56 (2:3, Et2O/petroleum spirit). 
1H NMR (500 MHz, CDCl3) δ 7.56 (dd, J = 8.5, 5.5 Hz, 2H ArH), 7.05 (t, J = 8.5 
Hz, 2H, ArH), 3.82 (s, 3H, OMe). 
13C NMR (125 MHz, CDCl3) δ 164.2 (d, J = 254 Hz, ArC), 154.6 (C1), 135.5 (d, J = 
9 Hz, ArCH), 116.4 (d, J = 10 Hz, ArCH), 115.9 (d, J = 4.0 Hz, ArC), 85.7 (C3), 
80.6 (C2), 53.1 (OMe). 













A dried and CO2 (balloon) infused Schlenk-flask, equipped with a magnetic stirrer 
and a septum, was charged with CsF (182 mg, 1.2 mmol, 1.2 equiv) in DMSO (2.5 
mL). Alkynylsilane 185 (210 mg, 1 mmol) in DMSO (0.5 mL) was added to the 
reaction mixture and the reaction was stirred at rt for 3 h. Methyl iodide (140 µL, 2.4 
mmol, 2.4 equiv) was added to the reaction mixture and the reaction was stirred at rt 
for 1 h.76 Saturated aqueous NH4Cl (10 mL) was added and the whole mixture was 
extracted with EtOAc (3 x 20 mL). The combined organic layers were washed with 
brine (10 mL) and dried over MgSO4. The organic phase was concentrated under 
reduced pressure and the crude material was purified by silica gel column 
chromatography (1:9, EtOAc/petroleum spirit) to afford the diester 194 (123 mg, 
63% yield) as a colourless oil. 
 
Rf = 0.68 (1:4, Et2O/petroleum spirit). 
1H NMR (500 MHz, CDCl3) δ 6.24 (dt, J = 10.8, 7.5 Hz, 1H, H5), 5.58 (d, J = 10.8 
Hz, 1H, H4), 3.76 (s, 3H, OMe1), 3.66 (s, 3H, OMe2), 2.65 (q, J =  7.5 Hz, 2H, H6), 
2.43 (t, J = 7.5 Hz, 2H, H7). 
13C NMR (1256 MHz, CDCl3) δ 173.0 (C8), 154.6 (C1), 148.7 (C5), 108.2 (C4), 
85.3 (C3), 83.0 (C2), 53.0 (OMe), 52.00 (OMe), 33.1 (C6), 26.4 (C7). 
Satisfactory EI or ESI MS data could not be obtained on this compound. 
 
Attempted to prepare 195 from 184 
 
A dried and CO2 (balloon) infused Schlenk-flask, equipped with a magnetic stirrer 
and a septum, was charged with CsF (182 mg, 1.2 mmol, 1.2 equiv) in DMSO (2.5 
mL). Alkynylsilane 184 (212 mg, 1 mmol) in DMSO (0.5 mL) was added to the 




mmol, 2.4 equiv) was added to the reaction mixture and the reaction was stirred at rt 
for 1 h.76 Saturated aqueous NH4Cl (10 mL) was added and the whole mixture was 
extracted with EtOAc (3 x 20 mL). The combined organic layers were washed with 
brine (10 mL) and dried over MgSO4. The organic phase was concentrated under 
reduced pressure and the crude material was purified by silica gel column 
chromatography (1:9, EtOAc/petroleum spirit) to afford the terminal alkyne lactone 
189 (130 mg, 03% yield) as a white solid. The desired product 195was not form in 
this reaction. 
 
Attempted with dihydroxylation of 194 
 
Potassium osmate dihydrate (9.2 mg, 0.025 mmol, 0.05 equiv) and NMO (191 mg, 
1.25 mmol, 2.5 equiv) were added to a solution of the alkene 194 (98 mg, 0.5 mmol) 
in acetone and water (5.0 mL, 3:2) and the mixtute was allowed to stir at 35 ºC for 1 
d.72 The organic phase was removed in vacuo and water (5 mL) was added. The 
aqueous phase was extracted with EtOAc (3 x 20 mL). The organic extracts were 
combined, dried over MgSO4, and filtered. No desired product was formed (TLC and 






To a solution of propargyl alcohol (2.5 g, 44.5 mmol) in dichloromethane (70 mL) 
were added imidazole (7.6 g, 112 mmol, 2.5 equiv) and tert-butyldimethylsilyl 
chloride (8.1 g, 52.5 mmol, 1.2 equiv) at rt. The reaction mixture was stirred at rt for 
4 h and quenched with water (100 mL).131 The organic phase was separated and the 
aqueous phase was extracted with CH2Cl2 (2 x 100 mL). The organic layers were 
combined, washed with water (150 mL) and brine (150 mL), dried over MgSO4 and 
concentrated under reduced pressure to give a colourless liquid. The crude product 




1H NMR (500 MHz, CDCl3) δ 4.30 (d, 2H, J = 2.5 Hz, H1), 2.39 (t, 1H, J = 2.5 Hz, 
H3), 0.91 (s, 9H, (CH3)3C), 0.12 (s, 6H, (CH3)2Si).  
13C NMR (125 MHz, CDCl3) δ 81.7 (C3), 72.2 (C2), 50.8 (C1), 25.2 ((CH3)3C), 17.6 
((CH3)3C), -4.3 (CH3Si). 
NMR spectroscopic data matched with the published data.131 
 






To a solution of the vinyl iodide 149 (1.182 g, 4.93 mmol) in Et3N (12 mL) under an 
argon atmosphere were added PdCl2(PPh3)2 (69 mg, 0.098 mmol, 0.02 equiv) and 
CuI (189 mg, 0.098 mmol,  0.2 equiv).69 The mixture was stirred for 15 min then a 
solution of alkyne 199 (1.005 g, 5.91 mmol, 1.2 equiv) in THF (6 mL) was added 
dropwise over a period of 30 min. After being stirred for 16 h, the mixture was 
diluted with Et2O (150 mL) and washed with saturated NH4Cl solution (2 x 30 mL). 
The organic layer was dried over Na2SO4 and filtered. The solvent was evaporated in 
vacuo and the residue was purified by column chromatography (1:9, 
EtOAc/petroleum spirit) to give the ene-yne 200 (874 mg, 70% yield) as a colourless 
oil. 
 
Rf = 0.62 (1:4, EtOAc/petroleum spirit). 
IR (neat, νmax/cm
-1): 2956, 1710, 1168, 1022, 919. 
1H NMR (500 MHz, CDCl3) δ 5.90 (dt, J = 10.7, 7.3 Hz, 1H, H4), 5.53 (d, J = 10.7 
Hz, 1H, H5), 4.46 (s, 2H, H8), 3.68 (s, 3H, MeO), 2.61 (dd, J = 14.8, 7.4 Hz, 2H, 
H3), 2.42 (t, J = 7.5 Hz, 2H, H2), 0.91 (s, 9H, (CH3)3C), 0.13 (s, 6H, CH3Si).  
13C NMR (125 MHz, CDCl3) δ 173.6 (C1), 141.6 (C4), 110.6 (C5), 93.2 (C6), 81.4 
(C7), 52.6 (C8), 52.0 (MeO), 33.6 (C3), 26.2 (C2), 25.9 ((CH3)3C), 18.7((CH3)3C), -
4.8 (CH3Si). 




HRESIMS calcd. for  C15H26O3SiNa, (M+H)







m-Chloroperbenzoic acid, which was purified following the procedure descrbed by 
Perrin,132 (743 mg, 4.2 mmol, 1.4 equiv) was added to a solution of the alkene 200 
(846 mg, 3 mmol) in CH2Cl2 (30 mL) and the mixture was stirred at rt for 14 h.
133 
The reaction was quenched with saturated NaHCO3 solution (50 mL) and the 
aqueous phase was extracted with Et2O (3 x 75 mL). The organic extracts were 
combined, dried over MgSO4 and filtered. The solvent was removed in vacuo and the 
residue was purified by column chromatography (1:8, EtOAc/petroleum spirit) to 
give the epoxide 198 (439 mg, 56% yield) as a colourless oil and the starting alkene 
(200 mg, 27%). 
 
Rf = 0.58 (1:4, EtOAc/petroleum spirit). 
 IR (neat, νmax/cm
-1): 2955, 2239, 1767, 1251, 1185, 1041. 
1H NMR (500 MHz, CDCl3) δ 4.34 (s, 2H, H8), 3.70 (s, 3H, MeO), 3.48 (d, J = 4.0 
Hz, 1H, H5), 3.14 (ddd, J = 6.6, 5.5, 4.0 Hz, 1H, H4), 2.53 (t, J = 7.4 Hz, 2H, H2), 
2.11 – 1.92 (m, 2H, H3), 0.90 (s, 9H, (CH3)3C), 0.11 (s, 6H, (CH3)2Si).
   
13C NMR (125 MHz, CDCl3) δ 173.4 (C1), 85.0 (C7), 79.5 (C6) , 57.2 (C4), 52.1 
(MeO), 52.0 (C8), 45.7 (C5), 30.7 (C2), 26.1 ((CH3)3C), 25.3 (C3), 18.6 ((CH3)3C), -
4.9 (CH3Si). 
ESIMS m/z  321 [(M+Na)+ 100%]. 
HRESIMS calcd. for  C15H26O4SiNa, (M+Na)











A solution of Me3SiN3 (243 mg, 2.11 mmol, 6 equiv) and Ti(Oi-Pr)4 (300 mg, 3 
equiv) in toluene (5 mL) was stirred at 75-80 ºC for 2 h. The mixture then allowed to 
cool to rt and a solution of the epoxide 198 (105 mg, 0.35 mmol) in toluene (1 mL) 
was added. The reaction mixture was stirred at 40 ºC for 18 h. The solvent was 
removed in vacuo and the residue was dissolved into Et2O (3 mL). To this solution, 
was added 5% H2SO4 solution (200 μL) and the mixture was stirred for 1 h at rt.
81 
Water (10 mL) was added and the aqueous phase was extracted with EtOAc (4 x 20 
mL). The organic extracts were combined, washed with saturated NaHCO3 solution 
(30 mL) and brine (30 mL), dried over MgSO4, and filtered. The solvent was 
removed in vacuo and the residue was purified by column chromatography (1:4 to 
1:1, EtOAc/petroleum spirit) to provide the azide 197 (43 mg, 40% yield) as a 





Rf = 0.63 (3:2, EtOAc/petroleum spirit). 
IR (neat, νmax/cm
-1): 2930, 2857, 2220, 2140, 1774, 1153, 1062, 814, 777. 
1H NMR (500 MHz, CDCl3) δ 4.54 (dt, J = 7.0, 6.0 Hz, 1H, H5), 4.41-4.37 (m, 1H, 
H1'), 4.39 (s, 1H, H4'), 2.67 (m, 1H, H3), 2.53 (m, 1H, H3), 2.35 (m, 1H, H4), 2.26 – 
2.16 (m, 1H, H4), 0.91 (s, 9H, (CH3)3C), 0.12 (s, 6H, (CH3)2Si). 
13C NMR (125 MHz, CDCl3) δ 176.2 (C2), 88.9 (C3'), 79.6 (C5), 76.0 (C2'), 56.0 
(C1'), 51.8 (C4'), 30.1 (C3), 26.0 ((CH3)3C), 23.7 (C4), 18.6 ((CH3)3C), -4.89 
(CH3Si) . 
ESIMS m/z 310 [(M+H)+ 100%]. 
HRESIMS calcd. for C14H24O3N3Si, (M+H)







Rf = 0.63 (3:2, EtOAc/petroleum spirit). 
IR (neat, νmax/cm
-1): 3293, 2924, 2313, 1764, 1647, 1398, 1136, 1013. 
1H NMR (500 MHz, CDCl3) δ 5.06 – 4.95 (m, 1H, CO2CH), 4.34 (s, 2H, H8), 4.20 
(d, J = 6.5 Hz, 1H, H5), 3.64 (ddd, J = 9.5, 6.5, 3.0 Hz, 1H, H4), 2.53 – 2.40 (m, 2H, 
H2), 2.00 (dtd, J = 10.5, 7.5, 3.0 Hz, 1H, H3), 1.79 (qd, J = 14.5, 7.5 Hz, 1H, H4), 
1.23 (d, J = 6.0 Hz, 6H, (CH3)2CH), 0.89 (s, 9H, (CH3)3C), 0.11 (s, 6H, (CH3)2Si). 
13C NMR (123 MHz, CDCl3) δ 173.9 (C1), 85.5 (C7), 83.1 (C6), 74.5 (C4), 68.3 
(CO2CH), 66.5 (C5), 52.0 (C8), 31.4 (C2), 27.9 (C3), 26.1 ((CH3)3C), 22.1 
((CH3)2CH), 18.6 ((CH3)3C), -4.8 (CH3Si). 
ESIMS m/z 367 [(M+Na)+ 100%]. 
HRESIMS calcd. for C17H32O5SiNa, (M+Na)






To a 100-mL flask were added PCC (1.9 g, 8.7 mmol) and dry CH2Cl2 (25 mL). 4-
Penten-1-ol (0.5 g, 5.8 mmol) in CH2Cl2 (4 mL) was added dropwise to the PCC 
solution over 5 h. The mixture was stirred for an additional 2 h at room temperature. 
At that time the black mixture was diluted with ether (35 mL). The brown suspension 
was then filtered through Florisil. The black tar that remained in the flask was 
washed with ether (3 x 20 mL), the washings were filtered through Florisil, and the 
Florisil was washed with ether (35 mL). The ethereal solutions were combined, dried 
over MgSO4, and filtered.
134 The solvent was carefully removed in vacuo to yield 4-
penten-1-al (0.41 g, 44%) as a 21% solution in CH2Cl2 and Et2O (yield and 
concentration was relatively determined by NMR analysis). 
 
1H NMR (500 MHz, CDCl3) δ 9.77 (s, 1H, H1), 5.92 – 5.71 (m, 1H, H4), 5.09 – 5.03 
(d, J = 17.0 Hz, 1H, H5), 5.02 (d, J = 10.5 Hz, 1H, H5), 2.53 (t, J = 7.5 Hz, 2H), 











To a solution of the azide 197 (28 mg, 0.09 mmol) in anhydrous THF (1.5 mL) was 
added PPh3 (26.2 mg, 0.1 mmol, 1.1 equiv) and the mixture was stirred at rt for 2 h. 
A solution of 5-pentenal (9.0 mg, 0.11 mmol, 1.2 equiv) in CH2Cl2 (0.5 mL) was 
then added and the mixture was allowed to stir at rt for 30 h. NaBH4 (7 mg, 0.18 
mmol, 2 equiv) and MeOH (200 µL) were then added sequentially. The mixture was 
stirred at rt for an additional 2 h.85 The reaction was quenched with H2O (5 mL) and 
extracted with EtOAc (3 x 20 mL). The organic extracts were combined, dried over 
MgSO4 and filtered. The solvent was removed in vacuo to give a mixture of amine 






      207 
 
1H NMR (300 MHz, CDCl3) δ 4.46 (dd, J = 6.8, 6.8 Hz, 1H, H5), 4.32 (s, 2H, H4'), 
3.78 (d, J = 6.8 Hz, 1H, H1'), 2.70 – 2.47 (m, 2H, H3), 2.42 – 2.29 (m, 1H, H4), 2.24 




To the above mixture of amine 207 and Ph3PO were added MeOH (1 mL) and Et3N 
(200 µL) and the reaction mixture was heated and stirred at reflux temperature for 14 
h.  The solvent was removed in vacuo and the residue was purified by column 
chromatography (9:1, EtOAc/MeOH) to provide the lactam 209 (21 mg, 81% yield 
from 197) as a colourless oil.136 
 
Rf = 0.59 (4:1, EtOAc/petroleum spirit). 
IR (neat, νmax/cm
-1): 3242, 2927, 1638, 1329, 1250, 1195, 1060, 834, 776. 
1H NMR (500 MHz, CDCl3) δ 5.75 (bs, 1H, NH), 4.40 (s, 1H, H6), 4.36 (s, 2H, H3'), 
4.12-3.07 (m, 1H, H5), 2.66 – 2.57 (m, 1H, H3), 2.38 – 2.29 (m, 1H, H3), 2.19 – 2.10 
(m, 1H, H4), 1.93 – 1.85 (m, 1H, H4), 0.91 (s, 9H, (CH3)3C), 0.12 (s, 6H, (CH3)2Si). 
13C NMR (125 MHz, CDCl3) δ 171.0 (C2), 86.3 (C2'), 80.3 (C1'), 65.4 (C5), 51.9 
(C6), 51.1 (C3'), 27.1 (C3), 26.6 (C2), 26.2 ((CH3)C), 18.6 ((CH3)3C), -4.82 (CH3Si). 
ESIMS m/z 284 [(M+H)+ 100%] 
HRESIMS calcd. for C14H26O3NSi, (M+H)
+ 284.1682, found: 284.1678. 
 




Lithium triflate (162 mg, 1 mmol, 1 equiv) and allylamine (114 mg, 2.0 mmol, 2.0 
equiv) were added to a solution of the epoxide 198 (298 mg, 1 mmol) in CH3CN (2 




110 ºC and 200 W for 20 min.87 The solvent was evaporated in vacuo and the residue 
was purified by column chromatography (1:3 to 100:0, EtOAc/petroleum spirit). 




Colourless oil, 26 mg, 8% yield. 
Rf = 0.55 (1:3, EtOAc/petroleum spirit). 
 IR (neat, νmax/cm
-1): 3321, 2954, 2929, 1776, 1625, 1462, 1411, 1255, 1085, 814, 
777. 
1H NMR (500 MHz, CDCl3) δ 5.84 (ddd, J = 16.5, 10.0, 6.0 Hz, 1H, H2''), 5.20 (d, J 
= 17.0 Hz, 1H, H3''(Z)), 5.10 (d, J = 9.5 Hz, 1H, H3''(E)), 4.59 – 4.53 (m, 1H, H5), 
4.31 (s, 2H, H4'), 3.58 (s, 1H, H1'), 3.48 (dd, J = 13.5, 4.5 Hz, 1H, H1''), 3.25 (dd, J 
= 13.5, 6.5 Hz, 1H, H1''), 2.65 – 2.57 (m, 1H, H3), 2.55 – 2.46 (m, 1H, H3), 2.36 – 
2.28 (m, 1H, H4), 2.25 – 2.17 (m, 1H, H4), 0.89 (s, 9H, (CH3)3C), 0.10 (s, 6H, 
(CH3)2Si). 
13C NMR (125 MHz, CDCl3) δ 177.0 (C1), 136.1 (C2''), 117.2 (C3''), 84.5 (C2'), 81.6 
(C3'), 81.5 (C5), 53.7 (C1'), 52.0 (C4'), 50.3 (C1''), 28.6 (C3), 26.1 (C4), 24.5 
((CH3)3C), 18.6((CH3)3C), -4.9 (CH3Si). 
ESIMS m/z  346 [(M+Na)+ 100%]. 
HRESIMS calcd. for  C17H29O3NSiNa, (M+Na)




Colourless oil, 61 mg, 19% yield. 
Rf = 0.65 (2:3, EtOAc/petroleum spirit). 
 IR (neat, νmax/cm
-1): 3352, 2955, 2929, 1621, 1472, 1255, 1091, 1075,  834, 777. 
1H NMR (500 MHz, CDCl3) δ 5.73 (ddt, J = 17.0, 10.5, 6.0 Hz, 1H, H2''), 5.20 (d, J 
= 17.0 Hz, 1H, H3''), 5.14 (d, J = 10.5 Hz, 1H, H3''), 4.71 (dd, J = 15.0, 2.5 Hz, 1H, 
H1''), 4.41 – 4.32 (m, 3H, H6 and H3'), 4.02 – 3.96 (m, 1H, H5), 3.50 (dd, J = 15.0, 
8.0 Hz, 1H, H1''), 2.61 (dt, J = 18.0, 5.0 Hz, 1H, H3), 2.43 (dt, J = 18.0, 9.0 Hz, 1H, 





13C NMR (125 MHz, CDCl3) δ 168.7 (C2), 132.7 (C2''), 118.6 (C3''), 86.5 (C2'), 79.6 
(C3'), 66.8 (C5), 54.1 (C4'), 51.9 (C1'), 47.9 (C1''), 29.6 (C3), 27.0 (C4), 26.1 
(CH3)3C), ((CH3)3C), -4.8 (CH3Si). 
ESIMS m/z  346 [(M+Na)+ 100%]. 
HRESIMS calcd. for  C17H29O3NSiNa, (M+Na)




Colourless oil, 26 mg, 8% yield. 
Rf = 0.69 (1:1, EtOAc/petroleum spirit). 
 IR (neat, νmax/cm
-1): 3312, 2928, 1689, 1635, 1452, 1418, 1260, 1128, 1074, 835. 
1H NMR (500 MHz, CDCl3) δ 5.76 (ddt, J = 17.5, 10.5, 6.0 Hz, 1H, H2''), 5.22 (d,  J 
= 17.5, 1H, H3''), 5.19 (d, J =10.5, 1H, H3'') 4.57 (d, J = 3.0 Hz, 1H, H1'), 4.36 – 
4.28 (m, 3H, H4' and H1''), 3.82 – 3.76 (m, 2H, H1'' and H5), 2.61 – 2.52 (m, 1H, 
H3), 2.36 – 2.28 (m, 1H, H3), 2.19 – 2.07 (m, 2H, H4), 0.90 (s, 9H, (CH3)3C), 0.10 
(s, 6H, (CH3)2Si). 
 13C NMR (125 MHz, CDCl3) δ 176.0 (C2), 133.2 (C2''), 118.3 (C3''), 86.0 (C2'), 
82.7 (C3'), 64.5 (C1'), 61.5 (C5), 51.9 (C4'), 44.8 (C1''), 30.4 (C3), 26.1 ((CH3)3C), 
21.2 (C4), 18.6((CH3)3C), -4.9 (CH3Si). 
ESIMS m/z  324 [(M+H)+ 100%]. 
HRESIMS calcd. for  C17H30O3NSi, (M+H)




yellow solid, 144 mg, 38% yield. 
Mp = 61-63 ºC 
Rf = 0.58 (:1, EtOAc/petroleum spirit). 
 IR (neat, νmax/cm
-1): 3267, 2930, 1633, 1550, 1250, 1093, 834, 777. 
1H NMR (500 MHz, CDCl3) δ 6.03 (bs, 1H, NH amide), 5.93 – 5.78 (m, 2H, H2' and 
H2''), 5.26 – 5.09 (m, 4H, H3' and H3''), 4.33 (s, 2H, H8), 3.87 (t, J = 5.0 Hz, 2H, 
H1''), 3.58 – 3.45 (m, 2H, H1' and H4), 3.28 (dd, J = 13.5, 6.0 Hz, 1H, H1'), 3.19 (d, 
J = 8.5 Hz, 1H, H5), 2.48 – 2.36 (m, 2H, H3), 2.18 (dd, J = 13.0, 6.5 Hz, 1H, H2), 




13C NMR (126 MHz, CDCl3) δ 173.3 (C1), 135.9 (C2''), 134.6 (C2'), 117.4 (C3''), 
116.6 (C3'), 84.9 (C6), 82.7 (C7), 72.7 (C4), 55.4 (C5), 52.1 (C8), 50.0 (C1'), 42.3 
(C1''), 33.4 (C2), 29.6 (C3), 26.1 ((CH3)3C), 18.6((CH3)3C), -4.8 (CH3Si).  
ESIMS m/z  381 [(M+H)+ 100%]. 
HRESIMS calcd. for  C20H37O3N2Si, (M+H)
+ 381.2581, found: 381.2573. 
 
Preparation of lactam 216 from the amino-lactone 215 
 
To solution of the amino-lactone 215 (24 mg, 0.07 mmol) in MeOH (1.0 mL) was 
added Et3N (250 μL, 20% volume in MeOH) and the mixture was stirred at reflux 
temperature for 3 d.136 The solvent was evaporated in vacuo and the residue was 
purified by column chromatography (9:1, EtOAc/petroleum spirit) to afford the 








Silver oxide (97 mg, 0.42 mmol, 3 equiv) and BnBr (100 µL, 0.84 mmol, 6 equiv) 
were added to a solution of the alcohol 216 (45 mg, 0.14 mmol) in anhydrous Et2O 
(5 mL) and the mixture was stirred at rt for 2 d in the dark. The mixture the filtered 
through a small pad of celite and the solid cake was washed with Et2O (2 x 25 mL). 
The solvent was removed in vacuo and the residue was purified by column 
chromatography (2:3, EtOAc/petroleum spirit) to provide compound 354 (19 mg, 
32% yield) as a colourless oil. 
 





-1): 2929, 1644, 1544, 1452, 1364, 1253, 1074, 919, 835, 734. 
1H NMR (500 MHz, CDCl3) δ 7.39 – 7.29 (m, 5H, ArH), 5.72 (ddt, J = 17.0, 10.0, 
4.5 Hz, 1H, H2''), 5.20 (d, J = 17.0 Hz, 1H, H3''), 5.17 (d, J = 10.5 Hz, 1H, H3''), 
4.76 – 4.69 (m, 1H, H1''), 4.66 (d, J = 12.0 Hz, 1H, CHHPh), 4.59 (d, J = 12.0 Hz, 
1H, CHHPh), 4.40 (d, J = 4.4 Hz, 1H, H6), 4.38 (s, 2H, H3'), 3.72 (dt, J = 11.0, 4.0 
Hz, 1H, H5), 3.49 (dd, J = 15.5, 8.0 Hz, 1H), 2.61 (ddd, J = 18.0, 7.0, 2.5 Hz, 1H, 
H3), 2.41 (ddd, J = 18.0, 10.5, 7.0 Hz, 1H, H3), 2.23 (qd, J = 11.0, 7.0 Hz, 1H, H4), 
2.03 – 1.96 (m, 1H, H4), 0.92 (s, 9H, (CH3)3C), 0.13 (s, 6H, (CH3)2Si). 
13C NMR (126 MHz, CDCl3) δ 168.8 (C2), 137.9 (C2''), 132.7 (ArC), 128.8 (ArCH), 
128.3 (ArCH), 128.1 (ArCH), 118.5 (C3''), 84.9 (C6'), 80.1 (C7'), 73.6 (C5), 71.4 
(CH2-Ar), 52.1 (C3'), 51.1 (C6), 47.9 (C1''), 29.9 (C3), 26.10 ((CH3)3C), 24.4 (C4), 
18.6 ((CH3)3C), -4.79 (CH3Si). 
ESIMS m/z  414 [(M+H)+ 100%]. 
HRESIMS calcd. for  C24H36O3NSi, (M+H)
+ 414.2464, found: 414.2482. 
 




Mesyl chloride (6.7 mL, 87 mmol, 1.5 equiv) was added dropwise to a solution of 4-
pentene-1-ol (5.0 g, 58 mmol) and Et3N (12.2 mL, 87 mmol, 1.5 equiv) in CH2Cl2 
(100 mL) in a period of 30 min at 0 0C under a N2 atmosphere.
90 The mixture then 
allowed to warm to rt and stir for 14 h. CH2Cl2 (100 mL) was added and the mixture 
was washed with saturated NaHCO3 solution (2 x 100 mL) and brine (100 mL). The 
organic layer was dried over MgSO4 and filtered. The solvent then was evaporated in 
vacuo to give the crude mesylate product 220 (9.24 g, 99% yield) as a pale yellow oil 
which was used for the next step without further purification.  
 
1H NMR (500 MHz, CDCl3) δ 5.79 (ddt, J = 17.0, 10.5, 6.5 Hz, 1H, H4), 5.08 (d,  J 
= 17.0 Hz, 1H, H5), 5.04 (d,  J = 10.5 Hz, 1H, H5), 4.23 (t, J = 6.0 Hz, 2H, H1), 3.00 




13C NMR (125 MHz, CDCl3) δ 136.9 (C4), 116.3 (C5), 69.6 (C1), 37.6 (Me), 29.7 
(C3), 28.5 (C2). 






To a solution of the mesylate 220 (9.15 g, 55.8 mmol) in MeOH (100 mL) was added 
28% NH3 solution (150 mL) and the mixture was stirred at rt for 2 days.
89 The 
mixture then was extracted with CH2Cl2 (3x 100 mL). The organic layers were 
combined, dried over MgSO4 and filtered. The solvent was carefully evaporated 
under reduced pressure (40 0C, 500 mbar) to afford 7.86 g of 41% solution of amine 
152 (68% yield) in CH2Cl2 (yield and concentration were determined by NMR) as a 
pale yellow solution. 
 
1H NMR (500 MHz, CDCl3) δ 5.76 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, H4), 4.96 (d, J = 
17.0 Hz, 1H, H5), 4.90 (d, J = 10.0 Hz, 1H, H5), 2.64 (t, J = 7.0 Hz, 1H, H1), 2.07 – 
2.00 (m, 2H, H3), 1.52 – 1.44 (m, 2H, H2). 



















Lithium triflate (162 mg, 1 mmol, 1 equiv) and 4-penten-1-amine (170 mg, 2 mmol, 
2 equiv) were added to a solution of epoxide 198 (298 mg, 1 mmol) in CH3CN (2 
mL) in a microwave reaction vial. The mixture was heated in a microwave reactor at 
110 ºC, 200 W for 1 h. The solvent was evaporated in vacuo and the residue was 
purified by column chromatography (1:3 to 100:0, EtOAc/petroleum spirit). Four 




Colourless oil, 46 mg, 13% yield. 
Rf = 0.58 (1:4, EtOAc/petroleum spirit). 
 IR (neat, νmax/cm
-1): 3330, 2929, 1765, 1657, 1461, 1253, 1080, 814, 777. 
1H NMR (500 MHz, CDCl3) δ 5.78 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, H4''), 5.00 (d, J 
= 17.0 Hz, 1H, H5''), 4.94 (d, J = 10.0 Hz, 1H, H5''), 4.54 (dd, J = 12.5, 4.5 Hz, 1H, 
H5), 4.31 (s, 2H, H4'), 3.53 (d, J = 4.5 Hz, 1H, H1'), 2.88 (dt, J = 11.5, 7.0 Hz, 1H, 
H1''), 2.65 – 2.55 (m, 2H, H1'' and H3), 2.51 (dt, J = 18.0, 9.0 Hz, 1H, H3), 2.36 – 
2.27 (m, 1H, H4), 2.24 – 2.14 (m, 1H, H4), 2.09 (q, J = 7.0 Hz, 2H, H3''), 1.59 – 1.53 




13C NMR (126 MHz, CDCl3) δ 177.1 (C2), 138.5 (C4''), 115.1 (C5''), 84.3 (C2'), 81.9 
(C3'), 81.5 (C5), 54.7 (C1'), 52.0 (C4'), 47.5 (C1''), 31.7 (C3''), 29.4 (C2''), 28.7 (C3), 
26.1 ((CH3)3C), 24.6 (C4), 18.6 ((CH3)3C), -4.8 (CH3Si). 
ESIMS m/z  374 [(M+Na)+ 100%]. 
HRESIMS calcd. for  C19H33O3NNaSi, (M+H)




Colourless oil, 92 mg, 26% yield. 
Rf = 0.58 (1:4, EtOAc/petroleum spirit). 
 IR (neat, νmax/cm
-1): 3250, 2928, 2857, 2310, 1635, 1471, 1251, 834 
1H NMR (500 MHz, CDCl3) δ 5.79 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, H4''), 5.02 (d, J 
= 17.0, 1H, H5''), 4.96 (d, J = 10.0 Hz, 1H, H5''), 4.35 (s, 2H, H3'), 4.32 (d, J = 4.5 
Hz, 1H, H6), 3.99 (dt, J = 10.0, 4.5 Hz, 1H, H5), 3.77 (dt, J = 14.0, 8.0 Hz, 1H, H1''), 
3.13 – 3.06 (m, 1H, H1''), 2.56 (ddd, J = 18.0, 6.5, 4.0 Hz, 1H, H3), 2.43 – 2.34 (ddd, 
J = 18.0, 10.0, 7.5 Hz, 1H, H3), 2.12 – 2.04 (m, 3H, H3'' and H4), 1.97 – 1.90 (m, 
1H, H4), 1.70 – 1.62 (m, 2H, H2''), 0.89 (s, 9H, (CH3)3C), 0.10 (s, 6H, (CH3)2Si). 
13C NMR (125 MHz, CDCl3) δ 168.9 (C2), 138.1 (C4''), 115.6 (C5''), 86.1 (C3'), 80.0 
(C2'), 66.9 (C5), 55.2 (C6), 51.9 (C3'), 46.1 (C1''), 31.4 (C3''), 29.6 (C3), 27.1 (C4), 
26.8 (C2''), 26.1 ((CH3)3C), 18.6 ((CH3)3C), -4.9 (CH3Si). 
ESIMS m/z  374 [(M+Na)+ 100%]. 
HRESIMS calcd. for  C19H33O3NNaSi, (M+H)




Colourless oil, 39 mg, 11% yield. 
Rf = 0.58 (1:4, EtOAc/petroleum spirit). 
 IR (neat, νmax/cm
-1): 3317, 2926, 1668, 1458, 1252, 1080, 1006, 998, 777. 
1H NMR (500 MHz, CDCl3) δ 5.80 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, H4''), 5.02 (d, J 
= 17.0 Hz, 1H, H5''), 4.97 (d, J = 10.0 Hz, 1H, H5''), 4.56 (d, J = 3.0 Hz, 1H, H1'), 
4.31 (s, 2H, H4'), 3.80 – 3.64 (m, 1H, H5), 3.66 (ddd, J = 14.0, 9.0, 8.0 Hz, 1H, H1''), 




1H, H3), 2.18 – 2.00 (m, 4H, H2'' and H3''), 1.75 – 1.69 (m, H4), 1.64 – 1.60 (m, 1H, 
H4), 0.90 (s, 9H, (CH3)3C), 0.10 (s, 6H, (CH3)2Si). 
13C NMR (125 MHz, CDCl3) δ 176.1 (C2), 138.0 (C4''), 115.5 (C5''), 86.0 (C3'), 82.6 
(C2'), 64.6 (C1'), 61.7 (C5), 51.9 (C4'), 41.8 (C1''), 31.4 (C3''), 30.5 (C3), 26.9 (C4), 
26.1 ((CH3)3C), 21.2 (C2''), 18.6 ((CH3)3C), -4.9 (CH3Si). 
ESIMS m/z  374 [(M+Na)+ 100%]. 
HRESIMS calcd. for  C19H33O3NNaSi, (M+H)




Yellow solid, 161 mg, 37% yield. 
Mp = 79-81 ºC 
Rf = 0.58 (1:4, EtOAc/Petroleum spirit). 
 IR (neat, νmax/cm
-1): 3401, 2952, 2931, 1460, 1562, 1249, 1168, 1030, 835,  
1H NMR (500 MHz, CDCl3) δ 6.63 (bs, 1H, NH amide), 5.82 – 5.72 (m, 2H, H4' and 
H4''), 5.00 (d, J = 17.0 Hz, 2H, H5' and H5''), 4.95 (d, J = 10.0 Hz, 2H, H5' and H5''), 
4.31 (s, 2H, H8), 3.58 – 3.53 (m, 1H, H4), 3.25 (d, J = 9.0 Hz, 1H, H5), 3.20 (dd, J = 
13.0, 6.5 Hz, 2H, H1'), 2.91 – 2.84 (m, 1H, H1''), 2.64 – 2.56 (m, 1H, H1''), 2.46 – 
2.35 (m, 2H, H2), 2.14 – 2.02 (m, 5H, H3', H3'' and H3), 1.75 (td, J = 14.5, 7.0 Hz, 
1H, H3), 1.66 – 1.54 (m 4H, H2' and H2''), 0.89 (s, 9H, (CH3)3C), 0.09 (s, 6H, 
(CH3)2Si). 
13C NMR (125 MHz, CDCl3) δ 174.8 (C1), 138.2 (C4'), 138.0 (C4''), 115.4 
(C5'),115.3 (C5''), 85.4 (C7), 81.9 (C6), 73.3 (C4), 55.8 (C5), 52.0 (C8), 46.9 (C1'), 
39.7 (C1''), 32.9 (C2), 31.6 (C3'), 31.3 (C3''), 29.3 (C3), 28.7 (C2'), 28.6 (C2''), 26.1 
((CH3)3C), 18.6 ((CH3)3C), -4.9 (C-Si). 
ESIMS m/z  437 [(M+H)+ 100%]. 
HRESIMS calcd. for  C24H45O3 N2Si, (M+H)
+ 437.3183, found: 437.3199. 
 
Preparation of lactam 196 from the amino-lactone 221 
 
To solution of the amino-lactone 221 (43 mg, 0.13 mmol) in MeOH (1.5 mL) was 
added Et3N (337 μL, 25% volume in MeOH) and the mixture was stirred at reflux 




purified by column chromatography (9:1, EtOAc/petroleum spirit) to afford the 
lactam 196 (41 mg, 96% yield) as a pale yellow oil.  
 




Thionylchloride (10.53 mL, 144.52 mmol, 2 equiv) was carefully added to a solution of 
4-methoxybenzylalcohol (9.0 mL, 72.26 mmol, 1 equiv) in anhydrous diethyl ether (144 
mL; 2 mL/mmol) and stirred for 5 h.91 The reaction mixture was quenched with water 
(144 mL). The organic layer was separated and the aqueous phase was extracted with 
CH2Cl2 (2 x 150 mL). The combined organic phases were washed with water (2 x 100 
mL), dried over MgSO4 and concentrated under reduced pressure. 4-
Methoxybenzylchloride 233 (11.08 g, 98% yield) was obtained as a light yellow oil and 
used without further purification. 
 
 1H NMR (CDCl3, 500 MHz): 7.29 (d, J = 7.5 Hz, 2H, ArH), 6.86 (d, J = 7.5 Hz, 2H, 
ArH), 4.56 (s, 2H, CH2Ar), 3.79 (s, 3H, OMe).  
13C NMR (CDCl3, 125 MHz): 160.0 (ArC), 130.4 (ArCH), 130.0 (ArC), 114.5 (ArCH), 
55.3 (OCH3), 46.3 (CH2Ar). 






To a solution of propargyl alcohol (1.50 mL, 25.8 mmol) in anhydrous THF (70 mL) 
was added NaH (1.86 g, 60 wt% in oil, 46.4 mmol, 1.8 equiv) portionwise at 0 ºC 




mL, 38.7 mmol, 1.5 equiv) and TBAI (1.24 g, 3.35 mmol, 0.13 equiv) were added at 
0 ºC.130 The reaction mixture was warmed to rt and stirred for 16 h. Then the mixture 
was cooled to 0 ºC and diluted with Et2O (50 mL) and saturated aqueous NH4Cl 
solution (50 mL) was added. The organic layer was separated and the aqueous phase 
was extracted with Et2O (3 x 50 mL). The combined organic layers were washed 
with brine (50 mL), dried over MgSO4, filtered and concentrated in vacuo. The 
resultant residue was purified by column chromatography (1:9, Et2O/petroleum 
spirit) to give the alkyne 230 (3.33 g, 74% yield) as a colorless oil. 
 
Rf = 0.65(1:4, Et2O/petroleum spirit). 
1H NMR (500 MHz, CDCl3) δ 7.32 (d, J = 8.5 Hz, 2H, ArH), 6.92 (d, J = 8.5 Hz, 
2H, ArH), 4.58 (s, 2H, CH2Ar), 4.17 (d, J = 2.5 Hz, 2H, H1), 3.84 (s, 3H, OMe), 
2.49 (t, J = 2.5 Hz, 1H, H3). 
13C NMR (125 MHz, CDCl3) δ 159.8 (ArC), 130.1 (ArCH), 129.7 (ArC), 114.2 
(ArCH), 80.1 (CH2Ar), 74.8 (C3), 71.5 (C2), 57.0 (C1), 55.6 (OMe). 
NMR spectroscopic data matched with the published data.137 
 




To a solution of the vinyl iodide 187 (1.484 g, 7 mmol) in Et3N (50 mL), were added 
PdCl2(PPh3)2 (112 mg, 0.154 mmol, 0.02 equiv) and CuI (267 mg, 1.54 mmol, 0.2 
equiv) under a nitrogen atmosphere.69 The mixture was stirred for 15 min then a 
solution of alkyne 230 (1.48 g, 8.4 mmol, 1.2 equiv) in THF (25 mL) was added 
dropwise over period of 30 min. After being stirred for 14 h, the mixture was diluted 
with Et2O (150 mL) and washed with saturated NH4Cl solution (2x 50 mL). The 
organic layer was dried over Na2SO4 and filtered. The solvent was evaporated in 




EtOAc/petroleum spirit) to give the ene-yne 231 (1.438 g, 79% yield) as a colourless 
oil. 
 
Rf = 0.61 (1:1, EtOAc/petroleum spirit). 
IR (neat, νmax/cm
-1): 3412, 2937, 1713, 1608, 1512, 1246, 1173, 1029, 818. 
1H NMR (500 MHz, CDCl3) δ 7.30 (d, J = 8.5 Hz, 2H, ArH), 6.90 (d, J = 8.5 Hz, 
2H, ArH), 5.97 (dt, J = 10.5, 7.5 Hz, 1H, H4), 5.57 (d, J = 10.5 Hz, 1H, H5), 4.56 (s, 
2H, OCH2Ar), 4.30 (s, 2H, H8), 3.82 (s, 3H, OMe), 3.67 (t, J = 6.5 Hz, 2H, H1), 2.44 
(q, J = 7.5 Hz, 2H, H3), 1.73 – 1.67 (m, 2H, H2). 
13C NMR (125 MHz, CDCl3) δ 159.7 (ArC), 143.9 (C4), 130.1 (ArCH), 129.8 (ArC), 
114.2 (ArCH), 109.7 (C5), 90.0 (C7), 83.4 (C6), 71.5 (OCH2Ar), 62.4 (C1), 57.9 
(C8), 55.6 (OMe), 31.9 (C2), 26.9 (C3). 
ESIMS m/z  283 [(M+Na)+ 100%]. 
HRESIMS calcd. for  C16H20O3Na, (M+Na)
+ 283.1316, found 283.1316. 
 
 (Z)-tert-Butyl(8-(4-methoxybenzyloxy)oct-4-en-6-ynyloxy)diphenylsilane (232) 
 
 
     
Imidazole (1.087 g, 15.83 mmol, 2.5 equiv) and TBDPSCl (1.98 mL, 7.59 mmol, 1.2 
equiv) were added to a solution of alcohol 231 (1.645 g, 6.33 mmol) in DMF (30 
mL) at rt under a N2 atmosphere and the mixture was stirred under the same 
conditions for 6 h.63 The reaction mixture then was poured into a beaker containing 
water (60 mL) and then extracted with EtOAc (3 x 100 mL). The organic extracts 
were combined, washed with water (2 x 100 mL), dried over MgSO4 and filtered. 
The solvent was evaporated in vacuo and the residue was purified by column 
chromatography (1:9, EtOAc/petroleum spirit) to give the TBS ether 232 (2.554 g, 
81% yield) as a colourless oil. 
 
Rf = 0.63 (1:4, EtOAc/petroleum spirit). 
IR (neat, νmax/cm




1H NMR (500 MHz, CDCl3) δ 7.69-7.63 (m, 4H, ArH), 7.46 – 7.33 (m, 6H, ArH), 
7.26 (d, J = 8.3 Hz, 2H, ArH), 6.86 (d, J = 8.3 Hz, 2H, ArH), 5.92 (dt, J = 10.7, 7.4 
Hz, 1H, H4), 5.50 (d, J = 10.7 Hz, 1H, H5), 4.52 (s, 2H, CH2Ph), 4.26 (s, 2H, H8), 
3.79 (s, 3H, OMe), 3.69 (t, J = 6.3 Hz, 2H, H1), 2.45 – 2.41 (m, 2H, H3), 1.72 – 1.64 
(m, 2H, H2), 1.04 (s, 9H, (CH3)3C). 
13C NMR (125 MHz, CDCl3) δ 159.7 (Ar), 144.4 (C4), 135.9 (Ar), 134.3 (Ar), 130.2 
(Ar),  130.1 (Ar), 130.0 (Ar), 129.9 (Ar), 128.0 (Ar), 127.9 (Ar), 109.1 (C5), 89.8 
(C7), 83.5 (C6), 71.4 (CH2Ar), 63.7 (C1), 57.9 (C8), 55.6 (OMe), 32.2 (C2), 27.3 
(C3), 27.2 ((CH3)3C), 19.6 ((CH3)3C). 
ESIMS m/z 521 [(M+Na)+ 100%]. 
HRESIMS calcd. for C32H38O3SiNa, (M+Na)





Purified m-chloroperbenzoic acid (1.283 g, 7.44 mmol, 1.3 equiv) was added to 
solution of the alkene 232 (2.85 g, 5.72 mmol) in CH2Cl2 (100 mL) and the mixture 
was stirred at rt for 14 h.133 The reaction was quenched with saturated NaHCO3 (60 
mL) and the aqueous phase was extracted with Et2O (3x 100 mL). The organic 
extracts were combined, dried over MgSO4 and filtered through a short column 
loaded with Al2O3. The solvent was removed in vacuo and the residue was purified 
by column chromatography (1:8, EtOAc/petroleum spirit) to give the epoxide 234 
(2.44 g, 64% yield) as a colourless oil and the starting alkene (684 mg, 24% yield). 
Rf = 0.60 (1:3, EtOAc/petroleum spirit). 
IR (neat, νmax/cm
-1): 3282, 2957, 2308, 1428, 1107, 818, 668. 
1H NMR (500 MHz, CDCl3) δ 7.72-7.64 (m, 4H, ArH), 7.43 – 7.34 (m, 6H, ArH), 
7.24 (d, J = 8.4 Hz, 2H, ArH), 6.86 (d, J = 8.4 Hz, 2H, ArH), 4.49 (s, 2H, CH2Ph), 




1H, H5), 3.09 (dd, J = 6.0, 3.5 Hz,  1H, H4), 1.86 – 1.75 (m, 4H, H2 and H3), 1.04 
(s, 9H, (CH3)3C). 
13C NMR (125 MHz, CDCl3) δ 159.8 (Ar), 135.9 (Ar), 135.1 (Ar), 134.2 (Ar), 130.1 
(Ar), 130.0 (Ar), 129.9 (Ar), 129.6 (Ar), 128.1 (Ar), 128.0 (Ar), 114.2 (Ar), 82.0 
(C6), 81.8 (C7), 71.6 (CH2Ar), 63.8 (C1), 58.3 (C4), 57.3 (C8), 55.6 (OMe), 45.6 
(C5), 29.3 (C3), 27.2 ((CH3)3C) 26.9 (C2), 19.6 ((CH3)3C). 
ESIMS m/z  537 [(M+Na)+ 100%]. 
HRESIMS calcd. for  C32H38O4SiNa, (M+Na)







Lithium triflate (162 mg, 1 mmol, 1 equiv) and allylamine (171 mg, 3 mmol, 3 
equiv) were added to solution of the epoxide 234 (514 mg, 1 mmol) in CH3CN (2 
mL) in a microwave reactor vial. The mixture was heated in a microwave reactor at 
110 ºC, 200 W for 1.5 h.87 The solvent was evaporated in vacuo and the residue was 
purified by column chromatography (3:7, EtOAc/petroleum spirit) to give the amine 
235 (411 mg, 72% yield) as a pale yellow oil. 
 
Rf = 0.62 (1:1, EtOAc/petroleum spirit). 
IR (neat, νmax/cm
-1): 3332, 2930, 1611, 1513, 1248, 1103, 1035, 821, 701. 
1H NMR (500 MHz, CDCl3) δ 7.69-7.65 (m, 4H, ArH), 7.43-7.33 (m, 6H, ArH), 7.25 
(d, J = 8.0 Hz, 2H, ArH), 6.86 (d, J = 8.0 Hz, 2H, ArH), 5.95-5.85 (m, 1H, H2'), 5.23 
(d, J = 17.0 Hz, 1H, H3'), 5.12 (d, J = 10.5 Hz, 1H, H3'), 4.50 (s, 2H, CH2Ph), 4.15 
(s, 2H, H8), 3.79 (s, 3H, OMe), 3.74-3.69 (m, 2H, H1), 3.53-3.45 (m, 2H, H4 and 




(m, 1H, H3), 1.87 – 1.77 (m, 1H, H2), 1.75 – 1.66 (m, 1H, H2) 1.57 – 1.46 (m, 1H, 
H3), 1.04 (s, 9H, (CH3)3C). 
13C NMR (126 MHz, CDCl3) δ 159.8 (Ar), 136.5 (Ar), 135.9 (C2'), 134.3 (Ar), 130.1 
(Ar), 129.9 (Ar), 129.8 (Ar). 128.0 (Ar), 116.9 (Ar), 114.2 (C3'), 85.4 (C6), 81.6 
(C7), 73.1 (C4), 71.6 (CH2-Ar) , 64.3 (C1), 57.5 (C8), 55.6 (OMe), 55.5 (C5), 50.1 
(C1'), 30.5 (C3), 29.0 (C2), 27.2 ((CH3)C) , 19.6 ((CH3)3C). 
ESIMS m/z 572 [(M+Na)+ 100%]. 
HRESIMS calcd. for  C35H46O4NSiNa, (M+Na)






1M tetrabutylamonium fluoride (TBAF) solution in THF (1.8 mL, 1.8 mmol, 1.5 
equiv) was added dropwise to a solution of the TBDPS ether 235 (685 mg, 1.2 
mmol) in THF (15 mL) at 0 0C and the mixture was warmed to rt and stirred for 4 
h.138 Saturated NaHCO3 (20 mL) was added and the aqueous phase was extracted 
with EtOAc (3x30 mL). The organic extracts were combined, dried over MgSO4 and 
filtered. The solvent was removed in vacuo and the residue was purified by column 
chromatography (9:1 to 100:0, EtOAc/petroleum spirit) to give the diol 236 (352 mg, 
88% yield) as a colourless oil. 
 
Rf = 0.68 (1:9, MeOH/EtOAc). 
IR (neat, νmax/cm
-1): 3355, 2930, 2852, 1611, 1513, 1453, 1248, 1062, 1031, 818. 
1H NMR (500 MHz, CDCl3,) δ 7.27 (d, J = 8.5 Hz, 2H, ArH), 6.89 (d, J = 8.5 Hz, 
2H, ArH), 5.89 (ddt, J = 17.0, 10.5. 5.5 Hz  1H, H2'), 5.23 (d, J = 17.0, Hz, 1H, H3'), 
5.13 (d, J = 10.5 Hz, 1H, H3'), 4.52 (s, 2H, OCH2Ar), 4.17 (s, 2H, H8), 3.81 (s, 3H, 




6.5 Hz, 1H, H1'), 3.20 (d, J = 9.0 Hz, 1H, H5), 2.02-1.95 (m, 1H, H3), 1.79 – 1.73 
(m, 2H, H2), 1.58 – 1.49 (m, 1H, H3). 
13C NMR (125 MHz, CDCl3,) δ 159.8 (ArC), 136.2 (C2'), 130.0 (ArCH), 129.6 
(ArC) , 117.1 (C3'), 114.2 (ArCH), 85.1 (C6), 81.8 (C7), 73.1 (C4), 71.6 (OCH2Ar), 
63.2 (C1), 57.4 (C8), 55.6 (OMe), 55.3 (C5), 50.0 (C1'), 31.1 (C3), 29.6 (C2). 
ESIMS m/z 334 [(M+H)+ 100%]. 
HRESIMS calcd. for C19H28O4N, (M+H)







To a solution of the amine 236 (165 mg, 0.5 mmol) and Et3N (85 μL, 0.6 mmol, 1.2 
eq) in CH2Cl2 (4 mL) was added a solution of (Boc)2O (116 mg, 0.53 mmol, 1.05 eq) 
in CH2Cl2 (1 mL) dropwise at rt. The reaction mixture was stirred at rt for 18 h and 
quenched with saturated aqueous NaHCO3 solution (10 mL).
95 The aqueous phase 
was extracted with CH2Cl2 (3 x 25 mL). The organic extracts were combined, dried 
over MgSO4, filtered, and evaporated in vacuo. The residue was purified by column 
chromatography (1:1, EtOAc/petroleum spirit) to give the Boc-diol 241 (190 mg, 
88% yield) as a colourless oil. 
 
Rf = 0.63 (3:2, EtOAc/petroleum spirit). 
IR (neat, νmax/cm
-1): 3413, 2920, 1667, 1513, 1455, 1398, 1248, 1141, 1066, 1032, 
819. 
1H NMR (500 MHz, CDCl3) δ 7.26 (d, J = 8.2 Hz, 2H, ArH), 6.88 (d, J = 8.2 Hz, 
2H, ArH), 6.01 – 5.87 (m, 1H, H2'), 5.22 (d, J = 17.0 Hz, 1H, H3'), 5.14 (d, J = 10.0 




(dd, J = 16.0, 6.5 Hz, 1H, H1'), 3.81 (s, 3H, OMe), 3.76-3.65 (m, 4H, H1, H4 and 
H5), 1.95 (dt, J = 6.5, 6.0 Hz, 1H, H3), 1.80-1.72 (m, 2H, H2), 1.55 (m, 1H, H3), 
1.46 (s, 9H, (CH3)3C). 
13C NMR (125 MHz, CDCl3) δ 159.8 (ArC), 156.6 (b, C=O), 135.6 (C2'), 130.1 
(ArCH), 129.6 (ArC), 117.0 (C3'), 114.2 (ArCH), 82.6 (C7), 81.3 (C6), 73.2 (b, C4), 
71.7 (OCH2Ar), 63.1 (C1), 57.3 (C8), 55.6 (OMe), 54.6 (b, C5), 48.1 (b, C1'), 31.3 
(C3), 29.4 (C2), 28.7 ((CH3)3)C),  [(CH3)3CO) not observed]. 
ESIMS m/z 456 [(M+Na)+ 100%]. 
HRESIMS calcd. for C24H35O6NNa, (M+Na)
+ 456.2362, found: 456.2340. 
 
tert-Butyl allyl((R*)-4-(4-methoxybenzyloxy)-1-((R*)-5-oxotetrahydrofuran-2-




To a solution of the Boc-diol 241 (170 mg, 0.92 mmol) in anhydrous CH2Cl2 (3 mL)  
were added TEMPO (13 mg, 0.078 mmol, 0.2 equiv) and BAIB (506 mg, 1.57 mmol, 
4equiv) at rt and the mixture was stirred at rt for 18 h.93 The reaction mixture was 
quenched by 0.1 M Na2S2O3 solution (5 mL) and the aqueous phase was extracted 
with CH2Cl2 (3x 15 mL). The organic extracts were combined, dried over MgSO4 
and filtered. The solvent was evaporated in vacuo and the residue was purified by 
column chromatography (2:3, EtOAc/petroleum spirit) to give the Boc-lactone 242 
(141 mg, 84% yield) as a colourless oil. 
 
Rf = 0.68 (3:2, EtOAc/petroleum spirit). 
IR (neat, νmax/cm
-1): 2953, 1754, 1680, 1513, 1366, 1248, 1140, 1062, 1033. 




5.93-5.83 (bm, 1H, H2''), 5.22-5.10 (bm, 2H, H3'), 4.69-4.63 (bm, 1H, H5), 4.52 (s, 
2H, OCH2Ar), 4.18 (s, 2H, H4'), 4.03-3.87 (bm, 3H, H1'' and H1'), 3.82 (s, 3H, 
OMe), 2.61-2.49 (m, 2H, H3), 2.40-2.32 (m, 1H, H4), 2.18-2.10 (m, 1H, H4), 1.47 
(s, 9H, (CH3)3C). 
13C NMR (125 MHz, CDCl3) 176.1 (C2), 159.5 (ArC), 155.8 (b, C2''), 135.0 
(ArCH), 129.7 (ArC), 116.3 (C3''), 113.9 (ArCH), 83.5 (b, OC(CH3)3), 81.4 (b, C3'), 
81.0 (b, C2'), 79.8 (b, C5), 71.4 (b, OCH2Ar), 56.9 (C4'), 56.3 (OMe), 51.8 (b, C1'), 
48.1 (b, C1''), 28.3 ((CH3)3C), 28.0 (C3), 24.8 (C4). 
ESIMS m/z 452 [(M+Na)+ 100%]. 
HRESIMS calcd. for C24H31O6NNa, (M+Na)
+ 452.2049, found: 452.2037. 
 
(9H)-Fluoren-9-yl)methyl allyl((4R*,5R*)-5,8-dihydroxy-1-(4-




To a solution of the amine 236 (333 mg, 1 mmol) in THF (10 mL) was added a 
saturated solution of Na2CO3 (5 mL) and the mixture was allowed to cool to 0 
0C. 
FmocCl (1.1 mmol, 1.1 equiv) was added portionwise at 0 0C and the reaction 
mixture was stirred at the same temperature for 4 h.95 The organic phase was 
removed in vacuo and the aqueous layer was extracted with EtOAc (3 x 30 mL). The 
organic extracts were combined, dried over MgSO4 and filtered. The solvent was 
removed in vacuo and the residue was purified by column chromatography (3:2, 
EtOAc/petroleum spirit) to give te Fmoc-diol 247 (539 mg 97% yield) as an waxy 
solid. 
 
Rf = 0.60 (9:1, EtOAc/petroleum spirit). 
IR (neat, νmax/cm




1H NMR (500 MHz, CDCl3) δ 7.79 (d, J = 8.5 Hz, 2H, ArH), 7.63 (d, J = 8.5 Hz, 
2H, ArH), 7.43 (t, J = 8.5 Hz, 2H, ArH), 7.34 (t, J = 8.5 Hz, 2H, ArH), 7.28 (d, J = 
9.0 Hz, 2H, ArH), 6.91 (d, J = 9.0 Hz, 2H, ArH), 5.80-5.73 (bm, 1H, H2'), 5.15-5.04 
(bm, 2H, H3'), 4.62-4.57 (bm, 1H, FmocCH2O), 4.52 (s, 2H, OCH2Ar), 4.23 (t, J = 
6.0 Hz. 1H, FmocCH), 4.19-4.16 (bm, 1H, H1'), 4.17 (s, 2H, H8), 3.90-3.86 (m, 1H, 
H1'), 3.83 (s, 3H, OMe), 3.72-3.67 (bm, 3H, H1 and H4), 1.92-1.86 (bm, 2H, H3), 
1.79-1.71 (bm, 2H, H2), 1.60-1.52 (bm, 1H, H2). 
13C NMR (125 MHz, CDCl3)  δ 159.8 (ArC), 144.2 (ArC), 141.7 (ArC), 134.9 (C3'), 
130.1 (ArC), 129.5 (ArC), 128.0 (ArC), 127.4 (ArC), 125.2 (ArC), 120.3 (ArC), 
115.2 (C5''), 114.1 (ArC), 82.8 (C7), 82.3 (C6), 73.2 (b, C4), 71.7 (OCH2Ph), 67.2 
(FmocCH2O), 63.1 (C1), 57.3 (C8), 55.6 (OMe), 55.0 (C5), 47.9 (C1"), 47.6 
(FmocCH), 45.6 (C1''), 31.2 (C3), 29.2 (C2). 
ESIMS m/z 578 [(M+Na)+ 100%]. 
HRESIMS calcd. for C34H37O6NNa, (M+Na)







To solution of the diol 247 (510 mg, 0.92 mmol) in anhydrous CH2Cl2 (10 mL) were 
added TEMPO (30 mg, 0.18 mmol, 0.2 equiv) and BAIB (1.1.8 g, 3.67 mmol, 4 
equiv) at rt and the mixture was stirred at the same temperature for 18 h.93 The 
reaction was quenched by 0.1 N Na2S2O3 solution (10 mL). The organic phase was 
separated and the aqueous phase was extracted with CH2Cl2 (3 x 30 mL). The 
organic extracts were combined, dried over MgSO4 and filtered. The solvent was 




EtOAc/petroleum spirit) to give the Fmoc-lactone 248 (435 mg, 86% yield) as an 
waxy solid. 
 
Rf = 0.63 (3:2, EtOAc/petroleum spirit). 
IR (neat, νmax/cm
-1): 2938, 1779, 1697, 1451, 1406, 1247, 1173, 1066, 917, 759, 741 
1H NMR (500 MHz, CDCl3) δ 7.79 (d, J = 7.5 Hz, 2H, ArH), 7.62 (dd, J = 7.0, 3.0 
Hz, 2H, ArH), 7.43 (t, J = 7.5 Hz, 2H, ArH), 7.35 (t, J = 7.5 Hz, 2H, ArH), 7.28 (d, J 
= 8.5 Hz, 2H, ArH), 6.91 (d, J = 8.5 Hz, 2H, ArH), 5.85-5.70 (bm, 1H, H2''), 5.15-
5.05 (bm, 3H, H3'' and H1'), 4.75-4.66 (bm, 2H, H5 and FmocCHHO), 4.65-4.55 
(bm, 1H, FmocCHHO), 4.55 (bs, 2H, OCH2Ph), 4.27 (t, J = 6.5 Hz, 1H, FmocCH), 
4.18 (bs, 2H, H8), 4.13-3.97 (bm, 1H, H1''), 3.94-3.84 (bm, 1H, H1''), 3.84 (s, 3H, 
OMe). 2.58-2.56 (bm, 1H, H2), 2.46-2.38 (bm, 1H, H2), 2.37-2.36 (bm, 1H, H3), 
2.12-2.02 (bm, 1H, H3) 
13C NMR (125 MHz, CDCl3) δ 176.2 (C2), 159.5 (Ar), 156.3 (b, COOCH2), 143.8 
(Ar), 141.4 (ArC), 134.2 (C2''), 129.7 (Ar), 129.1 (Ar), 127.7 (Ar), 127.1 (Ar), 124.9 
(Ar), 120.0 (Ar), 116.8 (b, C3''), 113.9 (Ar), 83.2 (C3'), 79.4 (b, C5), 79.6 (b, O-
C(CH3)3), 78.8 (b, C2'), 71.5 (OCH2Ph), 68.1 (b, FmocCH2O), 56.8 (C4'), 55.3 
(OMe), 52.8 (b, C1"), 47.3 (FmocCH), 28.1 (C3), 24.9 (C4). 
ESIMS m/z 552 [(M+H)+ 100%]. 
HRESIMS calcd. for C34H37O6NNa, (M+Na)






Triethylamine (2 mL) was added to a solution of the Fmoc-lactone 248 (716 mg, 1.3 
mmol) in CH3CN (8 mL) at rt and the mixture was allowed to stir at rt for 14 h. The 




chromatography (4:1, EtOAc/petroleum spirit) to give the lactone 243 (377 mg, 88% 
yield) as a pale yellow oil.96 
 
Rf = 0.57 (9:1, EtOAc/petroleum spirit). 
IR (neat, νmax/cm
-1): 3352, 2931, 1741, 1610, 1513, 1248, 1172, 1065, 1030. 
1H NMR (500 MHz, CDCl3) δ 7.28 (d, J = 8.5 Hz, 2H, ArH), 6.89 (d, J = 8.5 Hz, 
2H, ArH), 5.87 (ddt, J = 17.0, 10.5, 6.0 Hz, 1H, H2''), 5.24 (d, J = 17 Hz 1H, H1''), 
5.14 (d, J = 10.5 Hz, 1H, H1''), 4.61 (dd, J = 9.0, 5.5 Hz, 1H, H5), 4.52 (s, 2H, 
OCH2Ar), 4.17 (s, 2H, H4'), 3.81 (s, 3H, OMe), 3.64 (d, J = 5.5 Hz, 1H, H1'), 3.53 
(dd, J = 14.0, 5.5 Hz, 1H, H1''), 3.30 (dd, J = 14.0, 6.5 Hz, 1H, H1''), 2.64 (ddd, J = 
17.5, 10.0, 5.5 Hz, 1H, H3), 2.52 (dt, J = 17.5, 5.5 Hz 1H, H3), 2.39 – 2.31 (m, 1H, 
H4), 2.26 – 2.19 (m, 1H, H4). 
13C NMR (125 MHz, CDCl3) δ 177.0 (C1), 159.7 (ArC), 136.1 (C2''), 130.0 (ArCH), 
129.6 (ArC), 117.2 (C3''), 114.2 (ArCH), 83.4 (C2'), 81.9 (C3'), 81.5 (C5), 71.6 
(OCH2Ar), 57.3 (C4'), 55.6 (OMe), 53.7 (C1'), 50.4 (C1''), 28.6 (C3), 24.5 (C4). 
ESIMS m/z 330 [(M+H)+ 100%] 
HRESIMS calcd. for C19H24O4N, (M+H)







To solution of of the amino-lactone 243 (1.086 g, 3.3 mmol) in MeOH (12 mL) was 
added Et3N (3 mL) and the mixture was stirred at reflux temperature for 3 d.
136 The 
solvent was evaporated in vacuo and the residue was purified by column 
chromatography (9:1, EtOAc/petroleum spirit) to afford the hydroxyl-lactam 244 
(988 mg, 91% yield) as a pale yellow oil. 





-1): 3370, 2952, 2361, 1623, 1465, 1410, 1255, 1087, 998, 933, 777. 
1H NMR (500 MHz, CDCl3) δ 7.23 (d, J = 8.5 Hz, 2H, ArH), 6.86 (d, J = 8.5 Hz, 
2H, ArH), 5.71 (ddt, J = 17.0, 10.0, 4.5 Hz, 1H, H2''), 5.15 (d, J = 17.0 Hz, 1H, H3''), 
5.08 (d, J = 10.0 Hz, 1H, H3'') , 4.68 – 4.61 (m, 1H, H1"), 4.49 (s, 2H, OCH2Ar), 
4.32 (s, 2H, H3'), 4.16 (s, 1H, H6), 3.98 – 3.92 (m, 1H, H5), 3.77 (s, 3H, OMe), 3.51 
(dd, J = 15.0, 7.5 Hz, 1H, H1"), 2.61 – 2.54 (m, 1H, H3), 2.44 – 2.35 (m, 1H, H3), 
2.14 – 2.03 (m, 1H, H4), 1.94-1.87 (m, 1H, H4). 
13C NMR (126 MHz, CDCl3) δ 169.0 (C2), 159.8 (ArC), 132.6 (C2"), 130.0 (ArCH), 
129.4 (ArC), 118.5 (ArCH), 114.2 (C3"), 83.2 (C2'), 81.6 (C1'), 71.9 (OCH2Ar), 66.7 
(C5), 57.2 (C3'), 55.5 (OMe), 54.1 (C6), 48.0 (C1''), 29.6 (C3), 26.8 (C4). 
ESIMS m/z 330 [(M+H)+ 100%]. 
HRESIMS calcd. for C19H24O4N, (M+H)
+ 330.1705, found: 330.1698. 
 
Microwave assisted Boc-deprotection of 242 
 
A solution of the N-Boc protected amine 242 (135 mg, 0.31 mmol) in TFE (2 mL) 
was placed in a sealed microwave vial. The reaction mixture was heated at 100 ºC in 
a microwave reactor with stirring for 1 h. After cooling to room temperature, the 
mixture was evaporated to dryness under reduced pressure. The crude product was 
purified by flash-column chromatography (3:1 to 100:0, EtOAc/petroleum spirit) to 






Imidazole (2.176 g, 32 mmol, 2.5 equiv) and TBSCl (2.215 g, 14.72 mmol, 1.15 
equiv) were added to a solution of alcohol 231 (3.33 g, 12.8 mmol) in DMF (40 mL) 
at rt under a N2 atmosphere and the mixture was stirred at rt for 6 h.
63 The mixture 




EtOAc (3 x 100 mL). The organic extracts were combined, washed with water (2 x 
100 mL), dried over MgSO4 and filtered. The solvent was evaporated in vacuo and 
the residue was purified by column chromatography (1:9, EtOAc/petroleum spirit) to 
give the TBS ether 249 (4.453 g, 93% yield) as a colourless oil. 
 
Rf = 0.61 (1:3, EtOAc/petroleum spirit). 
IR (neat, νmax/cm
-1): 2931, 2856, 1512, 1426, 1248, 1107, 819, 741. 
1H NMR (500 MHz, CDCl3) δ 7.29 (d, J = 8.5 Hz, 2H, ArH), 6.88 (d, J = 8.6 Hz, 
2H, ArH), 5.96 (dt, J = 10.7, 7.4 Hz, 1H, H4), 5.52 (d, J = 10.7 Hz, 1H, H5), 4.55 (s, 
2H, OCH2Ar), 4.29 (s, 2H, H8), 3.80 (s, 3H, OMe), 3.64 (t, J = 6.5 Hz, 2H, H1), 2.38 
(q, J = 7.3 Hz, 2H, H3), 1.68 – 1.61 (m, 2H, H4), 0.89 (s, 9H, (CH3)3C), 0.05 (s, 6H, 
(CH3)2Si). 
13C NMR (125 MHz, CDCl3) δ 159.7 (ArC), 144.4 (C4), 130.1 (ArCH), 130.0 (ArC), 
114.2 (ArCH), 109.1 (C5), 89.8 (C7) , 83.5 (C6), 71.4 (OCH2Ar), 63.0 (C1), 57.9 
(C8), 55.6 (OMe), 32.4 (C2), 27.2 (C3), 26.3 ((CH3)3C), 18.7 ((CH3)3C), -4.9 
(CH3Si). 
ESIMS m/z 397 [(M+Na)+]. 
HRESIMS calcd. for C22H34O3SiNa, (M+Na)






Purified m-chloroperbenzoic acid (2.38 g, 13.8 mmol, 1.2 equiv) was added to 
solution of the alkene 250 (4.3 g, 11.5 mmol) in CH2Cl2 (150 mL) and the mixture 
was stirred at rt for 14 h.133 The reaction was quenched with saturated NaHCO3 
solution (100 mL) and the aqueous phase was extracted with Et2O (3 x 150 mL). The 




column loaded with Al2O3. The solvent was removed in vacuo and the residue was 
purified by column chromatography (1:8, EtOAc/petroleum spirit) to give the 
epoxide 250 (2.825 g, 63% yield) as a colourless oil and the starting alkene 249 
(0.989 g, 23%). 
Rf = 0.59 (1:3, EtOAc/petroleum spirit). 
IR (neat, νmax/cm
-1): 3312, 2930, 2856, 1612, 1513, 1465, 1248, 1094, 834, 755. 
1H NMR (500 MHz, CDCl3) δ 7.27 (d, J = 8.0 Hz, 2H, ArH), 6.88 (d, J = 8.0 Hz, 
2H, ArH), 4.52 (s, 2H, OCH2Ar), 4.17 (s, 2H, H8), 3.80 (s, 3H, OMe), 3.72 – 3.64 
(m, 2H, H1), 3.49 (d, J = 3.5 Hz, 1H, H5), 3.10 (dd, J = 7.0, 3.5 Hz, 1H, H4), 1.80-
1.71 (m, 4H, H2 and H3), 0.89 (s, 9H, (CH3)3C), 0.05 (s, 6H, (CH3)2Si). 
13C NMR (125 MHz, CDCl3) δ 159.8 (ArC), 130.1 (ArCH), 129.6 (ArC), 114.2 
(ArCH), 82.0 (C6), 81.8 (C7), 71.6 (OCH2Ar), 63.0 (C1), 58.3 (C4), 57.3 (C8), 55.6 
(OMe), 45.5 (C5), 29.5 (C3), 26.6 (C2), 26.3 ((CH3)3C), 18.6 ((CH3)3C), -5.0 
(CH3Si). 
ESIMS m/z  413 [(M+Na)+ 100%]. 
HRESIMS calcd. for C22H34O4SiNa, (M+Na)






Lithium triflate (162 mg, 1 mmol, 1 equiv) and 4-penteneamine (340 mg, 3 mmol, 3 
equiv) were added to solution of the epoxide 250 (390 mg, 1 mmol) in CH3CN (2 
mL) in a microwave reactor vial. The mixture was heated in a microwave reactor at 
110 ºC, 200 W for 1.5 h.87 The solvent was evaporated in vacuo and the residue was 
purified by column chromatography (3:7, EtOAc/petroleum spirit) to give the amine 




Rf = 0.60 (1:1, EtOAc/petroleum spirit). 
IR (neat, νmax/cm
-1): 3370, 2930, 2855, 1513, 1465, 1248, 1091, 833, 755. 
1H NMR (500 MHz, CDCl3) δ 7.29 (d, J = 8.0 Hz, 2H, ArH), 6.90 (d, J = 8.0 Hz, 
2H, ArH), 5.83 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, H4'), 5.05 (d, J = 17.0 Hz, 1H, H5'), 
4.98 (d, J = 10.0 Hz, 1H, H5'), 4.53 (s, 2H, OCH2Ar), 4.18 (s, 2H, H8), 3.83 (s, 3H, 
OMe), 3.69 (t, J = 6.0 Hz, 2H, H1), 3.46 (dd, J = 8.5, 6.0 Hz, 1H, H4), 3.17 (d, J = 
8.5 Hz, 1H, H5), 2.91 (dt, J = 11.5, 7.0 Hz, 1H, H1'), 2.64 (dt, J = 11.5, 7.0 Hz, 1H, 
H1'), 2.15 (q, J = 7.0 Hz, 2H, H3'), 1.97 – 1.88 (m, 1H, H3), 1.83-1.74 (m, 1H, H2), 
1.73 – 1.67 (m, 1H, H2), 1.66-1.57 (m, 2H, H2'), 1.54 – 1.45 (m, 1H, H3), 0.91 (s, 
9H, (CH3)3C), 0.07 (s, 6H, (CH3)2Si). 
13C NMR (125 MHz, CDCl3) δ 159.8 (ArC), 138.6 (C4'), 130.1 (ArCH), 129.8 
(ArC), 115.2 (C5'), 114.2 (ArCH), 85.7 (C6), 81.3 (C7), 73.2 (C4), 71.6 (OCH2Ar), 
63.6 (C1), 57.5 (C8), 56.3 (C5), 55.6 (OMe), 47.0 (C1'), 31.8 (C3'), 30.7 (C3), 29.6 
(C2), 29.3 (C2'), 26.3 ((CH3)C), 18.7 ((CH3)3C), -4.9 (CH3Si). 
ESIMS m/z 476 [(M+H)+ 100%]. 
HRESIMS calcd. for C27H46O4NSi, (M+H)






1M tetrabutylamonium fluoride solution in THF (3.8 mL, 3.8 mmol, 1.5 equiv) was 
added dropwise to a solution of the TBS ether 251 (1.19 g, 2.5 mmol) in THF (30 
mL) at 0 0C and the mixture was warmed to rt and stirred for 4 h.138 Saturated 
NaHCO3 (50 mL) was added and the aqueous phase was extracted with EtOAc (3 x 
100 mL). The organic extracts were combined, dried over MgSO4 and filtered. The 




chromatography (9:1 to 100:0, EtOAc/petroleum spirit) to give the diol 227 (890 mg, 
91% yield) as a colourless oil. 
 
Rf = 0.69 (1:9, MeOH/EtOAc). 
IR (neat, νmax/cm
-1): 3310, 2944, 1779, 1696, 1450, 1410, 1247, 1066, 1030, 740. 
1H NMR (500 MHz, CDCl3) δ 7.28 (d, J = 8.5 Hz, 2H, ArH), 6.90 (d, J = 8.5 Hz, 
2H, ArH), 5.82 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, H4'), 5.04 (d, J = 17.0, 1H, H5'), 
4.98 (d, J = 10.0 Hz, 1H, H5'), 4.52 (s, 2H, OCH2Ar), 4.17 (s, 2H, H8), 3.82 (s, 3H, 
OMe), 3.74-3.64 (m, 2H, H1), 3.48 – 3.43 (m, 1H, H4), 3.15 (d, J = 9.0 Hz, 1H, H5), 
2.90 (dt, J = 11.5, 7.0 Hz, 1H, H1'), 2.63 (dt, J = 11.5, 7.0 Hz, 1H, H1'), 2.14 (q, J = 
7.0 Hz, 2H, H3'), 2.04 – 1.95 (m, 1H, H3), 1.83 – 1.74 (m, 2H, H2), 1.63-1.59 (m, 
2H, H2'), 1.58 – 1.48 (m, 1H, H3).  
13C NMR (125 MHz, CDCl3) δ 159.8 (ArC), 138.5 (C4'), 130.1 (ArCH), 129.7 
(ArC), 115.3 (C5'), 114.2 (ArCH), 85.2 (C6), 81.7 (C7), 73.0 (C4), 71.6 (OCH2Ar), 
63.2 (C1), 57.4 (C8), 56.0 (C5), 55.6 (OMe), 46.9 (C1'), 31.7 (C3'), 31.1 (C3), 29.7 
(C2), 29.6 (C2'). 
ESIMS m/z 362 [(M+H)+ 100%]. 
HRESIMS calcd. for C21H32O4N, (M+H)







To a solution of the amine 227 (975 mg, 2.7 mmol) in THF (40 mL), was added a 
saturated solution of Na2CO3 (20 mL) and the mixture was allowed to cool to 0 
0C. 




reaction mixture was stirred at rt for 4 h.95 The organic phase was removed in vacuo 
and the aqueous layer was extracted with EtOAc (3 x 50 mL). The organic extracts 
were combined, dried over MgSO4 and filtered. The solvent was removed in vacuo 
and the residue was purified by column chromatography (3:2, EtOAc/petroleum 
spirit) to give the Fmoc-diol 252 (1.511 g, 96% yield) as a waxy solid. 
 
Rf = 0.60 (9:1, EtOAc/petroleum spirit). 
IR (neat, νmax/cm
-1): 3436, 2927, 1687, 1611, 1458, 1248, 1066, 1032, 739. 
1H NMR (500 MHz, CDCl3) δ 7.76 (J = 8.5 Hz, 2H, ArH), 7.59 (J = 8.5 Hz, 2H, 
ArH), 7.39 (t, J = 8.5 Hz, 2H, ArH), 7.31 (t, J = 8.5 Hz, 2H, ArH), 7.23 (J = 9.0 Hz, 
2H, ArH), 6.87 (J = 9.0 Hz, 2H, ArH), 5.72-5.62 (bm, 1H, H4''), 5.01-4.90 (bm, 2H, 
H5''), 4.77-4.72 (bm, 1H, FmocCH2O), 4.67-4.57 (bm, 2H, FmocCH2O and H1'), 
4.47 (s, 2H, OCH2Ar), 4.23 (t, J = 6.0 Hz. 1H, FmocCH), 4.12 (s, 2H, H4'), 3.80 (s, 
3H, OMe), 3.67-3.58 (bm, 3H, H1 and H4), 3.12-2.97 (bm, 2H, H1'), 1.90-1.80 (bm, 
2H, H3'), 1.75-1.65 (bm, 2H, H2'), 1.55-1.40 (bm, 4H, H2 and H3). 
13C NMR (125 MHz, CDCl3)  δ 159.7 (Ar), 144.1 (Ar), 141.6 (Ar), 138.0 (C4'), 
129.9 (Ar), 129.5 (Ar), 127.9 (Ar), 127.3 (Ar), 124.9 (Ar), 120.2 (Ar), 115.2 (C5''), 
114.1 (Ar), 82.5 (C7), 82.2 (C6), 73.0 (b, C4), 71.5 (OCH2Ar), 67.2 (FmocCH2O), 
63.0 (C1), 57.2 (C8), 55.5 (OMe), 54.9 (b,C5), 47.7 (FmocCH), 45.6 (b, C1''), 31.4 
(C3'), 31.2 (C2'), 29.4 (C3), 28.8 (b, C2). 
ESIMS m/z 606 [(M+Na)+ 100%]. 
HRESIMS calcd. for C36H41O6NNa, (M+Na)









To a solution of of the diol 252 (1.28 g, 2.2 mmol) in anhydrous CH2Cl2 (30 mL) 
were added TEMPO (69 mg, 0.44 mmol, 0.2 equiv) and BAIB (2.83 g, 8.8 mmol, 4 
eq) at rt and the mixture was stirred at rt for 18 h.93 The reaction was quenched by 
0.1 N Na2S2O3 solution (20 mL) . The organic phase was separated and the aqueous 
phase was extracted with CH2Cl2 (3 x 50 mL). The organic extracts were combined, 
dried over MgSO4 and filtered. The solvent was evaporated in vacuo and the residue 
was purified by column chromatography (3:2, EtOAc/petroleum spirit) to give the 
Fmoc-lactone 253 (813 mg, 84% yield) as a waxy solid. 
 
Rf = 0.65 (3:2, EtOAc/petroleum spirit) 
IR (neat, νmax/cm
-1): 3346, 2935, 1773, 1612, 1513, 1455, 1451, 1246, 1713, 1067, 
1029, 919, 817. 
1H NMR (500 MHz, CDCl3) δ 7.79 (d, J = 7.5 Hz, 2H, ArH), 7.63 (t, J = 7.0 Hz, 2H, 
ArH), 7.43 (t, J = 7.5 Hz, 2H, ArH), 7.35 (t, J = 7.0 Hz, 2H, ArH), 7.27 (d, J = 8.5 
Hz, 2H, ArH), 6.91 (d, J = 8.5 Hz, 2H, ArH), 5.72-5.3 (bm, 1H, H4''), 5.15-5.05 (bm, 
3H, H5'' and H1'), 4.71-4.63 (bm, 2H, H5 and FmocCH2O), 4.62-4.57 (bm, 1H, 
FmocCH2O), 4.50 (bs, 2H, OCH2Ar), 4.27 (t, J = 5.0 Hz, 1H, FmocCH), 4.16 (bs, 
2H, H4'), 3.84 (s, 3H, OMe), 3.34-3.26 (bm, 1H, H1'), 3.13-3.07 (bm, 1H, H1''), 
2.59-2.52 (bm, 1H, H3), 2.12-2.03 (bm, 3H, H3 and 2H3"), 1.89-1.83 (bm, 1H, H4), 
1.58-1.52 (bm, 1H, H2"), 1.45-1.38 (bm, 1H, H2"). 
13C NMR (126 MHz, CDCl3) δ 176.2 (C2), 159.5 (Ar), 156.3 (b, FmocCO), 143.8 
(Ar), 141.4 (Ar), 137.7 (C4''), 129.7 (Ar), 129.1 (Ar), 127.4 (Ar), 127.1 (Ar), 124.7 
(Ar), 120.0 (Ar), 115.1 (b, C3''), 113.9 (Ar), 83.2 (C3'), 79.4 (b, C5), 78.8 (b, C2'), 
71.4 (OCH2Ar), 67.1 (b, FmocCH2O), 56.8 (C4'), 55.3 (OMe), 52.4 (b, C1'), 47.3 
(FmocCH), 31.1 (C3"), 28.2 (C2"), 28.1 (b,C3), 24.9 (C4). 
ESIMS m/z 602 [(M+Na)+ 100%]. 
HRESIMS calcd. for C36H37O6NNa, (M+Na)














Triethyamine (5 mL) was added to a solution of the Fmoc-lactone 253 (2.432 g, 4.2 
mmol) in CH3CN (20 mL) at rt and the mixture was allowed to stir at rt for 14 h.
96 
The solvent was evaporated in vacuo and the residue was purified by column 
chromatography (4:1, EtOAc/petroleum spirit) to give the lactone 226 (1.289 g, 86% 
yield) as a pale yellow oil. 
 
Rf = 0.63 (9:1, EtOAc/petroleum spirit) 
IR (neat, νmax/cm
-1): 3343, 2935, 2841, 1773, 1611, 1512, 1247, 1067, 1029, 816. 
1H NMR (500 MHz, CDCl3) δ 7.28 (d, J = 8.5 Hz, 2H, ArH), 6.89 (d, J = 8.5 Hz, 2H 
ArH),  5.82 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, H4''), 5.03 (d, J = 17.0 Hz, 1H, H5''), 
4.97 (d, J = 10.0 Hz, 1H, H5'')), 4.60 (dd, J = 7.0, 5.5 Hz, 1H, H5), 4.52 (s, 2H, 
OCH2Ar), 4.17 (s, 2H, H4'), 3.81 (s, 3H, OMe), 3.59 (d, J = 5.5 Hz, 1H, H1'), 2.92 
(dt, J = 11.5, 7.0 Hz, 1H, H1''), 2.67 – 2.59 (m, 2H, H1'' and H3), 2.54 (m, 1H, H3), 
2.39 – 2.31 (m, 1H, H4), 2.27 – 2.19 (m, 1H, H4), 2.12 (q, J = 7.0 Hz, 2H, H3''), 1.64 
– 1.55 (m, 2H, H2''). 
13C NMR (125 MHz, CDCl3) δ 177.1 (C1), 159.7 (ArC), 138.5 (C4''), 130.0 (ArCH), 
129.6 (ArC), 115.1 (C5''), 114.2 (ArCH), 83.7 (C2'), 81.7 (C3'), 81.4 (C5), 71.6 
(OCH2Ar), 57.3 (C4'), 55.6 (OMe), 54.7 (C1'), 47.6 (C1''), 31.7 (C3''), 29.4 (C2''), 
28.7 (C3), 24.5 (C4). 
ESIMS m/z 380 [(M+Na)+ 100%]. 
HRESIMS calcd. for C21H27O4NSiNa, (M+Na)










To solution of the amino-lactone 226 (1.086 g, 3.3 mmol) in MeOH (12 mL) was 
added Et3N (3 mL) and the mixture was stirred at reflux temperature for 3 d.
136 The 
solvent was evaporated in vacuo and the residue was purified by column 
chromatography (9:1, EtOAc/petroleum spirit) to afford the lactam 225 (920 mg, 
84% yield) as a pale yellow oil.  
 
Rf = 0.63 (1:9, MeOH/EtOAc) 
IR (neat, νmax/cm
-1): 3361, 2930, 1614, 1513, 1438, 1413, 1247, 1067, 1031, 817 
1H NMR (500 MHz, CDCl3) δ 7.24 (d, J = 7.5 Hz, 2H, ArH), 6.87 (d, J = 7.5 Hz, 
2H, ArH), 5.79 (ddt, J = 17.0, 10.0, 4.5 Hz, 1H, H4''), 5.01 (d, J = 17.0 Hz, 1H, H5''), 
4.95 (d, J = 10.0 Hz, 1H, H5''), 4.49 (s, 2H, OCH2Ar), 4.32 (s, 1H, H6), 4.17 (s, 2H, 
H3'), 4.01 – 3.95 (m, 1H, H5), 3.79 (s, 3H, OMe), 3.81 – 3.71 (m, 1H, H1''), 3.12 (dt, 
J = 14.0, 7.0 Hz 1H, H1''), 2.59-2.53 (m, 1H, H3), 2.38 (dt, J = 11.5, 7.0 Hz, 1H, 
H3), 2.14 – 2.02 (m, 3H, H4 and H3''), 1.95-1.88 (m, 1H, H4), 1.76 – 1.62 (m, 2H, 
H2''). 
13C NMR (125 MHz, CDCl3) δ 169.0 (C1), 159.8 (ArC), 138.0 (C4''), 130.2 (ArCH), 
129.3 (ArC), 115.4 (C5''), 114.2 (ArCH), 83.2 (C2'), 81.8 (C1'), 71.9 (OCH2Ar), 66.8 
(C5), 57.3 (C3'), 55.6 (OMe), 55.2 (C6) 46.2 (C1''),  31.4 (C3''), 29.8 (C3), 29.5 (C4), 
26.7 (C2''). 
ESIMS m/z 380 [(M+Na)+ 100%]. 
HRESIMS calcd. for C21H27O4NSiNa, (M+Na)







enyl)piperidin-3-yl acetate (258) 
 
 
To an ice-bath cooled solution of the alcohol 225 (339 mg. 0.85 mmol) in CH2Cl2 
(10 mL) were added successively DMAP (25 mg, 8.62 mmol, 0.17 equiv), Ac2O 
(100 μL, 1.02 mmol, 1.2 equiv), and Et3N (140 μL, 42.25 mmol, 1.2 equiv). The 
mixture was stirred at room temperature for 14 h.100 The reaction was quenched with 
10 mL of saturated aqueous NaHCO3 solution and 10 mL of water at 0 
0C. The 
organic layer was separated and the aqueous layer was extracted with EtOAc (4 x 20 
mL). The combined organic layers were dried over anhydrous MgSO4, filtered, and 
concentrated under reduced pressure. The residue was purified by column 
chromatography (9:1, EtOAc/petroleum spirit) to afford the acetate 258 (345 mg, 
91% yield) as a pale yellow oil.  
Rf = 0.69 (4:1, EtOAc/petroleum spirit) 
IR (neat, νmax/cm
-1): 2936, 1743, 1640, 1513, 1369, 1235, 1031, 916, 819 
1H NMR (500 MHz, CDCl3) δ 7.25 (d, J = 7.0 Hz, 2H, ArH), 6.89 (d, J = 7.0 Hz, 
2H, ArH), 5.84 – 5.74 (m, 1H, H4''), 5.05- 4.94 (m, 3H, H5'' and H3), 4.52 (d, J = 1.5 
Hz, 1H, H2), 4.50 (s, 2H, OCH2Ar), 4.16 (s, 2H, H3'), 3.82 – 3.73 (m, 1H, H1''), 3.79 
(s, 3H, OMe), 3.12 (dt, J = 13.5, 7.0 Hz, 1H, H1''), 2.63-2.57 (m, 1H, H5), 2.51 – 
2.42 (m, 1H, H5), 2.29-2.26 (td, J = m, 1H, H4), 2.10 (s, 3H, MeCO), 2.08 – 2.01 
(m, 2H, H3''), 1.94-2.02 (m, 1H, H4), 1.73 – 1.65 (m, 2H, H2''). 
13C NMR (125 MHz, CDCl3) δ 170.5 (ester CO), 168.5 (C6), 159.8 (ArC), 138.0 
(C4''), 130.0 (ArCH), 129.4 (ArC), 115.4 (C5''), 114.2 (ArCH), 82.4 (C2'), 80.7 
(C1'), 71.5 (OCH2Ar), 68.5 (C3), 57.1 (C3'), 55.7 (OMe), 51.7 (C2), 46.2 (C1''),  
31.4 (C3''), 29.5 (C5), 26.7 (C2''), 23.7 (C4), 21.3 (MeCO). 
ESIMS m/z  422 [(M+Na)+ 100%]. 
HRESIMS calcd. for  C23H29NO5Na, (M+H)










To a mixture of the PMB ether 258 (620 mg, 1.55 mmol) in CH2Cl2 (50 mL) and 
water (5 mL), was added DDQ (633 mg, 2.79 mmol, 1.8 equiv) portionwise at 0 0C 
and the mixture was allowed to warm to rt and stirred for 18 h.104 Then the mixture 
was diluted with CH2Cl2 (100 mL) and washed with water (2 x 50 mL). The organic 
layer was dried over MgSO4 and filtered. The solvent was evaporated in vacuo and 
the residue was purified by column chromatography (4:1, EtOAc/petroleum spirit) to 
give the primary alcohol 267 (339 mg, 78% yield) as a yellow oil. 
 
Rf = 0.69 (4:1, EtOAc/petroleum spirit). 
IR (neat, νmax/cm
-1): 3361, 2936, 1743, 1625, 1415, 1369, 1228, 1043, 1026, 913, 
779. 
1H NMR (500 MHz, CDCl3) δ 5.73 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, H4''), 4.98  – 
4.88 (m, 3H, H5'' and H3), 4.44 (d, J = 3.0 Hz, 1H, H2), 4.21 (s, 2H, H3'), 3.69 (dt, J 
= 14.5, 7.0 Hz, 1H, H1''), 3.04 (dt, J = 14.5, 7.0 Hz, 1H, H1''), 2.54-2.48 (m, 1H, 
H5), 2.42-2.34 (m,1H, H5), 2.23 – 2.13 (m, 1H, H4), 2.05 (s, 3H, MeCO), 2.03-1.95 
(m, 2H, H3''), 1.90 (dd, J = 8.5, 4.0 Hz, 1H, H4 ), 1.65 – 1.56 (m, 2H, H2''). 
13C NMR (125 MHz, CDCl3) δ 170.4 (ester CO), 168.7 (C6), 137.7 (C4''), 115.3 
(C5''), 85.1 (C2'), 79.3 (C1'), 68.2 (C3), 51.5 (C2), 50.5 (C3’), 45.9 (C1''), 31.1 (C3''), 
29.1 (C5), 26.4 (C2''), 23.3 (C4), 21.1 (MeCO). 
ESIMS m/z 302 [(M+H)+ 100%] 
HRESIMS calcd. for C15H21O4NNa, (M+H)











To a solution of the primary alcohol 267 (310 mg, 1.1 mmol) in acetone (10 mL) was 
added Jones’ reagent (1.6 mL) dropwise at 0 0C. After being stirred for 30 min at 0 
0C, CH3OH (0.2 mL) was added and the reaction mixture was stirred for additional 
10 min at 0 0C. Water (15 mL)) was added and the mixture was extracted with 
CH2Cl2 (4 x 50 mL). The organic extracts were combined, dried over MgSO4 and 
filtered. The solvent was evaporated in vacuo to give the crude acid (286 mg, 88% 
yield) as a yellow solid which was used in the next step without further purification. 
To a solution of the above acid (286 mg, 0.97 mmol)  in anhydrous MeOH, was 
added TMSCl (250 µL, 1.95 mmol, 2 equiv) under a N2 atmosphere and the mixture 
was stirred at rt for 12 h.68 The volatiles were removed in vacuo and the residue was 
dissolved in CH2Cl2 (70 mL) and washed with NaHCO3 (2 x 20 mL). The organic 
layer was dried over MgSO4 and filtered. The solvent was evaporated in vacuo and 
the residue was purified by column chromatography (2:3, EtOAc/petroleum spirit) to 
give the hydroxyl ester 182 (80 mg, 30% yield) as a yellow oil. 
 
Rf = 0.69 (4:1, EtOAc/petroleum spirit). 
IR (neat, νmax/cm
-1): 3455, 2924, 2953, 17331718, 1272, 1177, 1131. 
1H NMR (500 MHz, CDCl3) δ 5.85 – 5.75 (m, 1H, H4''), 5.04 (d, J = 17.0 Hz, 1H, 
H5''), 4.98 (d, J = 10.0 Hz, 1H, H5''), 4.43 (d, J = 4.6 Hz, 1H, H2), 4.13 – 4.08 (m, 
1H, H5), 3.78 (s, 3H, OMe), 3.81 – 3.70 (m, 1H, H1''), 3.13 (dt, J = 13.0, 6.5, 1H, 
H1''), 2.64 – 2.57 (m, 1H, H5), 2.48 – 2.39 (m, 1H, H5), 2.10-2.19 (m, 1H, H4), 1.97-




13C NMR (126 MHz, CDCl3) δ 169.2 (C6), 153.7 (C3'), 137.8 (C4''), 115.5 (C5''), 
83.5 (C1'), 77.6 (C2'), 66.8 (C3), 55.2 (C2), 53.3 (OMe), 46.5 (C1''), 31.2 (C3''), 29.6 
(C5), 26.8 (C2''), 26.6 (C4). 
ESIMS m/z 288 [(M+Na)+ 100%]. 
HRESIMS calcd. for C14H19O4NNa, (M+Na)









To an ice-bath cooled solution of the alcohol 182 (66 mg, 0. 25 mmol) in CH2Cl2 
were added sequentially DMAP (7 mg, 0.043 mmol, 0.17 equiv), Ac2O (28 μL, 0.3 
mmol, 1.2 equiv), and Et3N (42 μL, 0.3 mmol, 1.2 equiv).
100 The mixture was stirred 
at rt for 16 h. The reaction was quenched with 10 mL of saturated aqueous NaHCO3 
solution and 10 mL of water at 0 0C. The organic layer was separated and the 
aqueous layer was extracted with EtOAc (4 x 20 mL). The combined organic layers 
were dried over anhydrous MgSO4, filtered, and concentrated under reduced 
pressure. The residue was purified by column chromatography (4:1, 
EtOAc/petroleum spirit) to afford the acetate 269 (62 mg, 81% yield) as a colourless 
oil.   
 
Rf = 0.69 (4:1, EtOAc/petroleum spirit). 
IR (neat, νmax/cm
-1): 2930, 2848, 2240, 1743, 1717, 1653, 1368, 1226, 1144, 909. 
NMR (500 MHz, CDCl3) δ 5.80 (ddt, J = 17.0, 10.5, 6.0 Hz, 1H, H4'’), 5.08-4.97 (m,  
3H, H5" and H3), 4.61 (d, J = 5.0 Hz, 1H, H2), 3.80 (s, 3H, OMe), 3.81-3.72 (m, 1H, 
H1''), 3.11 (dt, J = 14.0, 7.0 Hz, 1H, H1''), 2.65-2.59 (m, 1H, H5), 2.53-2.45 (m, 1H, 
H5), 2.30-2.22 (m, 1H, H4), 2.14 (s, 3H. CH3CO), 2.09-2.01 (m, 2H, H3"), 1.91-1.85 




13C NMR (126 MHz, CDCl3) δ 170.5 (CH3COO), 168.2 (C6), 153.4 (C3'), 137.8 
(C4''), 115.6 (C5''), 82.1 (C1'), 77.4 (C2'), 68.0 (C3), 53.3 (C2), 51.7 (OMe), 46.5 
(C1"), 31.2 (C3'), 29.4 (C5), 26.6 (C4), 23.8 (C2"), 21.2 (CH3CO). 
ESIMS m/z 308 [(M+H)+ 100%] 
HRESIMS calcd. for C16H22O5N, (M+H)







To a solution of the ene-yne 269 (46 mg, 0.15 mmol) in anhydrous CH2Cl2 (80 mL) 
was added Grubb’s 1st generation Ru catalyst (12.3 mg, 0.015 mmol, 0.1 equiv) 
under a N2 atmosphere and the mixture was stirred at rt for 8 h.
60 The reaction 
mixture then was exposed to the open air for 30 min. The solvent was evaporated in 
vacuo and the residue was purified by column chromatography (4:1, 
EtOAc/petroleum spirit) to give the bicyclic compound 270 (34 mg, 75% yield) as a 
yellow oil. 
 
Rf = 0.69 (4:1, EtOAc/petroleum spirit). 
IR (neat, νmax/cm
-1): 2925, 2853, 1739, 1737, 1373, 1224, 1196, 1107, 1012. 
1H NMR (500 MHz, CDCl3) δ 6.20 (s, 1H, H4 (Z)'), 5.83 (t, J = 8.0, 1H, H9), 5.60 (s, 
1H, H4' (E)), 5.20 (s, 1H, H1), 4.46 (s, 1H, H10a), 4.25 (dd, J = 13.5, 7.5 Hz, 1H, 
H6), 3.76 (s, 3H, OMe), 3.24 (td, J = 12.3, 6.8 Hz, 1H, H6), 2.65-2.49 (m, 2H, H8 
and H3), 2.46-2.40 (m, 1H, H3), 2.25 – 2.14 (m, 1H, H7), 2.11 – 2.02 (m, 1H, H2),  
2.03 (s, 3H, COMe), 1.97 – 1.80 (m, 2H, H8 and H2), 1.62-1.54 (m, 1H, H7). 
13C NMR (125 MHz, CDCl3) δ 169.9 (C4), 169.0 (CH3COO), 167.0 (C2'), 140.8 
(C10), 136.1 (C1'), 132.3 (C9), 129.8 (C4'), 67.0 (C1), 65.6 (C10a), 52.5 (OMe), 




ESIMS m/z 330 [(M+Na)+ 100%]. 
HRESIMS calcd. for C16H21O5NNa, (M+Na)







To a solution of the enone 270 (36.8 mg, 0.12 mmol) in anhydrous MeOH (5 mL) 
was added NaBH4 (41 mg, 1.1 mmol, 9 equiv) portionwise at 0 
0C under a N2 
atmosphere and the mixture was stirred at the same condition for 3 h.60 The reaction 
was quenched by adding saturated NaHCO3 solution (10 mL) at 0 
0C and the mixture 
was extracted with EtOAc (3 x 20 mL). The organic extracts were combined, dried 
over MgSO4 and filtered. The solvent was evaporated in vacuo and the residue was 
purified by column chromatography (3:1, EtOAc/petroleum spirit) to give 285 as an 
inseparable mixture of diasteroisomers (28 mg, 75% yield) as a pale yellow oil. 
 
Rf = 0.59 (4:1, EtOAc/petroleum spirit) 
IR (neat, νmax/cm
-1): 2921, 2918, 2848, 1739, 1616, 1452, 1324, 1157, 1092, 813. 
1H NMR (500 MHz, CDCl3) major diastereomer δ 5.89-5.83 (m, 1H, H9), 5.40 (s, 
1H, H1), 4.24 (d, J = 7.0 Hz, 1H, H10a), 4.24-4.18 (m, 1H, H6), 3.65 (m, 3H, OMe), 
2.93 (q, J = 7 Hz, 1H, H1'), 2.85 (dt, J = 12.0, 6.0 Hz, 1H, H6), 2.62-2.55 (m, 1H, 
H3), 2.55-2.40 (m, 2H, H3 and H8), 2.27-2.15 (m, 2H H2 and H7), 2.03 (s, 3H, 
MeCO), 1.99-1.89 (m, 2H, H2  and H8), 1.58-1.49 (m, 1H, H7), 1.34 (d, J = 7.0 Hz, 
3H, H4'). 
13C NMR (126 MHz, CDCl3) major diastereomer δ 174.7 (C2'), 170.1 (AcO), 169.0 
(C4), 136.2 (C10), 128.2 (C9), 67.8 (C10a), 67.4 (C1), 52.3 (OMe), 44.0 (C11), 42.9 




1H NMR (500 MHz, CDCl3) minor diastereomer δ 5.89-5.83 (m, 1H, H9), 5.47 (s, 
1H, H1), 4.26 (d, J = 7.0 Hz, 1H, H10a), 4.24-4.18 (m, 1H, H6), 3.71 (m, 3H, OMe), 
3.05 (q, J = 7 Hz, 1H, H1'), 2.85 (dt, J = 12.0, 6.0 Hz, 1H, H6), 2.73-2.64 (m, 1H, 
H3), 2.55-2.40 (m, 2H, H3 and H8), 2.27-2.15 (m, 1H H2), 2.14-2.08 (m, 1H, H7), 
2.03 (s, 3H, MeCO), 1.99-1.89 (m, 2H, H2  and H8), 1.58-1.49 (m, 1H, H7), 1.34 (d, 
J = 7.0 Hz, 3H, H4'). 
13C NMR (126 MHz, CDCl3) minor diastereomer δ 175.2 (C2'), 170.0 (AcO), 168.9 
(C4), 135.6 (C10), 127.4 (C9), 67.9 (C10a), 66.0 (C1), 52.5 (OMe), 43.0 (C11), 42.5 
(C6), 27.2 (C2), 24.9 (C3), 23.6 (C7), 21.2 (C8), 21.1 (CH3CO), 14.4 (C4'). 
ESIMS m/z 332 [(M+Na)+ 100%] 
HRESIMS calcd. for C16H23O5NNa, (M+Na)







Sodium hydride in mineral oil (60%, 60 mg, 1.5 mmol, 1.5 equiv), BnBr (300 μL, 
2.5 mmol, 2.5 equiv) and Bu4NI (37 mg, 0.1 mmol, 0.1 equiv) were added to a 
solution of the alcohol 270 (358 mg, 1 mmol) in DMF (15 mL) at 0 0C and the 
resultant mixture was warmed to rt and stirred for 19 h.107 The reaction mixture was 
diluted with EtOAc (15 mL), quenched with water (5 mL) and the aqueous layer 
extracted with EtOAc (2 x 25 mL). The combined organic extracts were washed with 
water (2 x 20 mL) and brine (20 mL), dried over MgSO4 and concentrated under 
reduced pressure to give the crude product. This was purified by column 
chromatography (3:2, EtOAc/petroleum spirit) to give the benzyl ether 271 (125 mg, 





Rf = 0.69 (4:1, EtOAc/petroleum spirit). 
IR (neat, νmax/cm
-1): 2947, 2317, 1639, 1513, 1249, 1168, 1098, 1070, 1028, 698. 
1H NMR (500 MHz, CDCl3) δ 7.40 – 7.28 (m, 5H, ArH), 7.24 (d, J = 8.2 Hz, 2H, 
ArH), 6.85 (d, J = 8.2 Hz, 2H, ArH), 5.80 (ddt, J = 17.1, 10.2, 6.5 Hz, 1H, H4''), 5.02 
(d, J = 17.1 Hz, 1H, H5''), 4.97 (d, J = 10.2 Hz, 1H, H5''), 4.67 (d, J = 11.8 Hz, 1H, 
OCH2Ph), 4.63 (d, J = 11.8 Hz, 1H, OCH2Ph), 4.52 (s, 2H, OCH2Ar), 4.39 (d, J = 
2.7 Hz, 1H, H5), 4.18 (s, 2H, H3'), 3.80 (s, 3H, OMe), 3.76 (dd, J = 14.8, 5.4 Hz, 2H, 
H1'' and H5), 3.16 – 3.09 (m, 1H, H1''), 2.63 – 2.56 (m, 1H, H3), 2.42-2.34 (m, 1H, 
H3), 2.26 – 2.16 (m, 1H, H4), 2.07 – 2.00 (m, 3H, H4 and 2H3''), 1.69-1.63 (m, 2H, 
H2''). 
13C NMR (125 MHz, CDCl3) δ 168.5 (C6), 159.6 (Ar), 142.0 (Ar), 137.8 (C4''), 
130.5 (Ar), 129.6 (Ar), 129.1 (Ar), 128.5 (Ar), 128.1 (Ar), 115.5 (C5''), 114.1 (Ar), 
85.2 (C2'), 79.0 (C1'), 73.5 (C5), 73.4 (OCH2Ar), 71.5 (OCH2Ph), 57.1 (C3'), 55.7 
(OMe), 51.7 (C6), 46.2 (C1''),  31.4 (C3''), 29.5 (C3), 26.7 (C2''), 23.7 (C4). 
ESIMS m/z 470 [(M+H)+ 100%]. 
HRESIMS calcd. for C28H33O4NNa, (M+Na)







To a mixture of the PMB ether 271 (179 mg, 0.4 mmol) in CH2Cl2 (10 mL) and 
water (1 mL) was added DDQ (163 mg, 0.72 mmol, 1.8 equiv) portionwise at 0 0C 
and the mixture was allowed to stirr at rt for 18 h.104 Then the mixture was diluted 
with CH2Cl2 (50 mL) and washed with water (2 x 2mL). The organic layer was dried 
over MgSO4 and filtered. The solvent was evaporated in vacuo and the residue was 
purified by column chromatography (4:1, EtOAc/petroleum spirit) to give the 




Rf = 0.60 (9:1, EtOAc/petroleum spirit). 
IR (neat, νmax/cm
-1): 3320, 2926, 2313, 1697, 1620, 1453, 1411, 1270, 1163, 1095, 
1070, 914, 740. 
1H NMR (500 MHz, CDCl3) δ 7.42 – 7.26 (m, 5H, ArH),  5.78 (ddt, J = 17.0, 10.5, 
6.5 Hz, 1H, H4''), 5.02 (d, J = 17.0 Hz, 1H, H5''), 4.97 (d, J = 10.5 Hz, 1H, H5''), 
4.64 (d, J = 17.0 Hz, 1H, OCH2Ph), 4.61 (d, J = 17.0 Hz, 1H, OCH2Ph), 4.33 (s, 1H, 
H6), 4.27 (s, 2H, H3'), 3.77 – 3.68 (m, 2H, H5 and H1''), 3.14 – 3.06 (m, 1H, H1''), 
2.61-2.55 (m, 1H, H3), 2.42 – 2.32 (m, 1H, H3), 2.23 – 2.12 (m, H, H4), 2.06 – 1.99 
(m, 2H, H3''), 1.99-1.93 (m, 1H, H4), 1.68 – 1.59 (m, 2H, H2''). 
13C NMR (125 MHz, CDCl3) δ 169.8 (C2), 138.0 (C4''), 137.6 (ArC), 128.9 (ArCH), 
128.4 (ArCH), 128.1 (ArCH), 115.4 (C5''), 84.8 (C2'), 80.7 (C1'), 73.5 (C5), 71.5 
(OCH2Ph), 52.5 (C6), 51.1 (C3'), 46.5 (C1''), 31.3 (C3''), 29.5 (C3), 26.6 (C2''), 23.9 
(C4). 
ESIMS m/z 350 [(M+Na)+ 100%]. 
HRESIMS calcd. for C20H25O3NNa, (M+Na)







To a solution of the primary alcohol 274 (95 mg, 0.29 mmol) in acetone (3 mL) was 
added Jones’ reagent (420 µL) dropwise at 0 0C. After stirring for 30 min at 0 0C, 
CH3OH (0.1 mL) was added at the same temperature and the reaction mixture was 
stirred for additional 10 min. Water (10 mL) was added and the mixture was 
extracted with CH2Cl2 (4 x 20 mL). The organic extracts were combined, dried over 
MgSO4 and filtered. The solvent was evaporated in vacuo to give the crude acid (95 
mg, 91% yield) as a yellow solid which was used in the next step without further 




mg, 0.56 mmol, 2 equiv) was added at rt and the mixture was stirred for 15 min 
under a N2 atmosphere. MeI (100 µL, 1.6 mmol, 6 equiv) was then added and the 
mixture was stirred at rt for 14 h.108 Water (10 mL) was added and the mixture was 
extracted with EtOAc (3 x 20 mL). The organic extracts were combined, dried over 
MgSO4 and filtered. The solvent was evaporated in vacuo and the residue was 
purified by column chromatography (2:3, EtOAc/petroleum spirit) to give the methyl 
ester 277 (63 mg, 65% yield) as a pale yellow oil.  
 
Rf = 0.69 (3:1, EtOAc/petroleum spirit). 
IR (neat, νmax/cm
-1): 2916, 2376, 2313, 1718, 1620, 1272, 1099, 698. 
H NMR (500 MHz, CDCl3) δ 7.42 – 7.26 (m, 5H, ArH), 5.72 (ddt, J = 17.0, 10.0, 6.5 
Hz, 1H, H4''), 4.95 (d, J = 17.0 Hz, 1H, H5''), 4.91 (d, J = 10.0 Hz, 1H, H5''), 4.58 (s, 
2H, OCH2Ph), 4.33 (d, J = 3.5 Hz, 1H, H2), 3.73 (s, 3H, OMe), 3.73-3.63 (m, 2H, 
H5 and H1''), 3.03 (dt, J = 13.5, 7.5 Hz, 1H, H1''), 2.57-2.51 (m, 1H, H5), 2.35-2.25 
(m, 1H, H5), 2.15-2.06 (m, 1H, H4), 2.03-1.92 (m, 3H, H4 and 2H3''), 1.61-1.54 (m, 
2H, H2''). 
13C NMR (125 MHz, CDCl3) δ 169.0 (C6), 153.7 (C3'), 138.0 (C4''), 137.6 (ArC), 
129 (ArCH), 128.9 (ArCH), 128.1 (ArCH), 115.5 (C5''), 83.3 (C1'), 77.2 (C2'), 73.4 
(C3), 71.7 (OCH2Ph), 53.2 (OMe), 52.8 (C2), 46.6 (C1''), 31.3 (C3''), 29.7 (C5), 26.7 
(C2''), 24.5 (C4). 
ESIMS m/z 378 [(M+Na)+ 100%]. 
HRESIMS calcd. for C21H25O4NNa, (M+Na)
+











To a solution of the ene-yne 277 (53 mg, 0.15 mmol) in anhydrous CH2Cl2 (40 mL) 
was added Grubb’s 1st generation Ru catalyst (12.4 mg, 0.015 mmol, 0.1 equiv) 
under a N2 atmosphere and the mixture was stirred at rt for 8 h.
60 The reaction 
mixture then was exposed to open air for 30 min. The solvent was evaporated in 
vacuo and the residue was purified by column chromatography (3:1, 
EtOAc/petroleum spirit) to give the bicyclic compound 278 (42 mg, 80% yield) as a 
pale yellow oil. 
 
Rf = 0.57 (4:1, EtOAc/petroleum spirit). 
IR (neat, νmax/cm
-1): 2937, 1740, 1635, 1623, 1451, 1250, 1171, 1050, 726. 
1H NMR (500 MHz, CDCl3) δ 7.37 – 7.24 (m, 5H, ArH), 6.10 (s, 1H, H4'), 5.88 (dd, 
J = 8.5, 6.5 Hz, 1H, H9), 5.54 (s, 1H, H4'), 4.60 (d, J = 12.0 Hz, 1H, OCH2Ph), 4.36 
(d, J = 12.5 Hz, 2H, OCH2Ph and H1), 4.24 (dd, J = 12.7, 7.3 Hz, 1H, H6), 3.76 (s, 
3H, OMe), 3.73 (s, 1H, H10a), 3.20 (td, J = 12.7, 6.8 Hz, 1H, H6), 2.72 – 2.61 (m, 
1H, H8 and H3), 2.39-2.33 (m, 1H, H3), 2.24 – 2.14 (m, 1H, H7 and H2), 1.94 – 1.86 
(m, 1H, H8), 1.77-1.69 (m, 1H, H2), 1.63 – 1.53 (m, 1H, H7). 
13C NMR (125 MHz, CDCl3) δ 169.6 (C4), 167.3 (C2'), 142.1 (C10), 138.6 (ArC), 
136.4 (C1'), 132.2 (C9), 128.6 (C4'), 128.4 (ArC), 127.6 (ArC), 127.3 (ArC), 71.9 
(C1), 70.9 (OCH2Ph), 66.7 (C10a), 52.5 (OMe), 42.7 (C6), 27.2 (C3), 24.0 (C7), 23.5 
(C2), 21.8 (C8). 
ESIMS m/z 378 [(M+Na)+ 100%]. 
HRESIMS calcd. for C21H25O4NNa, (M+Na)
+










Sodiumborohydride (34 mg, 0.9 mmol, 9 equiv) was added portionwise to a solution 
of the enone 278 (36 mg, 0.1 mmol) in anhydrous MeOH (3 mL) at 0 0C under a N2 
atmosphere and the mixture was stirred at 0 0C for 3 h.60 Saturated aqueous NaHCO3 
solution (10 mL) was added at 0 0C and the mixture was extracted with EtOAc (3 x 
20 mL). The organic extracts were combined, dried over MgSO4 and filtered. The 
solvent was evaporated in vacuo and the residue was purified by column 
chromatography (3:1, EtOAc/petroleum spirit) to give 286 (28 mg, 77% yield) as a 
pale yellow oil as an inseparable mixture of diastereomers. 
 
Rf = 0.62 (9:1, EtOAc/petroleum spirit) 
IR (neat, νmax/cm
-1): 2940, 1730, 1626, 1454, 1276, 1246, 1173, 1108, 1098, 736, 
717 
1H NMR (500 MHz, CDCl3) major diastereomer δ 7.34 – 7.24 (m, 5H, ArH), 5.88 (t, 
J = 7.0 Hz, 1H, H9), 4.60 (d, J = 11.0 Hz, 1H, OCH2Ph), 4.47 (d, J = 11.0 Hz, 1H, 
OCH2Ph), 4.20 (dd, J = 13.2, 7.3 Hz, 1H, H6), 4.04 (s, 1H, H1), 3.99 (s, 1H, H10a), 
3.67 (s, 3H, OMe), 2.95 (q, J = 7.0 Hz, 1H, H1'), 2.86-2.76 (m, 1H, H6), 2.74-2.64 
(m, 1H, H3), 2.64-2.56 (m, 1H, H8), 2.37 (dd, J = 17.5, 5.5 Hz, 1H, H3), 2.27-2.20 
(m, 1H, H2), 2.17-2.09 (m, 1H, H7), 1.91-1.73 (m, 2H, H8 and H2), 1.52-1.43 (m, 
1H, H7), 1.32 (d, J = 7.0 Hz, 3H, H4'). 
13C NMR (126 MHz, CDCl3) major diastereomer δ 174.8 (C2'), 169.6 (C4), 138.8 
(ArC), 136.8 (C10), 128.6 (ArC), 127.7 (ArC), 127.6 (ArC), 127.5 (C9), 72.4 (C1), 
71.2 (OCH2Ph), 69.2 (C10a), 52.3 (OMe), 44.3 (C1'), 43.0 (C6), 27.2 (C3), 24.0 
(C2), 23.9 (C7), 21.2 (C8), 19.1 (C4'). 
1H NMR (500 MHz, CDCl3) minor diastereomer δ 7.34 – 7.24 (m, 5H, ArH), 5.88 (t, 
J = 7 Hz, 1H, H9), 4.60 (d, J = 11.0 Hz, 1H, OCH2Ph), 4.40 (d, J = 11.0 Hz, 1H, 
OCH2Ph), 4.18 (dd, J = 13.2, 7.3 Hz, 1H, H6), 4.11 (s, 1H, H10a), 3.86 (s, 1H, H1), 
3.56 (s, 3H, OMe), 2.92-2.87 (m, 1H, H1'), 2.86-2.76 (m, 1H, H6), 2.74-2.64 (m, 1H, 
H3), 2.64-2.56 (m, 1H, H8), 2.37 (dd, J = 17.5, 5.5 Hz, 1H, H3), 2.27-2.20 (m, 1H, 
H2), 2.17-2.09 (m, 1H, H7), 1.91-1.73 (m, 2H, H8 and H2), 1.52-1.43 (m, 1H, H7), 
1.29 (d, J = 7.0 Hz, 3H, H4'). 
13C NMR (126 MHz, CDCl3) minor diastereomer δ 175.3 (C2'), 169.5 (C4), 138.4 




71.0 (OCH2Ph), 69.1 (C10a), 52.4 (OMe), 44.3 (C1'), 42.8 (C6), 27.2 (C3), 24.0 
(C2), 23.9 (C7), 21.3 (C8), 16.5 (C4'). 
ESIMS m/z 358 [(M+H)+ 100%]. 
HRESIMS calcd. for C21H28O4N, (M+H)







To a solution of the alcohol 225 (990 mg, 2.77 mmol) in CH2Cl2 (30 mL) were added 
TBSOTf (10.43 mL, 1.85 mmol, 0.67 equiv) and 2,6-lutidine (0.32 mL, 2.77 mmol, 1 
equiv) at 0 0C.109 The mixture was warmed to rt and stirred for 1 h. This step was 
repeated three times and the reaction mixture was stirred at rt for 12 h. The solvent 
was evaporated in vacuo and the residue was purified by column chromatography 
(3:2, EtOAc/petroleum spirit) to give compound 279 (1.16 g, 81% yield) as a 
colourless oil. 
 
Rf = 0.62 (9:1, EtOAc/petroleum spirit). 
IR (neat, νmax/cm
-1): 2936, 1742, 1635, 1610, 1462, 1231, 1170, 1032. 
1H NMR (500 MHz, CDCl3) δ 7.29 (d, J = 8.5 Hz, 2H, ArH), 6.90 (d, J = 8.5 Hz, 
2H, ArH), 5.84 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, H4''), 5.06 (d, J = 17.0 Hz, 1H, H5''), 
5.00 (d, J = 10.0 Hz, 1H, H5''), 4.55 (s, 2H, OCH2Ar), 4.23 (d, J = 3.0 Hz, 1H, H6), 
4.20 (s, 2H, H3'), 4.08 – 4.03 (m, 1H, H5), 3.83 (s, 3H, OMe), 3.79 (dt, J = 14.0, 7.0 
Hz, 1H, H1''), 3.18 (dt, J = 14.0, 7.0 Hz, 1H, H1''), 2.64-2.58 (ddd, J = 18.0, 7.0, 3.5 
Hz, 1H, H3), 2.61 (ddd, J = 18.0, 10.0, 7.0 Hz, 1H, H3), 2.25 – 2.15 (m, 1H, H4), 
2.10 (q, J = 7.0 Hz, 2H, H3''), 1.89 – 1.83 (m, 1H, H4), 1.72 (quin, J = 7.5 Hz, 2H, 




13C NMR (125 MHz, CDCl3) δ 169.0 (C2), 159.7 (ArC), 138.2 (C4''), 130.0 (ArCH), 
129.7 (ArC), 115.3 (C5''), 114.2 (ArCH), 82.8 (C2'), 81.6 (C1'), 71.3 (OCH2Ar), 68.2 
(C5), 57.2 (C3'), 55.6 (OMe), 55,5 (C6), 46.1 (C1''), 31.4 (C3''), 29.7 (C3), 27.5 (C4), 
27.0 (C2''), 26.0 ((CH3)3C), 18,4 ((CH3)3C), -4.2 (CH3Si). 
ESIMS m/z 494 [(M+Na)+ 100%]. 
HRESIMS calcd. for C27H41O4NSiNa, (M+Na)






To a mixture of the PMB ether 225 (1.178 g, 2.5 mmol) in CH2Cl2 (50 mL) and 
water (5 mL,) was added DDQ (1.022 g, 4.5 mmol, 1.8 equiv) portionwise at 0 0C 
and the mixture was allowed to stirred at rt for 18 h.104 Then the mixture was diluted 
with CH2Cl2 (100 mL) and washed with water (2 x 50 mL). The organic layer was 
dried over MgSO4 and filtered. The solvent was evaporated in vacuo and the residue 
was purified by column chromatography (4:1, EtOAc/petroleum spirit) to give the 
primary alcohol 282 (694 mg, 79% yield) as a yellow oil. 
 
Rf = 0.57 (9:1, EtOAc/petroleum spirit) 
IR (neat, νmax/cm
-1): 3326, 2926, 2869, 2361, 1622, 1454, 1126, 1024, 913. 
1H NMR (500 MHz, CDCl3) δ 5.81 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, H4''), 5.03 (d, J 
= 17.0 Hz, 1H, H5''), 4.98 (d, J = 10.0 Hz, 1H, H5'), 4.34 (s, 1H, H6), 4.31 (s, 2H, 
H3'), 4.05-4.00 (m, 1H, H5), 3.77 (dt, J = 13.5, 8.0 Hz, 1H, H1''), 3.12 (dt, J = 13.5, 
8.0 Hz, 1H, H1''), 2.59 (ddd, dt, J = 18.0, 6.5, 4.0 Hz 1H, H3), 2.40 (dt, J = 17.5, 7.5 
Hz 1H, H3), 2.13-2.03 (m, 3H, H4 and 2H3''), 1.98-1.91 (m,1H, H4), 1.67 (quin, J = 




13C NMR (126 MHz, CDCl3) δ 169.0 (C2), 137.8 (C4''), 111.1 (C5''), 85.2 (C2'), 80.6 
(C1'), 66.6 (C5), 54.9 (C6), 50.9 (C3'), 45.9 (C1''), 31.0 (C3), 29.7 (C3’’), 29.2 (C2''), 
26.1 ((CH3)3C), 26.0 (C4), 18.5 ((CH3)3C), -4.7 (CH3Si). 
ESIMS m/z 374 [(M+Na)+ 100%]. 
HRESIMS calcd. for C19H33O3NSiNa, (M+Na)







To a solution of the primary alcohol 282 (635 mg, 1.81 mmol) in acetone (20 mL) 
was added Jones’ reagent (2.7 mL) dropwise at 0 0C. After stirring for 30 min at 0 
0C, CH3OH (0.5 mL) was added and the reaction mixture was stirred for additional 
10 min at 0 0C. Water (40 mL) was added and the mixture then was extracted with 
CH2Cl2 (4 x 60 mL). The organic extracts were combined, dried over MgSO4 and 
filtered. The solvent was evaporated in vacuo to give the crude acid (594 mg, 90% 
yield) as a yellow solid, which was used in the next step without further purification. 
To a solution of this acid (594 mg, 1.63 mmol) in anhydrous DMF (20 mL), was 
added K2CO3 (450 mg, 3.26 mmol, 2 equiv) at rt and the mixture was stirred for 15 
min under a N2 atmosphere. Then MeI (610 μL, 9.8 mmol, 6 equiv) was added and 
the reaction mixture was allowed to stirred at rt for 14 h.108 Water (40 mL) was 
added and the mixture was extracted with CH2Cl2 (3 x 60 mL). The organic extracts 
were combined, dried over MgSO4 and filtered. The solvent was evaporated in vacuo 
and the residue was purified by column chromatography (2:3, EtOAc/petroleum 
spirit) to give the ester 141 (413 mg, 67% yield) as a pale yellow oil. 
 
Rf = 0.65 (4:1, EtOAc/petroleum spirit). 
IR (neat, νmax/cm




NMR (500 MHz, CDCl3) δ 5.82 (ddt, J = 17.5, 10.5, 6.0 Hz, 1H, H4''), 5.04 (d, J = 
17.5 Hz, 1H, H5''), 4.98 (d, J = 10.0 Hz, 1H, H5'), 4.27 (d, J = 3.5 Hz, 1H, H2), 4.10-
4.05 (m, 1H, H3), 3.78 (s, 3H, OMe), 3.74 (dt, J = 13.5, 8.0 Hz, 1H, H1''), 3.15 (dt, J 
= 13.5, 7.5 Hz, 1H, H1''), 2.63-2.57 (ddd, dt, J = 18.0, 7.0, 6.5, Hz 1H, H5), 2.38 
(ddd, J = 18.0, 10.0, 7.0 Hz 1H, H5), 2.16-2.10 (m, 1H, H4), 2.07 (quin, J = 6.5 Hz, 
2H, H3''), 1.91-1.85 (m, 1H , H4), 1.72-1.65 (m , 2H, H2''), 0.91 (s, 9H, (CH3)3C), 
0.12 (s, 6H, (CH3)2Si). 
13C NMR (125 MHz, CDCl3) δ 168.8 (C6), 153.8 (C3'), 138.0 (C4''), 115.5 (C5''), 
84.0 (C1'), 77.2 (C2'), 67.8 (C3), 55.7 (C5), 53.1 (OMe), 46.4 (C1''), 31.4 (C3''), 29.5 
(C5), 27.7 (C4),26.8 (C2''), 25.9 ((CH3)3C), 18.3 ((CH3)3C), -4.2 (CH3Si). 
ESIMS m/z 402 [(M+Na)+ 100%]. 
HRESIMS calcd. for C20H33O4NSiNa, (M+Na)









To a solution of the ene-yne 141 (872 mg, 2.3 mmol) in anhydrous CH2Cl2 (80 mL) 
was added Grubb’s 1st generation Ru catalyst (189 mg, 0.23 mmol, 0.1 equiv) under 
a N2 atmosphere and the mixture was stirred at rt for 8 h.
60 The reaction mixture then 
was exposed to open air for 30 min. The solvent was evaporated in vacuo and the 
residue was purified by column chromatography (3:2, EtOAc/petroleum spirit) to 
give the bicyclic compound 140 (680 mg, 78% yield) as a yellow oil. 
 
Rf = 0.69 (4:1, EtOAc/petroleum spirit). 
IR (neat, νmax/cm




1H NMR (500 MHz, CDCl3) δ 6.12 (s, 1H, H4'), 5.94 – 5.87 (t, J = 8.0 Hz, 1H, H9), 
5.73 (s, 1H, H4'), 4.27 (s, 1H, H10a), 4.23 (dd, J = 13.0, 7.5 Hz,  1H, H6),  4.00 (s, 
1H, H1), 3.77 (s, 3H, OMe), 3.20 (td, J = 13.0, 6.5 Hz, 1H, H6), 2.75 – 2.64 (m, 2H, 
H3 and H8), 2.34 (dd, J = 17.7, 5.7 Hz, 1H, H3), 2.23 – 2.13 (m, 1H, H7), 1.96 – 
1.90 (m, 1H, H2), 1.90 – 1.76 (m, 2H, H8 and H2), 1.58 – 1.49 (m, 1H, H7), 0.88 (s, 
9H, (CH3)3C),  0.02 (s, 6H, (CH3)2Si). 
13C NMR (126 MHz, CDCl3) δ 169.5 (C4), 167.5 (C2'), 142.3 (C10), 136.1 (C1'), 
132.8 (C9), 127.4 (C4'), 67.6 (C10a), 66.5 (C1), 52.5 (OMe), 42.3 (C6), 28.1 (C2), 
27.1 (C3), 26.2 ((CH3)3C), 24.0 (C7), 22.1 (C8), 18.5 ((CH3)3C), -4.7 (CH3Si). 
ESIMS m/z 380 [(M+H)+ 100%]. 
HRESIMS calcd. for C20H34O4NSi, (M+H)







Sodiumborohydride (532 mg, 14 mmol, 8 equiv) was added portionwise to a solution 
of the enone 140 (663 mg, 1.75 mmol) in anhydrous MeOH (20 mL) at 0 0C under a 
N2 atmosphere and the mixture was stirred at 0 
0C for 3 h.60 Saturated aqueous 
NaHCO3 solution (30 mL) was added at 0 
0C and the mixture was extracted with 
EtOAc (3 x 50 mL). The combined organic extract was dried over MgSO4 and 
filtered. The solvent was removed in vacuo and the residue was purified by column 
chromatography (3:2, EtOAc/petroleum spirit) to give an unseparable mixture of 
diasteroisomers 139 (517 mg, 78% yield) as a pale yellow oil.  
 
Rf = 0.69 (4:1, EtOAc/petroleum spirit) 
IR (neat, νmax/cm





1H NMR (500 MHz, CDCl3) δ major diastereomer 5.86-5.79 (m, 1H, H9), 4.26-4.19 
(m, H1 and H6), 3.93 (s, 1H, H10a), 3.69 (s, 3H, OMe), 3.04-2.96 (m, 1H, H1'), 
2.85-2.69 (m, 2H, H6 and H3), 2.69-2.56 (m, 1H, H8), 2.41-2.32 (m, 1H, H3), 2.16-
2.07 (m, 1H, H7), 2.02-1.94 (m, 1H, H2), 1.91-1.83 (m, 1H, H2), 1.83-1.75 (m, 1H, 
H8), 1.34 (d, J = 7.5 Hz, 3H, H4'), 0.86 (s, 9H, (CH3)3C), 0.11 (s, 6H, (CH3)2Si). 
13C NMR (125 MHz, CDCl3) δ 174.5 (C2’), 169.5 (C4), 135.9 (C10), 127.8 (C9), 
69.2 (C1), 66.9 (C10a), 52.1 (OMe), 44.8 (C1'), 42.1 (C6), 28.4 (C2), 27.1 (C3), 26.1 
((CH3)3C), 23.9 (C7), 21.5 (C8), 19.0 (C4'), 18.5 ((CH3)3C), -4.7 (CH3Si). 
1H NMR (500 MHz, CDCl3) δ minor diastereomer (in part) 5.86-5.79 (m, 1H, H9), 
4.19-4.13 (m, H1 and H6), 3.97 (s, 1H, H10a), 3.70 (s, 3H, OMe), 3.04-2.96 (m, 1H, 
H1'), 2.94-2.86 (m, 1H, H6), 2.85-2.69 (m, 1H, H3), 2.69-2.56 (m, 1H, H8), 2.41-
2.32 (m, 1H, H3), 2.16-2.07 (m, 1H, H7), 2.02-1.94 (m, 1H, H2), 1.91-1.83 (m, 1H, 
H2), 1.83-1.75 (m, 1H, H8), 1.35 (d, J = 7.5 Hz, 3H, H4'), 0.86 (s, 9H, (CH3)3C), 0.1 
(s, 6H, (CH3)2Si). 
13C NMR (125 MHz, CDCl3) δ 174.4 (C2’), 169.5 (C4),134.7 (C10), 127.5 (C9), 
69.8 (C1), 65.8 (C10a), 52.4 (OMe), 43.2 (C1'), 42.1 (C6), 28.2 (C2), 27.0 (C3), 26.1 
((CH3)3C), 23.8 (C7), 21.5 (C8), 19.0 (C4'), 18.5 ((CH3)3C), -4.7 (CH3Si). 
ESIMS m/z  382 [(M+H)+ 100%]. 
HRESIMS calcd. for C20H36NO4Si, (M+H)
+ 382.2414, found: 382.2411. 
 
Attempted bromolactonization of 139 
 
To a solution of mixture 139 (57 mg, 0.15 mmol) in MeOH (12.5 mL), was added 
slowly aqueous 1M NaOH  solution (1.6 mL) at 0 0C and the mixture was stirred at 0 
0C for 8 h. The reaction mixture then was acidified with 1M HCl solution to pH = 5 
and extracted with EtOAc (4 x 50 ml). Organic extracts were combined, dried over 
MgSO4 and filtered. Solvent was evaporated in vacuo to afford a crude mixture of 
acids, which was used in the next step without further purification. The crude acid 
was dissolved in CHCl3 (15 mL), and CuBr2 on alumina (0.85 mg) was added. The 
mixture was heated at 65 ˚C for 60 h. After filteration, the solid was washed with 
MeOH, and the filterate was concentrated. Water (5 mL) was added to the residue, 
and the aqueous layer was extracted with EtOAc (3 x 20 mL). The combined organic 




concebtrated. The residue was dissolved in EtOAc (3.5 mL), and Et3N (40 μL, 0.3 
mmol) was added and the solution was stirred at rt for 16 h. EtOAc (20 mL) was 
added and the mixture was washed with 10% HCl solution, brine and saturated 
NaHCO3 solution. The organic layer was dried over MgSO4, filtered and 
concentrated. 1H NMR analysis of the residue showed a diastereomeric mixture of 
acids. From this crude mixture the major diastereomer (290) was purely isolated by 
column chromatography (9:1, EtOAc/petroleum spirit).60 
 
2-((1R,10aR)-1-(tert-Butyldimethylsilyloxy)-4-oxo-1,2,3,4,6,7,8,10a-




Mp = 207-209 ºC 
Rf = 0.69 (4:1, EtOAc/petroleum spirit) 
IR (neat, νmax/cm
-1): 2951, 1718, 1615, 1256, 1092, 1067, 988, 924, 838. 
1H NMR (500 MHz, CDCl3) δ 5.88 (t, J = 7.5 Hz, 1H, H9), 4.22 (s, 1H, H1), 4.16 
(dd, J = 13.1, 7.2 Hz, 1H, H6), 4.11 (s, 1H, H10a), 3.09 – 2.99 (m, 2H, H6 and H1'), 
2.81 – 2.72 (m, 1H, H3), 2.61 (m, 1H, H8), 2.44 (dd, J = 17.7, 5.5 Hz, 1H, H3), 2.20 
– 2.10 (m, 1H, H7), 2.02 – 1.96 (m, 1H, H2), 1.89 (m, 2H, H8 and H2), 1.51 (dt, J = 
13.2, 6.4 Hz, 1H, H7), 1.40 (d, J = 7.1 Hz, 3H, H3'), 0.88 (s, 9H, (CH3)3C), 0.09 (s, 
3H, CH3Si), 0.03 (s, 2H), 0.03 (s, 3H, CH3Si). 
13C NMR (125 MHz, CDCl3) δ 178.3 (C2'), 170.4 (C4), 134.7 (C10), 127.4 (C9), 
69.8 (C1), 65.7 (C10a), 43.2 (C1’), 42.7 (C6), 28.1 (C2), 26.9 (C3), 26.1 ((CH3)3C), 
23.9 (C7), 21.5 (C8), 18.4 ((CH3)3C), 15.8 (C3'), -4.2 (CH3Si), -4.71 (CH3Si). 
ESIMS m/z 368 [(M+H)+ 100%]. 
HRESIMS calcd. for C19H32NO4Si, (M+H)










Diphenyl diselenide (16 mg, 0.05 mmol, 0.05 equiv) was added to a solution of 4-
pentenoic acid (100 mg, 1.00 mmol) in CH3CN (3 mL) and the resulting mixture was 
cooled to -30 0C. N-bromosuccinimide (231 mg, 1.3 mmol, 1.3 equiv) was added 
with stirring, and the resulting reaction mixture was stirred at -30 0C for 3 h.111 The 
resulting solution was concentrated to <1 mL in vacuo, and EtOAc (60 mL) was 
added. The resulting organic layer was washed with water (2 x 10 mL), dried over 
MgSO4 and filtered. The solvent was evaporated in vacuo to afford a yellow residue, 
which was purified by silica gel column chromatography (1:3, EtOAc/petroleum 
spirit) to give compound 300 (152 mg, 68% yield) as a white solid. 
 
1H NMR (500 MHz, CDCl3) δ 4.73 (ddd, J = 12.0, 6.8, 5.1 Hz, 1H), 3.54 (d, J = 4.9 
Hz, 2H, H1'), 2.65 – 2.49 (m, 2H), 2.45 – 2.37 (m, 1H), 2.12 – 2.03 (m, 1H). 
NMR spectroscopic data matched with the published data.139 




To a solution of 139 (648 mg, 1.3 mmol) in MeOH (15 mL), was added slowly 1M 
aqueous NaOH solution (13.7 mL) at 0 0C and the mixture was stirred at 0 0C for 8 h. 
The mixture the was acidified to pH = 5 with 1M HCl solution and extracted with 




filtered. The solvent was evaporated in vacuo to afford a diasteromeric mixture of 
acids, which was used in the step without further purification. 
To a solution of this acid in CH3CN (4 mL) was added diphenyl diselenide (21 mg, 
0.65 mmol, 0.05 equiv) and the resulting mixture was cooled to -30 0C. N-
bromosuccinimide (277 mg, 1.69 mmol, 1.3 equiv) was added with stirring, and the 
resulting reaction mixture was stirred at -30 0C for 3 h.111 The resulting solution was 
concentrated to <1 mL in vacuo, and EtOAc (60 mL) was added. The resulting 
organic layer was washed with water (2 x 10 mL), dried over MgSO4 and filtered. 
The solvent was evaporated in vacuo to afford a yellow residue, which then was 
dissolved in EtOAc (10 mL). Et3N (0.2 mL) was added to the resulting solution and 
the mixture was stirred at rt for 18 h. The mixture was then diluted with EtOAc (40 
mL), washed with water (2 x 10 mL), dried over MgSO4 and filtered.  Purification by 
column chromatography (6:4 to 9:1, EtOAc/petroleum spirit) of the resulting residue 
gave the tricyclic compounds 301 (192 mg, 31% yield) and 302 (124 mg, 20% yield) 




Mp = 137-139 ºC 
Rf = 0.69 (4:1, EtOAc/petroleum spirit). 
IR (neat, νmax/cm
-1): 2951, 2930, 1751, 1630, 1253, 1196, 1148, 1082, 993, 835, 776. 
1H NMR (500 MHz, CDCl3) δ 4.97 (d, J = 9.5 Hz, 1H, H3a), 4.71 (s, 1H, H11a), 
4.52 (d, J = 10.5 Hz, 1H, H6), 4.21 (s, 1H, H11), 2.79 – 2.69 (m, 1H, H9), 2.54 – 
2.47 (m, 1H, H4), 2.42-2.36 (m, 1H, H9), 2.27 – 2.15 (m, 1H, H6), 2.02-1.96 (m, 2H, 
H10), 1.90 (s, 3H, CH3), 1.88-1.81 (m, 1H, H5), 1.75-1.65 (m, 1H, H5), 1.22 – 1.14 
(m, 1H, H4), 0.84 (s, 9H, (CH3)3C), 0.03 (s, 6H, (CH3)2 Si). 
13C NMR (125 MHz, CDCl3) δ 173.5 (C2), 169.9 (C8), 163.6 (C11b), 124.2 (C1), 
83.9 (C3a) , 67.7 (C11), 63.2 (C11a), 47.6 (C6), 36.5 (C4) , 28.4 (C10), 26.6 (C9), 
26.0 ((CH3)3C), 25.1 (C5), 18.2 ((CH3)3C), 9.74 (C1’),  -4.6 (CH3Si), -4.9 (CH3Si). 
ESIMS m/z 366 [(M+H)+ 100%]. 
HRESIMS calcd. for C19H32NO4Si, (M+H)







Mp = 140-142 ºC 
Rf = 0.69 (4:1, EtOAc/petroleum spirit). 
IR (neat, νmax/cm
-1): 2954, 2930, 1749, 1628, 1254, 1160, 1103, 938, 834, 777. 
1H NMR (500 MHz, CDCl3) δ 4.80 (d, J = 11.0 Hz, 1H, H3a), 4.51 – 4.45 (m, 1H, 
H11), 4.37-4.30  (m, 1H, H6), 4.27 (d, J = 3.0 Hz, 1H, H11a), 2.94 – 2.87 (m, 1H, 
H6), 2.57 (dt, J = 17.5, 7.0 Hz, 1H, H9), 2.44 (dt, J = 17.5, 7.0 Hz 1H, H9), 2.33 – 
2.26 (m, 1H, H4), 2.19 – 2.07 (m, 3H, H10 and H5), 2.10 (s, 3H, H1’), 1.74 – 1.63 
(m, 1H, H5), 1.60-1.54 (m, 1H, H4), 0.86 (s, 9H, (CH3)3C), 0.12 (s, 3H, CH3Si), 0.07 
(s, 3H, CH3Si). 
13C NMR (125 MHz, CDCl3) δ 174.5 (C2), 170.1 (C8), 157.3 (C11b), 123.3 (C1), 
83.4 (C3a), 68.3 (C11), 62.3 (C11a), 46.1 (C6), 29.3 (C9), 28.3 (C4), 27.9 (C10), 
26.0 ((CH3)3C), 21.5 (C5), 18.3 ((CH3)3C), 12.6 (C1’), -4.2 (CH3Si), -4.6 (CH3Si). 
ESIMS m/z 366 [(M+H)+ 100%]. 
HRESIMS calcd. for C19H32NO4Si, (M+H)
+ 366.2101, found: 366.2110. 
 
Synthesis of 301 from 302 
 
To a solution of compound 302 (104 mg, 0.28 mmol) in CHCl3 (2 mL), was added 
DBU (3 drops) and the mixture was stirred at rt for 2 d. The solvent was evaporated 
in vacuo and the residue was purified by column chromatography (4:1, 










To a solution of the TBS ether 301 (30 mg, 0.082 mmol) and acetic acid (12 μL, 
0.206 mmol, 3 equiv) in anhydrous THF at 0 ºC was added a 1M solution of TBAF  
in THF (206 µL, 0.206 mmol, 3 equiv).139 The mixture was then warmed to rt and 
stirred for 14 h. The reaction was quenched with saturated NaHCO3 solution (5 mL) 
and extracted with EtOAc (3 x 15 mL). The organic extracts were combined, dried 
over MgSO4 and filtered. The solvent was evaporated in vacuo and the residue was 
purified by column chromatography (9:1, EtOAc/petroleum spirit) to give the alcohol 
307 (16 mg, 78% yield) as a pale yellow solid. 
 
Mp = 137-139 ºC 
Rf = 0.69 (9:1), EtOAc/MeOH) 
IR (neat, νmax/cm
-1): 3326, 2925, 1774, 1498, 1177, 1166, 1137, 1071, 1025, 769, 
682. 
1H NMR (500 MHz, CD3OD) δ 5.10 (d, J = 7.1 Hz, 1H, H3a), 4.96 (d, J = 2.5 Hz, 
1H, H11a), 4.42 (dd, J = 13.9, 4.7 Hz, 1H, H6), 4.22 (s, 1H, 11), 2.76 – 2.67 (m, 1H, 
H9), 2.49 – 2.41 (m, 1H, H4), 2.40 – 2.29 (m, 2H, H6 and H9), 2.11 – 1.96 (m, 2H, 
H10), 1.90 (s, 3H, H11'), 1.87 – 1.81 (m, 1H, H5), 1.73 – 1.62 (m, 1H, H5), 1.22 
(tdd, J = 14.2, 10.1, 3.9 Hz, 1H, H4). 
13C NMR (125 MHz, CD3OD) δ 176.0 (C2), 172.8 (C8), 165.5 (C1a), 125.2 C1), 
85.6 (C3a), 66.7 (C11), 63.8 (C11a),48.4 (C6), 37.1 (C4), 28.4 (C9), 27.5 (C10), 26.0 
(C5), 9.3 (C1'). 
ESIMS m/z 252 [(M+H)+ 100%]. 
HRESIMS calcd. for C13H18NO4, (M+H)










Magnesium tunnings (39 mg, 1.64 mmol, 15 equiv) were added to a solution of the 
α,β-unsaturated lactone 301 (40 mg, 0.11 mmol) in MeOH (1.2 mL) at 0 0C. The 
mixture was warmed to rt and stirred for 1 d.114 After cooling to 0 0C, acetic acid (12 
µL, 0.22 mmol. 2 equiv) was added and the resulting mixture was stirred at rt for 30 
min. Water (5 mL) was added and the mixture was extracted with EtOAc (3 x 15 
mL). The organic extracts were combined, dried over MgSO4 and filtered. The 
solvent was evaporated in vacuo and the residue was purified by column 
chromatography (7:3, EtOAc/petroleum spirit) to provide compound 306 (29 mg, 
71% yield) as a white solid. Recrystalization for X-ray structural analysis was 
performed using a solvent mixture of CH2Cl2 and n-hexane at rt. 
 
Mp = 160-162 ºC 
Rf = 0.65 (9:1, EtOAc/petroleum spirit). 
IR (neat, νmax/cm
-1): 3233, 2957, 2318, 1765, 1632, 1448, 1390, 1253, 1185, 1101, 
1065, 1014, 774. 
1H NMR (500 MHz, CDCl3) δ 4.79 (td, J = 11.5, 2.5 Hz, IH, H3a), 4.48 (d, J = 13.5 
Hz, IH, H6), 4.25 (s, 1H, H11), 3.73 (d, J = 7 Hz, 1H, H11a), 2.86 (dq, J = 14.0, 7.0 
Hz, 1H, H1), 2.71-2.60 (m, 2H, H6 and H9), 2.43-2.31 (m , 3H, H9, H4 and H11b), 
2.09-2.03 (m, 1H, H10), 1.92-1.84 (m, 2H, H10 and H5), 1.68-1.58 (m, 1H, H5), 
1.43-1.33 (m, 1H, H4), 1.30 (d, J = 7.0 Hz, 3H, H1'), 0.88 (s, 9H, (CH3)3C), 0.16 (s, 
3H, CH3Si), 0.12 (s, 3H, CH3Si). 
13C NMR (125 MHz, CDCl3) δ 177.9 (C2), 169.9 (C8), 79.7 (C3a), 66.0 (C11), 59.3 
(C11a), 53.4 (C11b), 43.1 (C6), 37.9 (C1), 28.0 (C9), 26.8 (C10), 26.2 ((CH3)3C), 
25.1 (C5), 18.3 ((CH3)3C), 15.2 (C1'), -2.9 (CH3Si), -4.7 (CH3Si). 
ESIMS m/z 368 [(M+H)+ 100%]. 
HRESIMS calcd. for C19H34O4NSi, (M+H)















To a solution of the TBS ether 306 (30 mg, 0.082 mmol) and acetic acid (12 μL, 
0.206 mmol, 3 equiv) at 0 ºC was added a solution of 1M TBAF in THF (206 µL, 
0.206 mmol, 3 equiv). The mixture then was warmed to rt and stirred for 14 h.139 The 
reaction was quenched with saturated NaHCO3 solution (5 mL) and extracted with 
EtOAc (3 x 15 mL). The organic extracts were combined, dried over MgSO4 and 
filtered. The solvent was evaporated in vacuo and the residue was purified by column 
chromatography (4:1, EtOAc/petroleum spirit) to give the alcohol 138 (16 mg, 80% 
yield) as a pale yellow solid.  
 
Mp = 254-256 ºC 
Rf = 0.68 (9:1, EtOAc/MeOH) 
IR (neat, νmax/cm
-1): 3340, 2957, 2856, 1765, 1624, 1183, 1104, 1067, 1012, 870, 
794. 
1H NMR (500 MHz, CD3OD) δ 4.86 – 4.78 (m, 1H, H3a), 4.28 (d, J  =13.5 Hz, 1H, 
H6β), 4.22 (s, 1H, H11), 3.85 (dd, J  =7.5, 2.0 Hz 1H, H11a), 3.18 (dq, J = 14.0, 7.0 
Hz, 1H, H1), 2.84 (t, J = 13.5 Hz, 1H, H6α), 2.71 – 2.61 (m, 1H, H9), 2.61-2.54 (m, 
1H, H10), 2.30 (m, 1H, H9), 2.25-2.19 (m, 1H, H4), 2.01 – 1.88 (m, 1H, H10), 1.85-
1.79 (m, 1H, H5), 1.59 (m, 1H, H5), 1.46 (m, 1H, H4), 1.27 (d, J = 7.0 Hz, 3H, H1'). 
13C NMR (125 MHz, CD3OD) δ 181.1 (C2), 172.9 (C8), 81.9 (C3a), 64.6 (C11), 59.5 
(C11a), 53.90 (C11b), 44.2 (C6), 39.1 (C1), 36.0 (C4), 28.3 (C10), 27.7 (C9), 25.7 
(C5), 15.0 (C1'). 
ESIMS m/z 354 [(M+H)+ 100%]. 
HRESIMS calcd. for C13H20O4N, (M+H)





Preparation of 138 from 307 
 
Magnesium tunnings (36 mg, 1.5 mmol, 15 equiv) were added to a solution of the 
α,β-unsaturated lactone 307 (24 mg, 0.1 mmol) in MeOH (1.00 mL) at 0 0C. The 
mixture was warmed to rt and stirred for 1 d. After cooling to 0 0C, acetic acid (12 
µL, 0.20 mmol. 2 equiv) was added and the resulting mixture was stirred at rt for 30 
min.114 Water (5 mL) was added and the mixture was extracted with EtOAc (3 x 15 
mL). The organic extracts were combined, dried over MgSO4 and filtered. The 
solvent was evaporated in vacuo and the residue was purified by column 
chromatography (7:3, EtOAc/petroleum spirit) to provide compound 138 (17 mg, 
70% yield). 
 
Attempted synthesis of 137 
 
To a solution of 138 (15.7 mg) in CH2Cl2 (3 mL) were added BIAB (24 mg, 0.07 
mmol, 1.2 equiv) and I2 (16.6 mg, 0.065 mmol, 1.05 equiv). The mixture the was 
irradiated with a UV lamp at rt, 500 W for 30 min.58 The reaction was quenched with 
1M Na2S2O3 (3 mL) and extracted with CH2Cl2 (3 x 10 mL). The organic extracts 
were combined, dried over MgSO4 and filtered. The solvent was evaporated in vacuo 
and the residue was purified by column chromatography (2:3, EtOAc/petroleum 
spirit) to give the major product 318 (3.4 mg, 16% yield) as a pale yellow oil and as a 




Rf = 0.69 (4:1, EtOAc/petroleum spirit) 
IR (neat, νmax/cm
-1): 2924, 1764, 1640, 1501, 1448, 1397, 1244, 973. 
1H NMR (500 MHz, CDCl3) major isomer δ 9.79 (s, 1H, CHO), 7.06 (d, J = 9.0 Hz, 




2.62 (m, 3H, H3, H2' and H3'), 2.42-2.37 (m, 1H, H3a and H8), 2.11 (s, 3H, 
CH3CO), 180-1.75 (m, 1H, H7), 1.68-1.56 (m, 2H, H8 and H7), 1.25 (d, J = 7.0 Hz, 
3H, H3"). 
13C NMR (125 MHz, CDCl3) major isomer δ 200.9 (C4'), 177.0 (C2), 171.5 (C1), 
170.0 (CH3CO), 82.6 (C4), 78.1 (C8a), 55.2 (C3a), 41.0 (C6), 39.1 (C2'), 34.4 (C8), 
25.4 (C3'), 23.5 (C7), 21.0 (CH3CO), 14.7 (C3"). 
1H NMR (500 MHz, CDCl3) minor isomer (in part) δ 9.81 (s, 1H, CHO), 6.66 (d, J = 
8.0 Hz, 1H, H4), 4.13-4.07 (m, 2H, H8a and H6), 2.34-2.27 (m, 1H, H3a), 2.03 (s, 
3H, CH3CO), 1.21 (d, J = 7.0 Hz, 3H, H3"). 
13C NMR (125 MHz, CDCl3) minor isomer δ 200.6 (C4'), 177.4 (C2), 171.8 (C1), 
169.0 (CH3CO), 78.2 (C4), 77.3 (C8a), 54.0 (C3a), 41.0 (C6), 38.5 (C2'), 34.0 (C8), 
25.9 (C3'), 23.5 (C7), 20.8 (CH3CO), 15.0 (C3"). 
ESIMS m/z 366 [(M+Na)+ 100%]. 
HRESIMS calcd. for C15H21O8NNa, (M+Na)






Lawessons’ reagent (21.2 mg, 0.053 mmol, 0.055 equiv) was added to a solution of 
the lactam 306 (35 mg, 0.095 mmol) in THF (12 mL) and the reaction mixture was 
heated at reflux temperature for 3 h.25 The solvent was evaporated in vacuo and the 
residue was purified by column chromatography (3:1, EtOAc/petroleum spirit) to 
give the thio-lactam 324 (29 mg, 80% yield) as a white solid.  
 
Mp = 154-156 ºC 
Rf = 0.61 (4:1, EtOAc/petroleum spirit). 
IR (neat, νmax/cm




1H NMR (500 MHz, CDCl3) δ 5.31 (dd, J = 13.5, 4.0 Hz, 1H, H6β), 4.69 (dt, J = 
11.5, 3.5 Hz, 1H, H3a), 4.34 (s, 1H, H11), 3.76 (dd, J  = 7.5, 2.0 Hz 1H, H11a), 3.19-
3.09 (m, 3H, H6 and H9), 2.88 (dq, J = 14.0, 7.0 Hz, 1H, H1), 2.60 – 2.52 (m, 1H, 
H11b), 2.40-2.33 (m, 1H, H4), 2.10 – 1.83 (m, 4H, H5 and H10), 1.47 (qd, J = 13.0, 
5.5 Hz, 1H, H4), 1.31 (d, J = 7.0 Hz, 3H, H1'), 0.87 (s, 9H, (CH3)3C), 0.15 (s, 3H, 
CH3Si), 0.11 (s, 3H, CH3Si). 
13C NMR (125 MHz, CDCl3) δ 201.1 (C8), 177.4 (C2), 79.3 (C3a), 66.1 (C11), 62.2 
(C11a), 52.9 (C11b), 51.2 (C6), 38.0 (C1), 37.0 (C9), 35.4 (C4), 28.0 (C3), 26.2 
((CH3)3C), 23.1 (C5), 18.3 ((CH3)3C), 15.3 (C1'), -2.9 (CH3Si), -4.8 (CH3Si). 
ESIMS m/z 384 [(M+H)+ 100%]. 
HRESIMS calcd. for C19H34O3NSiS, (M+H)







An excess amount of Raney Ni (ca 20 mg) was added to a solution of the thio-lactam 
324 (26.5 mg, 0.07 mmol) in EtOH (4 mL) and the mixture was heated at reflux 
temperature for 4 h.25 The mixture was filtered through a small pad of celite and the 
filtered cake was washed with EtOH (60 mL). The solvent was evaporated in vacuo 
and the residue was purified by column chromatography (4:1, EtOAc/petroleum 
spirit) to give the amine 325 (19 mg, 75% yield) as a pale yellow solid.  
 
Mp = 117-119 ºC 
Rf = 0.58 (4:1, EtOAc/petroleum spirit). 
IR (neat, νmax/cm
-1): 2946, 2927, 1762, 1465, 1325, 1209, 1165, 1025. 
1H NMR (500 MHz, CDCl3) δ 5.01 (dt, J = 10.5, 3.0,  1H, H3a), 3.94 (s, 1H, H11), 




8.0 Hz, 1H, H6), 2.48-2.40 (m, 2H, H6 and H8), 2.36 (d, J = 7.5 Hz, 1H, H11a), 2.28 
(dd, J = 10.0, 5.0 Hz, 1H, H4), 2.19 (apparent dt, J = 12.0, 9.0 Hz, 1H, H11b), 2.00 – 
1.91 (m, 1H, H3), 1.91 – 1.83 (m, 1H, H3), 1.69 (dt, J = 16.0, 8.0 Hz, 2H, H5), 1.41 
– 1.33 (m, 2H, H9), 1.31 – 1.21 (m, 1H, H4), 1.30 (d,  J = 7.0 Hz, 3H, H1'), 0.89 (s, 
9H, (CH3)3C), -0.11 (s, 6H (CH3)2Si,). 
13C NMR (125 MHz, CDCl3) δ 179.3 (C2), 80.5 (C3a), 67.7 (C11), 63.7 (C11a), 58.8 
(C8), 55.0 (C6), 53.8 (C11b), 37.6 (C1), 36.1 (C4), 32.7 (C10), 27.7 (C5), 26.3 
((CH3)3C), 21.5 (C9), 18.5 ((CH3)3C)  15.2 (C1'), -3.0 (CH3Si), -4.6 (CH3Si). 
ESIMS m/z 354 [(M+H)+ 100%]. 
HRESIMS calcd. for C19H36O3NSi, (M+H)







To a solution of the TBS ether 325 (23 mg, 0.065 mmol) and acetic acid (11 μL, 
0.195 mmol, 3 equiv) at 0 ºC was added a 1M solution of TBAF  in THF (195 μl, 
0.195 mmol, 3 equiv).139 The mixture then was warmed to rt and stirred for 14 h. The 
reaction was quenched with saturated aqueous NaHCO3 solution (5 mL) and 
extracted with EtOAc (3 x 15 mL). The organic extracts were combined, dried over 
MgSO4 and filtered. The solvent was evaporated in vacuo and the residue was 
purified by column chromatography (4:1, EtOAc/petroleum spirit) to give the alcohol 
326 (17 mg, 78% yield) as a pale yellow solid.  
 
Mp = 210-212 ºC 
Rf = 0.61 (9:1, EtOAc/petroleum spirit) 
IR (neat, νmax/cm
-1): 3431, 2928, 1762, 1453, 1261, 1182, 1165, 1125, 1102, 1075, 




1H NMR (500 MHz, CDCl3) δ 4.77 (dt, J = 11.0, 3.5 Hz, 1H, H3a), 3.86 (s, 1H, 
H11), 2.96-2.84 (m, 2H, H1 and H8), 2.75 – 2.68 (m, 1H, H6), 2.56 – 2.46 (m, 2H, 
H6 and H8), 2.46 – 2.42 (m, 1H, H11a), 2.31 (d, J = 10.0 Hz, 1H, H4), 2.20 
(apparent ddd, J = 12.5, 11.0, 8.0 Hz, 1H, H11b), 1.89 – 1.76 (m, 3H, H10, H9 and 
H5), 1.70 – 1.58 (m, 1H, H5), 1.54 – 1.48 (m, 1H, H9), 1.43 – 1.32 (m, 1H, H10), 
1.32 – 1.23 (m, 1H, H4), 1.22 (d, J = 7.0 Hz, 3H, H1'). 
13C NMR (126 MHz, CDCl3) δ 178.7 (C2), 80.6 (C3a), 65.7 (C11), 64.1 (C11a), 59.3 
(C8), 55.3 (C6), 53.4 (C11b), 37.7 (C1), 35.7 (C4), 32.0 (C10), 27.8 (C5), 21.2 (C9), 
14.4 (C1'). 
ESIMS m/z 240 [(M+H)+ 100%]. 
HRESIMS calcd. for C13H22O3N, (M+H)
+ 240.1600, found: 240.1601. 
 
Attempted photochemical cyclization reaction of 323 
 
To a solution of 323 (14.4 mg, 0.06 mmol) in CH2Cl2 (2 mL) were added BIAB (24 
mg, 0.07 mmol, 1.2 equiv) and I2 (16.6 mg, 0.065 mmol, 1.05 equiv). The mixture 
the was irradiated with a UV lamp at rt, 500 W for 15 min.58 The reaction was 
quenched with 1M Na2S2O3 (3 mL) and extracted with CH2Cl2 (3 x 10 mL). The 
organic extracts were combined, dried over MgSO4 and filtered. The solvent was 
evaporated in vacuo. The 1H NMR analysis of the crude reaction mixture and TLC 








Thionyl chloride (38 mL, 189 mmol, 3 equiv) was added to the lactone acid 166 
(8.19 g, 63 mmol) and the mixture was stirred at 60 ºC for 4 h. The excess thionyl 




crude product (7.7 g, 82% yield) was used for the next step without further 
purification.121 
A saturated NH3 solution in Et2O was prepared in a 2L 2-necked flask under a N2 
atmosphere by bubbling NH3 gas through Et2O (200 mL). The acid chloride (3.5 g, 
23.6 mmol) then was added dropwide at rt via syringe to this solution (while still 
bubbling with NH3) over a period of 20 min.
121 The mixture then was stirred for 
additional 20 min. The solid was filtered and put in a flask with CHCl3 (300 mL) and 
stirred for 45 min. The solid was filtered and the solid cake was washed with hot 
CHCl3 (100 mL). The washings were combine and the solvent was removed in vacuo 
to afford the lactone amide 334 (2.22 g, 73%) as a white solid, which had 
spectroscopic data consistent with those in the literature.140 
1H NMR (500 MHz, DMSO-D6) δ 7.52 (bs, 2H, NH2), 4.84 (m, 1H, H5), 2.76-1.72 






To a solution of the primary lactone amide 334 (1.7 g, 7.75 mmol) in DMF (120 mL) 
at 0 ºC were added 18-crown-6 (40 mg, 0.15 mmol, 0.2 eq), TBAI (200 mg, 0.54 
mmol, 0.07 eq) and t-BuOK (955 mg, 8.53 mmol, 1.1 eq) under a N2 atmosphere. 
The mixture was stirred at 0 ºC for 30 min then allowed to warm to rt and stirred for 
14 h.121 The reaction was quenched with water (150 mL) at 0 ºC and extracted with 
EtOAc (3 x 150 mL). The organic extracts were combined, wash with water (100 
mL), dried over MgSO4, and filtered. The solvent was removed in vacuo and the 
residue was purified by column chromatography (3:7, EtOAc/petroleum spirit) to 
provide the amide 333 (1.61 g, 62% yield) as a pale yellow oil and the imide 335 
(597 mg, 23% yield) as a pale yellow oil. 
 
[𝛼]𝐷




Rf = 0.68 (1:1, EtOAc/petroleum spirit) 
IR (neat, νmax/cm
-1): 3390, 2941, 1743, 1665, 1369, 1319, 1127, 997. 
1H NMR (500 MHz, CDCl3) δ 6.41 (bs, 1H, NH),  5.79 (ddt, J = 17.0, 10.0, 6.5 Hz, 
1H, H4'), 5.04 (d, J = 17.0 Hz, 1H, H5'), 5.00 (d, J = 10.0 Hz, 1H, H5'), 4.84 (t, J = 
7.5 Hz, 1H, H5), 3.39 – 3.23 (m, 2H, H1'), 2.69 – 2.59 (m, 1H, H3), 2.59 – 2.53 (m, 
2H, H4), 2.40-2.32 (m, 1H, H3), 2.09 (dd, J = 14.0, 7.0 Hz, 2H, H3'), 1.69 – 1.59 (m, 
2H, H2'). 
13C NMR (125 MHz, CDCl3) δ 176.0 (C2), 169.5 (CO-NH), 137.7 (C4'), 115.9 (C5'), 
77.8 (C5), 39.2 (C1'), 31.3 (C3'), 28.8 (C2'), 28.0 (C4), 26.2 (C3). 
ESIMS m/z 198 [(M+H)+ 100%]. 
HRESIMS calcd. for C10H16O3N, (M+H)






To a solution of the lactone amide 333 (887 mg, 4.5 mmol) in THF (50 mL) at -78 ºC 
was added t-BuOK (151 mg, 1.35 mg, 0.3 eq). The mixture was stirred at -78 ºC for 
2 h and quenched with H2O (50 mL).
121 The aqueous phase was extracted with 
EtOAc (3 x 75 mL). The organic extracts were combined, wash with H2O (100 mL), 
dried over MgSO4, and filtered. The solvent was removed in vacuo and the residue 
was purified by column chromatography (1:1, EtOAc/petroleum spirit) to provide the 
imide 335 (807 mg, 91% yield) as a pale yellow oil, which had spectroscopic data 
consistent with the literature. 
 
[𝛼]𝐷
23 -67.2 (c 5.0, CHCl3) 
Rf = 0.68 (3:2, EtOAc/petroleum spirit). 
IR (neat, νmax/cm




1H NMR (500 MHz, CDCl3) δ 5.80 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, H4'), 5.02 (d, J 
= 17.0, Hz, 1H, H5'), 4.96 (d, J = 10.0 Hz, 1H, H5'), 4.20 (dd, J = 12.5, 5.5 Hz, 1H, 
H3), 3.83 – 3.75 (m, 1H, H1'), 3.75 – 3.68 (m, 1H, H1'), 2.90 – 2.83 (m, 1H, H5), 
2.66 – 2.57 (m, 1H, H5), 2.35 – 2.28 (m, 1H, H4), 2.05 (q, J = 7.0 Hz, 2H, H3'), 1.88 
(m, 1H, H4), 1.64 – 1.56 (m, 2H, H2'). 
13C NMR (125 MHz, CDCl3) δ 175.5 (C2), 171.5 (C6), 137.8 (C4'), 115.4 (C5'), 68.6 
(C3), 40.4 (C1'), 31.3 (C5), 31.2 (C3'), 27.2 (C2'), 25.7 (C4). 
ESIMS m/z 198 [(M+H)+ 100%]. 
HRESIMS calcd. for C10H16O3N, (M+H)






To a solution of compound 335 (600 mg, 3.2 mmol) in EtOH (20 mL) was added 
portionwise NaBH4 (610 mg, 16 mmol, 5 equiv) at -30 ºC under a N2 atmosphere and 
the mixture was stirred at -30 ºC for 2 h.121 Saturated NaHCO3 solution (20 mL) and 
saturated NaCl solution (70 mL) were added and the mixture was extracted with 
EtOAc (3 x 100 mL). The organic extracts were combined, dried over MgSO4, and 
filtered. The solvent was removed in vacuo and the residue was purified by column 
chromatography (9:1, EtOAc/petroleum spirit) to provide the hemiaminal 332 (528 
mg, 87% yield) as a colourless oil and as a mixture of diastereomers (dr = 3.8:1). 
 
Rf = 0.53 (100:0, EtOAc/petroleum spirit). 
IR (neat, νmax/cm
-1): 3292, 2930, 1635, 1611, 1278, 972, 911. 
1H NMR (500 MHz, CDCl3) δ 5.82 (ddt, J = 17.0, 10.5, 6.5 Hz, 1H, H4'), 5.04 (d, J 
= 17.0 Hz, 1H, H5'), 4.98 (d, J = 10.5 Hz, 1H, H5'), 4.78 (dd, J = 6.0, 4.0 Hz, 1H, 
H6), 3.96 (d, J = 3.0 Hz, 1H, H5), 3.71 – 3.60 (m, 1H, H1'), 3.27 – 3.16 (m, 1H, H1'), 




H4), 2.09 (dd, J = 14.5, 7.5 Hz, 2H, H7), 1.84 (dt, J = 12.5, 6.0 Hz, 1H, H4), 1.71 
(m, 2H, H2'). 
13C NMR (126 MHz, CDCl3) δ 170.0 (C2), 138.3 (C4'), 115.4 (C5'), 84.5 (C6), 69.0 
(C5),  44.8 (C1'), 31.4 (C3'), 28.0 (C3), 27.4 (C2'), 23.8 (C4). 
ESIMS m/z 200 [(M+H)+ 100%]. 
HRESIMS calcd. for C10H18O3N, (M+H)






β-Styryl boronic acid (122 mg, 0.825 mmol, 0.55 equiv) and β-styryl 
potassiumtrifluoroborate (174 mg, 0.825 mmol. 0.55 equiv) were added to a solution 
of the diol 332 (300 mg, 1.5 mmol) in CH3CN (25 mL) at rt. The mixture the was 
cooled to 0 ºC and BF3.Et2O (15 mmol, 3.0 equiv) was added dropwise. The resulting 
reaction mixture was stirred at 0 ºC for 45 min then warmed to rt and stirred for 15 
h.121 The reaction mixture was cooled to 0 ºC and quenched with saturated NH4Cl 
(10 mL) and saturated NaCl (10 mL) solutions. The mixture was extracted with 
EtOAc (3 x 70 mL). The organic extracts were combined, dried over MgSO4, and 
filtered. The solvent was removed in vacuo and the residue was purified by column 
chromatography (9:1 to 100:0, EtOAc/petroleum spirit) to provide the the diene 331 
(339 mg, 79% yield) as a colourless oil. 
[𝛼]𝐷
23 -7.2 (c 2.97, CHCl3). 
Rf = 0.68 (90:10, EtOAc/MeOH). 
IR (neat, νmax/cm
-1): 3281, 2928, 1637, 1362, 1279, 972, 912, 694. 
1H NMR (500 MHz, CDCl3) δ 7.42-7.24 (m, 5H, ArH), 6.51 (d, J = 16.0 Hz, 1H, 
H2''), 6.25 (dd, J = 16.0, 7.0 Hz, 1H, H1'), 5.77 (ddt, J = 17.0, 10.0, 6.5 Hz 1H, H4'), 




Hz, 1H, H6), 4.08 (dt, J = 10.0, 5.0 Hz, 1H, H5), 3.93 – 3.83 (m, 1H, H1'), 2.83 – 
2.74 (m, 1H, H1'), 2.56 (dt, J = 18.0, 5.0 Hz 1H, H3), 2.43 (dt, J = 18.0, 9.0 Hz 1H, 
H3), 2.07-2.00 (m, 2H, H3'), 1.93-1.85 (m, 2H, H4), 1.69-1.61 (m, 2H, H2'). 
13C NMR (125 MHz, CDCl3) δ 169.7 (C2), 138.0 (C4'), 136.2 (ArC), 134.8 (C2''), 
129.0 (ArC), 128.4 (ArC), 126.9 (ArC), 125.1 (C1''), 115.3 (C5'), 68.1 (C5), 63.7 
(C6), 46.0 (C1''), 31.3 (C3''), 29.7 (C3), 26.9 (C2''), 26.3 (C4). 
ESIMS m/z 286 [(M+H)+ 100%]. 
HRESIMS calcd. for C18H24O2N, (M+Na)







To a solution of the diene 331 (286 mg, 1 mmol) in CH2Cl2 (80 mL) were added 1,4-
benzoquinone (145 mg, 1.32 mmol, 1.32 equiv) and Grubbs’ 2nd generation Ru 
catalyst (170 mg, 0.2 mmol, 0.2 equiv).121 The reaction mixture was stirred at 35 ºC 
for 4 h. The solvent was removed in vacuo and the residue was purified by column 
chromatography (1:9, MeOH/EtOAc) to provide the bicyclic compound 330 (151 
mg, 84% yield) as a brown oil. 
 
[𝛼]𝐷
23 +25.5 (c 1.43, CHCl3) 
Rf = 0.68 (1:4, MeOH/EtOAc). 
IR (neat, νmax/cm
-1): 3317, 2930, 1606, 1457, 1271, 1077, 1038, 872. 
1H NMR (500 MHz, CDCl3) δ 6.00 (dt, J = 10.8, 5.0 Hz, 1H, H9), 5.73 (d, J = 10.8 
Hz, 1H, H10), 4.48 – 4.39 (m, 1H, H6), 4.19 (s, 1H, H10a), 4.10 – 4.03 (m, 1H, H1), 
2.87-2.80 (m, 1H, H6), 2.65-2.54 (m, 1H, H3), 2.43 – 2.34 (m, 1H, H3), 2.34 – 2.23 
(m, 1H, H7), 2.17 – 2.08 (m, 1H, H7), 2.06 – 1.91 (m, 2H, H3 and H7), 1.91-1.83 




13C NMR (125 MHz, CDCl3) δ 169.7 (C4), 133.6 (C9), 127.6 (C10), 66.3 (C1), 62.4 
(C10a), 45.9 (C6), 28.7 (C3), 25.8 (C2), 25.3 (C8), 25.1 (C7). 
ESIMS m/z 182 [(M+H)+ 100%]. 
HRESIMS calcd. For C10H16O2N, (M+H)







Triethyamine (80 μL, 0.59 mmol, 1.5 equiv) and methyl malonylchloride (51 μL, 
0.47 mmol, 1.2 equiv) were added to a solution of the alcohol 330 (71 mg, 0.39 
mmol) in CH2Cl2 (2 mL) at 0 ºC under a N2 atmosphere.
100 The reaction mixture then 
was allowed to warm to rt and stirred for 14 h. Water (10 mL) was added and the 
aqueous phase was extracted with CH2Cl2 (3 x 15 mL). The organic extracts were 
combined, dried over MgSO4 and filtered. The solvent was removed in vacuo and the 
residue was purified by column chromatography (4:1, EtOAc/petroleum spirit) to 
provide the ester 345 (91 mg, 50% yield) as a brown oil and the starting alcohol 330 
(26 mg, 36%). 
 
[𝛼]𝐷
23 -58.8 (c 1.93, CHCl3). 
Rf = 0.58 (9:1, EtOAc/petroleum spirit) 
IR (neat, νmax/cm
-1): 2954, 1730, 1604, 1272, 1204, 1044, 1016 
1H NMR (500 MHz, CDCl3) δ 5.90 (dt, J = 10.0, 5.0 Hz, 1H, H9), 5.54 (d, J = 10.0 
Hz, 1H, H10), 5.23 – 5.17 (m, 1H, H1), 4.46 – 4.39 (m, 1H, H6), 4.31 (s, 1H, H10a), 
3.72 (s, 3H, OMe), 3.37 (s, 2H, H2'), 2.86 – 2.78 (m, 1H, H6), 2.54 (dt, J = 17.5, 6.5 
Hz, 1H, H3), 2.44 (dt, J = 17.5, 7.5 Hz 1H, H3), 2.29 – 2.18 (m, 1H, H8), 2.12-2.03 




13C NMR (125 MHz, CDCl3) δ 168.6 (C4), 166.8 (C3'), 165.8 (C1'), 133.5 (C9), 
126.9 (C10), 69.8 (C1), 59.6 (C10a), 52.9 (OMe), 45.9 (C6), 41.6 (C2'), 28.6 (C3), 
25.1 (C8), 25.0M (C7), 23.6 (C2). 
ESIMS m/z 281 [(M+H)+ 100%]. 
HRESIMS calcd. for C14H20O5N, (M+H)







To a solution of the alkene 345 (54 mg, 0.13 mmol) in CH2Cl2 (5 mL) was added 
purified m-CPBA (31.4 mg, 0.18 mmol, 1.4 equiv) and the mixture was stirred at rt 
for 14 h.133 The reaction mixture was quenched with saturated NaHCO3 solution (10 
mL) and extracted with CH2Cl2 (3 x 15 mL). The organic extracts were combined, 
dried over MgSO4, and filtered. The solvent was removed in vacuo and the residue 
was purified by column chromatography (4:1, EtOAc/petroleum spirit) to give the 




23 -71.7 (c 2.92, CHCl3). 
Rf = 0.53 (9:1, EtOAc/petroleum spirit). 
IR (neat, νmax/cm
-1): 2955, 1743, 1625, 1467, 1272, 1229, 1182, 1117, 1011. 
1H NMR (500 MHz, CDCl3) δ 5.30 – 5.24 (m, 1H, H1), 4.64 – 4.57 (m, 1H, H6), 
3.76 (s, 3H, OMe), 3.64 (t, J = 6.0 Hz, 1H, H9b), 3.46 (s, 2H, H2'), 3.21 (dd, J = 6.0, 
4.5 Hz, H9a), 3.12 (q, J = 6.0 Hz, H9), 2.64-2.58 (m, 2H, H6 and H3), 2.55-2.46 (m, 




13C NMR (126 MHz, CDCl3) δ 167.9 (C4), 166.8 (C1'), 166.0 (C3'), 69.0 (C1), 59.0 
(C9b), 54.6 (C9a), 54.1 (C9), 53.0 (OMe), 48.7 (C6), 41.5 (C2'), 29.4 (C3), 28.7 
(C8), 23.7 (C7), 22.9 (C2). 
ESIMS m/z 320 [(M+Na)+ 100%]. 
HRESIMS calcd. for C14H19O6NNa, (M+Na)
+ 320.1110, found: 320.1098. 
Attempted cyclization of 329 
 
To a solution of 329 (10 mg, 0.034 mmol) in THF (0.6 mL) at 0 ºC was added t-
BuOK (6 mg, 0.051 mmol, 1.5 equiv) and the solution was stirred for 1 h. The 
mixture was then warmed to rt and stirred for 1 h. The mixture was quenched with 
saturated NH4Cl (2 mL) and the aqueous phase was extracted with EtOAc (3 x 5 
mL). The organic extracts were combined, dried over MgSO4, filtered and 
concentrated in vacuo. 1H NMR analysis of the crude mixture indicated that no 
reaction occurred only the unreacted starting material remained in the crude mixture. 
Attempts with n-BuLi (1.5 equiv) in THF ºC (-78 ºC 1 h and to rt 1 h) and LDA (1.5 
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